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Infection of IFNγ receptor knockout (IFNγ R-/-) mice with murine gammaherpesvirus-68 
(MHV-68) results in fibrosis in the lung, spleen, liver and lymph nodes. In the spleen, 
pathology involves an increase in the number of latently infected B cells that corresponds 
with a Th2 biased immune response, in which germinal centres become walled off and 
fibrosis dominates the splenic architecture. Remarkably, the spleen recovers from this 
pathology, and the starting point for this process is a loss of latently infected B cells. The 
aim of this project is to gain further understanding of the control of MHV-68 latent infection 
in the absence of IFNγ response. This project investigates: (1) the mechanisms that result in 
the loss of splenocytes, in particular the reduction of latently infected B cells; (2) the 
dynamics of macrophages in the induction, expression and recovery of fibrosis. 
Several approaches were employed to examine the hypothesis that the massive cell loss in 
IFNγR-/- spleen is caused by apoptosis. However, there was no evidence for excessive 
apoptosis throughout the development of fibrosis. Moreover, RT-PCR analysis showed that 
there was no significant increase in expression of viral genes associated with lytic infection.  
Hence it is unlikely that viral reactivation and subsequent lytic infection occurs. These data 
suggest apoptosis and viral reactivation are not the main mechanisms that cause splenic cell 
loss. Furthermore, B cell subpopulations and cells that express viral ORF73 in IFNγR-/- mice 
were examined using a recombinant virus. The ORF73-expressing cells are mainly germinal 
centre B cells and memory B cells. These two subpopulations undergo a drastic decrease in 
numbers during fibrosis, whereas naïve B cells, which are less susceptible to infection, 
maintain a relatively stable population. Therefore, the significant reduction of latently 
infected B cells appears to be related to the removal of germinal center B cells and memory 
B cells.  
IV 
 
Macrophages induced by Th2 cytokines are considered to be pro-fibrotic, and they are 
reported to have the potential to differentiate into myofibroblasts. In order to determine the 
role played by macrophages in MHV-68 induced fibrosis, transgenic mice with eGFP 
constitutively expressed in macrophages and dendritic cells were used. A different pattern of 
macrophage distribution in IFNγR-/- mice was observed compared to that in wild type mice. 
Moreover, the number of splenic macrophages changed dramatically in the spleen at 
different stages of fibrosis. The possibility that alternatively activated macrophages 
differentiate into myofibroblasts was investigated by co-staining with α-SMA antibody. 
However, no evidence was found that macrophages are one of the origins of myofibroblasts. 
This suggests macrophages may play other roles in regulating fibrosis rather than 
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Chapter 1                                                                                                              Introduction 
1.1 Herpesviruses  
There are more than 130 herpesviruses which can infect a broad range of hosts, from human 
to animals. All herpesviruses share the abilities to (1) encode enzymes related to nucleic acid 
synthesis and metabolism such as viral DNA polymerase and protein processing proteins 
such as protein kinase; (2) synthesise viral DNA and assemble capsids in the nucleus of an 
infected cell; (3) conduct productive replication and produce infective progeny with host cell 
lysis; and (4) establish latent infection in natural hosts (Roizman and Pellett, 2001). The 
virus particles of all herpesviruses vary from 120 to 300 nm in diameter, and contain double-
stranded, linear DNA genomes of which sizes range from about 120 to 250 kilo base pairs. 
The viral genome is packed within an icosahedral protein capsid, forming a core which is 
about 100 nm in diameter and consists of 162 capsomeres. Outside of the capsid lies the 
tegument, which is mainly a proteinaceous matrix, and then the virion is wrapped by a lipid 
bilayer envelope. The envelope is initially formed while the virion particle is budding from 
the host membrane, and contains glycoproteins whose functions include mediating 
attachment to the host cell and viral entry (Roizman and Pellett, 2001; Ackermann, 2004).  
1.1.1 Classification 
Based on the virion morphology and biological characteristics such as cell tropism, 
Herpesviridae was classified into 3 subfamilies: the Alphaherpesvirinae, the 
Betaherpesvirinae and the Gammaherpesvirinae. The development of modern sequencing 
technology refined the classification of subfamilies and has now becomes the main approach 
for viral genetic studies. Therefore recently, herpesviridae has been re-named as new order 
Herpesvirales, which is divided into 3 families: Herpesviridae, Alloherpesviridae, and 
Malacoherpesviridae. The new family Alloherpesviridae includes which viruses that infect 
fish and frogs, while the only invertebrate herpesvirus is assigned to family 
Malacoherpesviridae. Most members of the family of Herpesviridae remain unchanged, 
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incorporating viruses which infect mammals, birds and reptiles. Within Herpesviridae, 3 
new genera have been created. Proboscivirus was added in the Betaherpseviridae subfamily, 
while Macavirus and Percavirus were created within Gammaherpesviridae (Davison et al., 
2009). Despite the newly updated taxonomy of herpesviruses, the classification of the most 
important herpesviruses has not been changed. Therefore this introduction follows the 
traditional classification.  
Alphaherpesviruses have a relatively wide range of hosts, and are characterised by a rapid, 
lytic proliferative infection. Members of this subfamily include herpes simplex virus 1 and 2 
(HSV-1 and HSV-2), which have the ability of establishing latency in neurons, such as 
sensory ganglion (Whitley and Roizman, 2001). While a chicken alphaherpesvirus, Marek’s 
disease virus (MDV), establishes latency in CD4+ T cells (Osterrieder et al., 2006).     
Betaherpesviruses have a narrower range of hosts. This subfamily has the lowest 
reproductive rate among the three, and mainly establishes latency in leukocytes. This 
subfamily includes Human cytomegalovirus (CMV), Human herpesvirus-6 and 7 (HHV-6 
and -7), and Murine cytomegalovirus (MCMV) (Griffiths et al., 2000). 
Gammaherpesviruses undergo productive infection in lymphoid cells, as well as fibroblastic 
cell lines and epithelial cell lines in vitro. Compared with the other two subfamilies, the 
gammaherpesviruses have the strictest host specificity, in which infection is often limited to 
the family or order of the natural host. Generally, latency is established in lymphoid cells 
and macrophages within lymphoid tissue. Traditionally the subfamily is divided into two 
main genera: Lymphocryptovirus (e.g., EBV) and Rhadinovirus (e.g., KSHV and MHV-68) 
(Ackermann, 2006). A detailed introduction of gammaherpesviruses occurs in section 1.2. A 
selection of important members from the herpesvirus family and the diseases in which they 
involved are listed in Table 1.1.
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Table 1.1 Classification of Herpesviruses and related diseases  
Subfamily and genus Name Host Related diseases 
Simplex 
Herpes Simplex virus-
1 (HHV-1/HSV1) and 
Herpes Simplex virus-
2 (HHV-1/HSV2) 
Human Cold sores, keratitis,  
Varicellovirus Varicella-zoster virus (HHV-3/VZV) Human 
Chicken pox in children 






Chicken Marek’s disease (T cell lymphoma) 
Alpha 














Mouse Cyto-megalic inclusion disease 
Beta 
Resolarvirus Human herpes virus-6 (HHV-6) Human 
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1.1.2 Herpesvirus life cycle—Productive infection 
The studies of productive infection of herpesviruses mainly focused on herpes simplex virus 
by describing lytic gene functions. This is because HSV lytic infection can be maintained in 
tissue culture system which allows gene function studies. On the other hand, it is very 
difficult to study lytic infection of EBV and KSHV, for they are mostly latent in tissue 
culture. Considering the virus genes which are involved in viral replication are highly 
conservative, it is very likely that herpesviruses share similar mechanisms of productive 
infection. Moreover, our work is mainly concentrated on latent infection. Therefore, despite 
the fact that every member of the herpesvirus family has its own cell tropism during 
productive infection, we discuss HSV productive infection within a single cell as a 
representative of all herpesviruses as below. The unique mechanisms utilised by important 
gammaherpesviruses are discussed later on.  
1.1.2.1 Attachment and entry 
Glycoproteins (gB, gC, gD, gH and gL) on the envelope layer of the virion facilitate the 
primary attachment of the virus to the cell. In the case of HSV, the initial attachment (Figure 
1.1 ⑴) is mediated by gB and gC binding to cell heparan sulphate proteoglycans (Laquerre 
et al., 1998; Shukla and Spear, 2001). Following first binding, the virus penetrates into host 
cells which involve gB, gD, gH, and gL. Among the four, gD and gH are essential fusion 
proteins (Campadelli-Fiume et al., 2007; Heldwein et al., 2006). gD can bind to a number of 
cellular receptors, including nectin-1 and -2 (members of the immunoglobulin superfamily), 
herpesvirus entry mediator (HVEM, a member of TNF receptor family) and 3-O sulphated 
heparin sulphate (3-O-S HS) (Shukla et al., 1999; Spear, 2004). Binding of gD with cellular 
receptor facilitates and activates the glycoprotein complex of gB, gD, gH, and gL, which 
mediates the virion envelope fusion with cell membrane and nucleocapsid and tegument 
proteins are released into the cytoplasm (Atanasiu et al., 2007). 
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1.1.2.2 Transportation of viral DNA to cell nucleus and viral gene 
expression 
The viral DNA is transported into the nucleus through capsid proteins binding to 
microtubules through the nuclear pore, where it undergoes circularisation. Meanwhile, 
tegument proteins play important roles in shutting off host gene expression by RNA 
degradation (Vhs) (Elgadi et al., 1999) (Figure 1.1 (5c)), or by interacting with host 
transcription pathways to initiate the expression of viral immediate-early genes utilising host 
machinery (VP16) (Campbell and Preston, 1987; Goding and O'Hare, 1989) (Figure 1.1 
(5b)) . Immediate-early proteins are mainly transcription factors, which are necessary for the 
transcription of the second cascade of viral genes expression. The early genes contain those 
required for viral nucleic acid metabolism (e.g., TK gene) and DNA replication (e.g., viral 
DNA polymerase). The late genes can be divided into two groups according to their 
different roles in viral replication, as well as the order of their expression: the early-late 
genes are expressed while viral DNA replication occurs, and their replication is enhanced by 
viral DNA replication. The true late genes are mainly viral structural proteins and their 
expression depends strictly on the on-going viral DNA replication (Figure 1.1 ⒁ to ⒅) 
(reviewed in Taylor et al., 2002). 
1.1.2.3 Viral DNA replication, assembly, and wrapping with envelope 
Herpesvirus DNA replication begins when early genes are expressed. At least 7 gene 
products are necessary for replication, including DNA polymerase, single stranded DNA 
binding protein, origin binding protein, and proteins which form a helicase-primase complex. 
Viral DNA replication is carried out by a rolling circle mechanism. As a result, a concatemer 
which contains several copies of whole viral DNA sequences linked in series is produced 
and later on cleaved into single genomes. The viral genome is then packed into capsid the 
components of which are translated from a subset of late genes (Figure 1.1 ⒅). Newly 
formed nucleocapsid, along with some tegument proteins, then bud from the nuclear 
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membrane from inside into the perinuclear lumen, releasing the nucleocapsid into cytoplasm, 
while the virus leaves this initial envelop in the perinuclear lumen (Figure 1.1 (20 a-c)). The 
nucleocapsid with tegument proteins then are transported into a Golgi compartment (Figure 
1.1 (21)), in which the viral tegument and mature envelope is acquired (Figure 1.1 (22)), and 
the virion is completed for release by exocytosis (Figure 1.1 (23)). Although it is possible to 
interrupt productive infection by raising the temperature or applying chemicals which target 
certain key proteins in viral replication, it is generally believed that the lytic replication of 
most herpesviruses causes cell death (Reviewed by Longnecker and Neipel, 2007).  
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Figure 1.1 Herpes simplex virus type 1 productive infection on a single –cell.  
(Figure resource: Flint et al., Principles of virology, 3rd ed., vol. 1) 
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1.1.3 Latent infection  
Establishment of latent infection is a key feature of herpesviruses which allows the virus to 
evade the host immune system to achieve long-term latency. Latent infection of 
herpesviruses usually has strict specificity on cell type (e.g., HSV establish latency in 
neurons, while gamma herpesviruses preferentially establish latency in lymphocytes), and is 
characterised by the shutting off of most of the viral genes expression which are important in 
lytic infection and activation of latent transcripts. During latent infection, the viral genome 
forms a circular episome and is maintained in the nucleus. Under certain circumstances, the 
latent virus undergoes a productive cycle and the infection becomes lytic, which is called 
reactivation. In the case of HSV, cell stress, tissue damage, and immunosuppression are 
factors which may trigger reactivation from latent infection. HSV only produces latent 
associated transcripts (LATs), which are about 1.5 to 2 kb and located in the repeats flanking 
the UL region of the genome. LATs play important roles in both establishing and 
maintaining latency. The function of these viral-encoded RNAs include down-regulating 
productive-cycle genes expression (Garber et al., 1997) and inhibiting host cell apoptosis 
(Perng et al., 2000). The mechanisms of the switch between lytic and latent transcriptional 
programs are poorly understood. The research on EBV, KSHV, and MHV-68 latency is 
discussed in further detail in sections 1.2 and 1.3 respectively. 
9 
 
Chapter 1                                                                                                              Introduction 
1.2  Important human and veterinary gammaherpesviruses 
The gammaherpesvirus subfamily was first distinguished by cellular tropism for 
lymphocytes. Later, molecular phylogenetic analysis confirmed the close relationship among 
these viruses which is distinct from alpha- and beta-herpesviruses. There are now 4 genera 
within this family: Lymphocryptovirus, Rhadinovirus, and the newly created genera 
Macavirus (e.g., Bovine herpesvirus 6 (BoHV6) and Ovine herpesvirus 2 (OvHV2)) and 
Percavirus (e.g., Equine herpesvirus 2 and 5 (EHV2 and EHV5)). Lymphocryptoviruses are 
represented by the famous Epstein-Barr virus (EBV), which leads to lymphoproliferative 
disorders in immune compromised patients. Rhadinoviruses are represented by Kaposi’s 
sarcoma-associated herpesvirus (KSHV), which causes Kaposi’s sarcoma, primary effusion 
lymphoma, and multicentric Castleman’s disease in immunosuppressed hosts. Although 
EBV and KSHV are the most intensively -studied within the subfamily, as they infect 
humans, there are gammaherpesvirus members which infect cows (e.g., Bovine herpesvirus 
4 (BoHV-4)), horses (e.g., Equid herpesvirus 2 (EHV-2)), and mice (Murid herpesvirus 4 
(MHV-68)). Also, Alcelaphine herpesvirus 1 (AIHV-1) and Ovine herpesvirus-2(OvHV-2), 
which cause no syndromes in their natural hosts, lead to malignant catarrhal fever when they 
infect cattle (Ensser et al., 1997).  
1.2.1 Epstein-Barr virus (EBV) 
As the first virus discovered related to tumourigenesis, EBV was found to be the aetiological 
agent of Burkitt’s lymphoma (Epstein et al., 1964). By analysing antibodies in the peripheral 
blood, it was found that EBV was widespread in the human population. The antibody against 
EBV was found not only in patients with Burkitt’s lymphoma but also in healthy children 
from all over the world (Henle et al., 1969). Furthermore, serological investigations showed 
that more than 90% of adults in the world were seropositive for EBV (Rickinson, 2002). 
These results suggest the infection of EBV is common in the world. Although EBV can 
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infect several cell types, such as T cells and NK cells, B cells and epithelial cells are the 
major infection sites. In vitro, EBV has the ability to immortalise primary B cells in cell 
culture (Henle et al., 1967), and the cell lines carrying the viral genome are lymphoblastoid 
cell lines (LCLs). These cells express limited viral genes and offer an important tool for 
studying EBV latent infection. 
1.2.1.1 EBV genome  
The EBV strain B95-8 genome was the first herpesvirus genome sequenced (Baer et al., 
1984) and this sequence was later completed by adding the 11kb sequence provided by the 
strain Raji (Parker et al., 1990). The size of the EBV genome is about 172 kb and contains at 
least 86 ORFs. A long unique region is separated by 4 major internal repeats (IR1 to IR4) 
and flanked by terminal repeats (TR) at both sides.  
1.2.1.2 Lytic infection of EBV 
Treatment with phorbol ester can induce viral reactivation from latently infected B cell lines, 
which is the common approach to study lytic infection of EBV. EBV gp350/220 is a 
homologue of gC in HSV, which has a similar function in facilitating first attachment. It 
binds to complement receptor 2 (CR2) on the B cell surface (Prota et al., 2002). 
Glycoproteins gB, gH, gL, and gp42 are required for viral fusion (Molesworth et al., 2000). 
Gp42 can bind HLA class II efficiently (Spriggs et al., 1996) and it is also associated with 
gHgL, forming a three-part complex, which is considered to initiate the B cell fusion (Hutt-
Fletcher, 2007). 
1.2.1.3 Latent infection of EBV 
During EBV latency the viral gene expression is highly restricted, and there are different 
patterns of EBV latent gene expression in different states of B cells (e.g., proliferating and 
non-proliferating, healthy or malignant B cells). There are now mainly 4 types of latency 
which have been defined in lymphomas and LCLs: Latency I, II, III, and 0, based on the 
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expression of EBNAs and LMPs. These are also called latency programmes, respectively: 
‘EBNA 1-only’, default programme, growth program, and latency program. 
The demonstration that EBV transformed B cells into LCLs is crucial not only because it 
directly links EBV infection to Burkitt’s lymphoma, but also because it provides a tool to 
study viral gene expression, especially the essential genes required in immortalised B cells. 
The viral proteins expressed in LCLs include 6 Epstein-Barr nuclear antigens (EBNA1, 
EBNA2, EBNA3A, EBNA3B, EBNA3C, EBNA-LP) and 3 membrane proteins, latency-
associated membrane proteins 1, 2A, 2B (LMP1, -2A, -2B) (Rowe et al., 1992). This pattern 
is termed type III. By expressing these products, the virus can drive resting B cells which 
appear to be ‘activated’ and undergo proliferation and differentiation. It is most likely a 
virus strategy which exploits host B cell germinal centre proliferation in order to enlarge the 
pool of latent infected cells (Reviewed in Barton et al., 2011). It was surprising when EBV 
gene expression was found to be very much different in B cells from most of the cases of 
Burkitt’s lymphoma: only EBNA1 is expressed in Burkitt’s lymphoma cells, while other 
genes are perfectly silenced. It was called latency I since only EBNA1 is expressed (Rowe et 
al., 1986; Masucci et al., 1987). Latency II was found first in undifferentiated 
nasopharyngeal carcinoma (NPC) (Young et al., 1988; Fahraeus et al., 1988), and later in 
Hodgkin’s lymphoma (Niedobitek et al., 1991; Pallesen et al., 1991) and NK/T cell 
lymphomas (Chiang et al., 1996). This type of latency is like an intermediate state between 
latency III and latency I: along with EBNA1, transcripts of LMPs are expressed, while other 
EBNAs are not expressed. However, the level of each gene expression differs among B cells 
from different origins. The role of EBNA1 is to maintain and help replication of the latent 
viral episome during cell replication. Therefore, it is essential for the survival of the latent 
virus. However, in B cells which are not dividing (memory B cells in periphery circulation), 
EBNA1 is not required, as there is no viral antigen expressed (latency 0). This state of 
latency may refer to long-term latency in immune competent hosts (Rowe et al., 2009).   
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Different transcriptional programs are the basis of latency states, and accumulating evidence 
suggests that the ‘switch’ among latency types is programmed and coordinates with host B 
cell proliferation and differentiation. EBNAs’ expression in Latency I is driven by promoter 
Qp (Schaefer et al., 1995), while latency III is driven by promoter Wp/Cp (Woisetschlaeger 
et al., 1990). Studies of the viral transcripts in a subset of Burkitt’s lymphoma cells infected 
with EBV that lacking EBNA2 suggest that the expression of EBNA2 is essential for the 
expression of LMPs in latency III (Wang et al., 1990). However, only EBNA1 and LMPs 
are expressed in Latency II, which means the expression of LMPs is independent of EBNA2 
in this type of latency (Johannsen et al., 1995). EBNA2 is the transcription activator which 
activates promoters Wp and Cp (promoter next to Wp) and it controls expression of Latency 
III transcripts (Tempera and Lieberman, 2010). It has also been shown to interact with 
cellular factors so that it can regulate the Notch pathway. However, the role of this 
regulation in the latent infection is not yet clear (Reviewed in Barton et al., 2011). Among 
LMPs, LMP1 is able to transform mouse fibroblast on its own, while it can only transform 
human B cells with the help of EBNAs. LMP1 belongs to TNF receptor superfamily and 
may possibly mimic the reactivated state of the CD40 receptor which is expressed on B cells 
facilitating the interaction with T cells during B cell differentiation from germinal centre B 
cells to either memory B cells or plasma cells (Reviewed in Barton et al., 2011). The control 
of latent types’ transcription, especially the mechanisms of how EBV switches between Qp 
and Cp, is under intensive investigation and still not clear. 
As discussed above, EBNA1 is the only viral protein expressed during latency I, which 
suggests it is the only viral protein required for viral episome replication in dividing memory 
B cells. Moreover, it is the EBV homologue of MHV-68 ORF73 (mLANA), so here we pay 
special attention to the introduction of EBNA1 in latent infection. EBNA is expressed in all 
latency types but latency type 0. EBNA1 binds to OriP at both functional elements FR and 
DS of the plasmid-like viral latent genome. The binding with dyad symmetry (DS) is 
13 
 
Chapter 1                                                                                                              Introduction 
important for viral DNA replication in a way similar to SV40 DNA replication using the 
host cell machinery (Gahn and Schildkraut, 1989; Yates et al., 1984). On the other hand, 
binding with family of repeats (FR) is important in mitotic segregation of EBV epitome 
during host cell division. There is evidence showing that EBNA1 tethers the EBV episome 
with chromosomes in mitosis, in which the interaction between EBNA1 and human cellular 
protein EBP2 maintains the attachment of EBNA1 with chromosomes in the mid and late 
stage of mitosis (Kapoor and Frappier, 2003, 2005; Nayyar et al., 2009; Shire et al., 1999; 
Wu et al., 2000). This mechanism is so sophisticated that the replication happens only once 
every cell cycle, and eventually the viral genomes are segregated evenly; therefore there is 
no net increase in either of the daughter cells after mitosis. Also, EBNA1 can enhance Cp 
transcription in type III latency by up-regulating EBNA2 expression, so that it controls the 
initiation of the Cp transcription and LMPs expression in latency III (Altmann et al., 2006; 
Gahn and Sugden, 1995), EBNA1 can also self-limit its expression in order to evade from 
host immune recognition (Yin et al., 2003).  
1.2.1.4 EBV associated diseases 
In the majority of cases, the first exposure to EBV occurs in childhood and is followed by a 
symptom-free viral latency throughout the whole lifetime. The spread of EBV might be 
through saliva. If the first exposure occurs in adulthood, the infection lead to a syndrome 
termed infectious mononucleosis (IM). IM was first reported in a scientist who was studying 
EBV. The clinical signs of IM, such as fever and sore throat, can last for weeks (Henle et al., 
1968). The infection induces B cells to undergo proliferation, which consequently activates 
the CD8 T cells. These cytotoxic CD8 T cells which specifically target infected B cells, 
undergo significant proliferation. Therefore, the lymph cell proliferation in lymph organs 
which is induced by EBV infection causes swelling of glands, splenomegaly, and tonsillitis, 
and mononucleosis in peripheral blood.   
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EBV is famous for its association with many tumourigeneic diseases, such as Burkitt’s 
lymphoma in African children, Hodgkin’s lymphoma, nasopharyngeal carcinoma, and post- 
transplantation lympho-proliferative disorder (Tanner and Alfieri, 2001). Burkitt’s 
lymphoma (BL) is endemic in equatorial Africa, and may develop in the jaw, ovary, 
mammary gland, liver, intestine, and kidney. BL is either composed of rapidly proliferating 
small B cells or germinal centre B cells. In other areas, BL occurrence is less related with 
EBV; for example, EBV is only present in 20% of BL patients in Europe and North America.  
1.2.2 Kaposi’s sarcoma-associated herpes virus  
Kaposi’s sarcoma (KS) was first described by Miriz Kaposi in 1872 and was not noticed 
until the 1980s, when a dramatic increase of KS in AIDS patients was observed following 
the outbreak of HIV infection. As a pathogen of KS, KSHV was first identified by Chang in 
1994 (Chang et al., 1994). Despite the fact that KSHV was discovered 30 years later than 
EBV, the discovery and association with human diseases for both of them is very similar. 
Like EBV, transmission of KSHV requires intimate contact, through saliva, for example 
(Martro et al., 2004). Also, infection with KSHV in immune competent individuals shows 
no symptoms, while primary infection with KSHV in children can cause a skin rash. 
However, in contrast to the wide prevalence of EBV, serological studies show that the 
percentage of KSHV positive persons in the human population is highly variable. For 
example, in 1996, the infection rate was over 50% in Africa, whereas it was 1 to 6% in 
northern Europe and the USA (Gao et al., 1996; Kedes et al., 1996; Simpson et al., 1996). 
Due to the difficulties in detecting viral DNA in KSHV carriers, who show no symptoms, 
the site of KSHV latency in healthy humans is poorly understood at this time.   
1.2.2.1 KSHV genome  
The size of the KSHV genome varies from 165 to 170Kbp depending on the strains (Neipel 
et al., 1998; Renne et al., 1996b), and it shares a common structure with other 
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Rhadinoviruses in that the linear double stranded DNA has a long unique region of low GC 
DNA flanked by multi-repetitive high GC terminal repeats (Bornkamm et al., 1976; Russo et 
al., 1996). This feature leads to the tendency of the viral genome to break apart when it is 
isolated by density centrifugation (Roizman et al., 1981). Referring to this feature of the 
genome, the genera’s name comes from the Greek word ‘rhadino’, which means fragile. For 
different strains, the number of terminal repeats varies but their function remains. The long 
unique region of the KSHV genome contains at least 89 ORFs, of which 62 have 
homologues or encode proteins which have similar functions in other herpesviruses. These 
homologue genes are primarily limited to genes required for cleavage and packaging of the 
viral DNA and infection of susceptible host cells, for example, those which encode enzymes 
involved in DNA replication, regular gene expression, and glycoproteins (Longnecker and 
Neipel, 2007). Apart from the conserved genes, ORFs which are unique to KSHV are named 
from K1 to K15.  
1.2.2.2 Lytic infection of KSHV 
In vitro, the lytic cycle can be induced using chemical treatment such as TPA on latently 
infected cells. Strictly speaking, it is a model of lytic replication following reactivation. The 
key feature of the lytic lifecycle is the production of linearised viral DNA. As found in lytic 
infection of other herpesviruses, three classes of viral genes (immediate-early, early, and late) 
are expressed in strict order. In KSHV, the master controller for initiating lytic replication is 
Rta, which is encoded by ORF50. Rta activates viral promoters for lytic gene expression by 
direct binding or interaction with cellular gene RBPJk. The mechanism of productive 
infection of KSHV is very similar to other herpes family members.   
1.2.2.3 Latent infection of KSHV 
Using B cell lines derived from primary effusion lymphoma (PEL) and epithelial cells, the 
latent gene expression of KSHV has been intensively studied, as has the role of latency-
associated KSHV antigens and non-coding RNAs (Wen and Damania, 2010). Latent-
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associated genes are mainly located in the same region, such as latent-associated nuclear 
antigen (LANA), cyclin D homolog (v-cyclin), and FLICE inhibitory protein homologue (v-
FLIP). Here we mainly introduce LANA, which is the homologue of the viral protein 
encoded by MHV-68 ORF73 (mLANA) and has a function very similar to that of EBNA1 of 
EBV, followed by a short introduction of other important viral genes. 
The function of LANA in maintaining the latent genome is similar to EBNA1; it tethers the 
episome onto the host chromosome while the host cell undergoes mitosis. It binds the TR 
region of the KSHV genome with its C terminus while binding host nucleosomes with its N 
terminus (Schwam et al., 2000). Moreover, LANA is essential in latent viral genome 
replication like EBNA1 in EBV latency. Besides, LANA also has multiple functions in 
regulating both viral activity and host cell status. Apart from maintaining the viral genome 
during mitosis, LANA is a main controller of the viral life cycle by inhibiting Rta function. 
It inhibits Rta expression both by direct binding to the Rta protein and by down-regulating 
the activity of the Rta promoter, therefore inhibiting reactivation so that the latency can be 
maintained (Lan et al., 2004). Overexpression of Rta leads to a significant up-regulation of 
the mRNA transcripts of LANA, which suggest LANA expression may change as a response 
to viral reactivation (Nakamura et al., 2003). Transient transfection experiments show that 
Rta elevates LANA expression by interacting with the LANA promoter (Lan et al., 2005). 
Therefore, LANA, along with Rta, may act as a switch between the two important viral 
lifestyles: latency and productive infection (Verma et al., 2007). Similar mechanisms were 
also found in HVS (Schafer et al., 2003) and MHV-68 (Hair et al., 2007). Moreover, LANA 
regulates many cellular factors and pathways whose functions involve the cell cycle, namely 
proliferation (e.g., inhibits functions of p53, GSK-3β, and β-catenin) and differentiation (e.g. 
induces expression of Id proteins), host immunity (e.g., binds to IFN-induced protein 
MNDA), tumour suppression, and apoptosis (Verma et al., 2007). Cellular protein p53 
functions as a tumour suppressor by suppressing cell proliferation and initiating apoptosis 
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(Levine, 1997). LANA has been shown to interact with p53 and inhibit its functions, as well 
as to down-regulate the level of p53 expression (Friborg et al., 1999). Later studies suggest a 
repressive function of LANA on p53 which promotes the stability of the host chromosome 
and facilitates the formation of KSHV-associated tumours (Si and Robertson, 2006).   
Besides LANA, important viral genes encoded by KSHV also include v-FLIP, an anti-
apoptotic protein which inhibits Fas-mediated apoptosis. LANA2, also known as v-IRF3, is 
a member of the interferon regulatory factor family which modulates host immunity. In 
addition, this part of the KSHV genome also encodes 12 pre-micro RNAs and subsequently 
generates 18 miRNAs. Moreover, at the left end of the genome, a membrane protein K1 is 
encoded, which is a constitutively signalling B cell receptor and may shares as similar 
function with LMP2a of EBV. Ten of 12 miRNAs are located in the non-coding region 
between K12 and K13 ORFs, and the other 2 are located within ORF K12 (Cai et al., 2005; 
Pearce et al., 2005; Pfeffer et al., 2005; Samols et al., 2005). All of the KSHV miRNAs are 
expressed during latency (Cai and Cullen, 2006; Murphy et al., 2008; Pearce et al., 2005; 
Samols et al., 2007) and a subset of them are expressed in lytic cycle as well (Wen and 
Damania, 2010).  
1.2.2.4 KSHV associated diseases 
Kaposi’s sarcoma is a highly vascular tumour, which is characterised by spindle shaped, 
poorly differentiated but rapidly proliferating cells with endothelial lymphatic origin (Wang 
et al., 2004; Beckstead et al., 1985; Dupin et al., 1999). Histologically, KS also shows 
extravasation of red blood cells, along with inflammatory infiltration and neo-angiogenesis 
(Gessain and Duprez, 2005). KSHV was found in more than 95% of KS lesions. Clinically, 
there are 4 types of KS: classic KS, African endemic KS, epidemic (AIDS-associated) KS, 
and post-transplant KS. The classic Kaposi’s sarcoma predominantly occurs in elderly male 
patients who are HIV-negative in Mediterranean countries. It is characterised by multiple 
reddish-brown patches on the lower extremities. Cases of endemic KS are mostly found in 
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HIV-negative patients in Africa, and show different clinical signs to classic KS: they can 
either present as a benign nodular cutaneous disease in young individuals, or as a fatal 
aggressive localised cutaneous disease affecting connective tissue and bone. In addition, 
there are other clinical types of African endemic KS, as mucocutaneous and visceral disease 
in adults, or lymphadenopathic disease in children. In AIDS patients, KS arises more quickly 
and presents as multifocal and symmetrical. Although advanced therapies have been 
developed and the mortality and incidence of AIDS-associated KS has significantly dropped 
(Eltom et al., 2002; Tam et al., 2002), KS remains the most common tumour associated with 
HIV- infection (Casper and Wald, 2007). In immune suppressed cases such as patients who 
have had organ transplantation, the infection may trigger bone marrow failure, splenomegaly, 
and fever (Luppi et al., 2002). Moreover, KSHV may be transmitted during organ 
transplantation from the donor, which causes KS to break out in the organ recipient (Barozzi 
et al., 2003; Marcelin et al., 2004).   
KSHV also causes other types of tumour: primary effusion lymphoma (PEL) and 
multicentric Castleman’s disease (MCD). PEL was initially called body cavity based 
lymphoma (BCBL) and was first reported by Chang and Moore as a rare B cell lymphoma in 
AIDS patients (Cesarman et al., 1995b). PEL is different from KS in many different ways. 
The cell origin of PEL is clonally expanding malignant B cells and the tumours are usually 
effusive and occur in body cavities. However, PEL is also reported to present as a solid mass 
in lymph nodes (Arvanitakis et al., 1996). Cells in PEL are mainly red blood cells and 
tumour cells which are morphologically larger than normal lymphocytes, and they express 
CD45, activation-associated antigens, clonal immunoglobulin rearrangements, but not B cell 
associated antigens (Nador et al., 1996). The progression of PEL is quicker and more 
aggressive than KS, and most patients die within 6 months. PELs can be KSHV positive 
only, or positive for both KSHV and HIV, in which the KSHV viral genome copy number 
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can be 50 to 150 copies per cell (Renne et al., 1996a; Cesarman et al., 1995a; Staudt et al., 
2004).  
Multicentric Castleman’s disease (MCD) is a lympho-proliferative disorder symptoms of 
which include lymphadenopathy, fever, and infiltration in the spleen (Castleman et al., 1956). 
However there is another type of MCD, the hyaline variant, which is not associated with 
KSHV. MCD is more a rare polyclonal lympho-proliferative disease rather than a cancer 
(Dupin et al., 2000). Histological study shows there are germinal centre reactions and 
vascular endothelial proliferation within the lymph node where MCD occurs. A key factor in 
triggering this disorder is thought to be KSHV encoded v-IL-6 and inflammation. (Soulier et 
al., 1995).  
1.2.3 Gammaherpesviruses of veterinary importance 
Apart from EBV and KSHV which infect humans, there are important gamma-herpesviruses 
infecting animals, especially livestock. In this section we introduce gammaherpesviruses of 
veterinary importance. 
1.2.3.1 Alcelaphine herpesvirus 1 (AIHV-1) and Ovine herpesvirus-2(OvHV-2) 
Malignant catarrhal fever (MCF) mainly occurs in cattle, deer, other ruminants, and 
occasionally pigs. It is a fatal disease which is caused by either Alcelaphine herpesvirus 1 
(AIHV-1) or Ovine herpesvirus-2 (OvHV-2). However, some cases of animals with mild 
symptoms and chronic infection are reported. Although there have been reports of outbreaks 
in a large population of animals within a herd, this disease is generally sporadic. The clinical 
signs include fluctuating fever, nasal discharge, corneal ulceration, and lymphadenopathy. 
MCF is characterised by enlarged lymph organs, infiltration of CD8+ T cells in multiple 
organs, and vasculitis. These pathological changes occur with or without detection of viral 
replication (Coulter et al., 2001). Small animal models for studying AIHV-1 and OvHV-2 
infection have been reported. Since lab mice are not infected by neither of the viruses, 
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experimental infection has been established in hamsters (both), rats (AIHV-1), guinea pigs 
(AIHV-1), and rabbits (OvHV-2) (Buxton et al., 1988; Jacoby et al., 1988a; Jacoby et al., 
1988b). Although causing the same disease, the two viruses show different features in cell 
culture: OvHV-2 mainly establishes latent infection in bovine T cell lines, while AIHV-1 
can grow in tissue culture (Rosbottom, 2003)  
1.2.3.2 Equid herpesvirus 2(EHV-2)  
Equid herpesvirus 2 (EHV-2) and Equid herpesvirus 5 (EHV-5) were originally classified as 
betaherpesviruses; however, they were later re-classified as gammaherpesviruses based on 
results of sequencing analysis (Telford et al., 1995). Epidemiological study shows that EHV-
2 infection is ubiquitous. A study in horses in Sweden shows 56 to 68% of the horse 
population tested positive, whereas 71% of horses tested in England were infected. The 
infection sites include respiratory mucosa, conjunctiva, and WBC of normal horses of all 
ages. It is believed to be associated with immunosuppression diseases; however, the 
pathogenesis and clinical significance is obscure. 
1.2.3.3 Bovine herpesvirus 4 (BoHV-4) 
BoHV-4 infection is wide-spread. The virus can be isolated both from cattle with clinical 
diseases as well as healthy cattle. Potential clinical diseases associated with BoHV-4 include 
respiratory and ocular disease, abortion, metritis, pneumonia, diarrhea, and mammary 
pustular dermatitis. In vitro, BoHV-4 is capable of infecting many cell lines such as B cells, 
T cells, macrophages, endothelial cells and mammary gland cells (Ackermann, 2006). 
1.2.4 Animal model for gammaherpesvirus infection 
It is very difficult to study the nature of viral pathogenesis especially primary productive 
infection due to lack of subjects as the primary infection with both EBV and KSHV is 
asymptomatic. Moreover, an in vivo system which would allow clinical trials for potential 
therapies and vaccinations is also required. Therefore, for decades there have been attempts 
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to establish suitable animal models for viral infection. In the case of EBV, the first idea was 
to infect primates. EBV was able to establish B cell proliferative disorder in New World 
primates, cotton-top tamarins, and this animal model supported studies on 
lymphoproliferative disorder and potential vaccines (Epstein et al., 1985). However, so 
many symptoms developed in cotton-top tamarins which were obviously different from 
those in humans that this model cannot reflect the lytic infection of EBV. The common 
marmoset inoculated with EBV shows an IM-like syndrome (Wedderburn et al., 1984), but 
shows no signs of B cell proliferative disorder (Emini et al., 1986). Moreover, the expression 
of EBNA1 in the common marmoset is shown to be aborted in late time points (Farrell et al., 
1997). Therefore this animal model is not successful either. On the other hand, inoculation 
shows that EBV fails to infect Old World primates (Moghaddam et al., 1998; Wang et al., 
2001).  
In the case of KSHV, several rhadinoviruses which are closely related to KSHV have been 
found in primates. Therefore the infection of these viruses in primates became potential 
animal models. For example, herpesvirus saimiri (HVS) isolated from the squirrel monkey 
(Saimiri sciureus) is asymptomatic when infecting natural hosts, while it causes T cell 
lymphoma in New World primates. HVS was made popular as a model for 
gammaherpesviruses oncogenesis, for it consistently produces T lymphoma and is easy to 
grow in vitro. Homologues of KSHV and EBV have been found in HVS, which is involved 
in transforming and proliferating tumour cells, as well as viral latency (Damania, 2004). 
Although several animal models have been established in primates, small animal models 
such as rodents are increasingly used because of the privileges they offer: relatively low cost, 
easy to generate transgenic strains, and easy to keep. Murine models were established for 
both EBV and KSHV infection, not in normal mice, but in immune deficient mice. EBV-
positive B cell lymophoproliferative disease was developed in severe combined 
immunodeficiency (SCID) mice injected with peripheral blood mononuclear cells (PBMC) 
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from EBV positive humans (Johannessen and Crawford, 1999). In the case of KSHV, 
following implantation of infected human tissue, primary lytic infection and latency in B 
cells were established in SCID mice (Dittmer et al., 1999). However, It seems none of the 
murine models inoculated using human tissue or cells is good enough to reflect the 
pathogenesis of gammaherpesvirus and viral/host interaction. Instead of inoculating mice 
with EBV or KSHV infected human tissue, murine viruses are also used to develop a mouse 
model for gammaherpesvirus infection. MHV-68 (murine gammaherpesvirus-68, murid 
herpesvirus 4) infection of laboratory mice has provided a widely used small animal model 
for gammaherpesvirus pathogeneses and host immune response. In the next sections we 
introduce this virus in detail and review the knowledge gained from this valuable small 




Chapter 1                                                                                                              Introduction 
1.3 Murine gammaherpesvirus-68 (MHV-68) 
Murine gammaherpesvirus 68 (MHV-68) was initially isolated from the bank vole in 1980 
(Blaskovic et al., 1980). Genetically, MHV-68 is relatively close to KSHV and EBV (Nash 
et al., 2001; Virgin et al., 1997). MHV-68 latent infection shows multiple cell tropisms in 
mice, including B cells, macrophages, dendritic cells, and lung epithelial cells, which is also 
found in human gammaherpesviruses (Flano et al., 2000; Stewart et al., 1998). The MHV-68 
infection causes an infectious mononucleosis-like syndrome and establishes life-long viral 
persistency, which are analogous to features of EBV infection (Reviewed in Doherty et al., 
1997; Simas and Efstathiou, 1998). Moreover, MHV-68 is easily grown in many tissue 
culture systems, and with its known genome sequence and structure it is relatively easy to 
make a mutant virus. MHV-68 not only shows remarkable similarities with EBV and KSHV 
in in vivo infection, but also has features which benefit in vitro study and genome 
manipulation. Hence, with MHV-68, a small animal model of gammaherpesviruses has been 
established to reveal the mechanism of infection.   
1.3.1 Structure and genome 
MHV-68 shares general characterisation of rhadinoviruses in genome structure: it has a 
unique region of 118.2 kbp flanked by a variable number of 1.23 kbp repeat units at both 
ends (Efstathiou et al., 1990a; Efstathiou et al., 1990b). In the same work of Efstathiou et al., 
MHV-68 was reclassified as a gammaherpesvirus based on sequence analysis on 9 genes 
which had high homology within EBV. Two independent groups have published the 
complete genome of MHV-68; their results are similar except for a few differences (Nash et 
al., 2001; Virgin et al., 1997). The unique region of MHV-68 is largely collinear with KSHV 
and HVS, which contains 73 open reading frames, along with 8 viral tRNA-like molecules 
and 15 microRNAs (Bowden et al., 1997; Pfeffer et al., 2005; Virgin et al., 1997; Zhu et al., 
2010). The organisation of gammaherpesviruses genomes, the conserved genes shared 
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among them, and the unique genes for each member are illustrated in Figure 1.2. Most of the 
genes which relate to viral DNA replication and virion structure are conserved between 
MHV-68 and other gammaherpesviruses. Rhadinoviruses also share some genes which are 
important for latent infection, such as LANA, v-Cyclin, and vGPCR. Transposon 
mutagenesis shows that the unique genes of MHV-68 compared to KSHV are not required in 
lytic infection but are related to latent infection (Moorman et al., 2004; Song et al., 2005). 
Important MHV-68 genes which are associated with latent infection are introduced in detail 








Figure 1.2 Genome map of important gammaherpesviruses showing their conserved and 
unique genes (Figure source: Barton et al., 2011). Genes present in all gammaherpesviruses 
are shown at the top. In addition, viral genes which either are essential or play an important 
role in MHV-68 replication in permissive fibroblasts in tissue culture are indicated 
(Moorman et al., 2004; Song et al., 2005).  
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1.3.2 In vitro infection of MHV-68 
In vitro, MHV-68 is able to infect and replicate in many epithelial and fibroblast cell lines 
(Svobodova et al., 1982). However, persistent infection is established only in 
limitedlymphoid cell lines. Unlike KSHV, MHV-68 seems not to infect T cells and the 
existing cell lines are restricted B cell lines. NS0 cell line is derived from mouse myeloma B 
cells (Sunil-Chandra et al., 1993). The infection of NS0 is persistent; namely, there are both 
latent and lytic infections. The virus is mainly maintained as latent, while 5% of infected 
cells are under reactivation. The first B cell line of MHV-68, S11, is derived from B cell 
lymphoma developed in MHV-68 infected mice (Usherwood et al., 1996b). Both linear and 
episomal forms of viral genome were found in the S11 cell line, and an inoculation to nude 
mice led to tumour development (Usherwood et al., 1996b). The feature of the S11 cell line 
suggests it is more analogous to Burkitt’s lymphoma cells in the case of EBV rather than 
LCLs. However, attempts to establish KSHV and MHV-68 transformed B cell lines were 
unsuccessful (Dutia et al., 1999; Jarousse et al., 2008). Recently, Liang et al. found that 
MHV-68 is able to infect murine foetal liver progenitor B cells, which results in 
immortalisation and differentiation into B plasmablasts (Liang et al., 2011), which may 
indicate a similarity to KSHV.  
1.3.3 Viral Gene expression in pathogenesis 
1.3.3.1 Genes expressed in productive infection in vitro 
Ebrahimi et al. have profiled the viral RNA expression in the 3 stages of productive 
infection using oligonucleotide-based microarray (Ebrahimi et al., 2003). In this study, viral 
genes which expressed despite the cycloheximide treatment which inhibits cell de novo 
protein synthesis are defined as immediate early genes. This class of genes include: M4, K3, 
ORF38 (tegument-associated membrane protein), ORF50 (Rta), ORF57 and ORF73 
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(mLANA). Early genes were defined as those are sensitive to protein synthesis inhibitor, but 
expressed despite the treatment of DNA polymerase inhibitor, phosphoroacetic acid, which 
include: ORF24, ORF29a, ORF36, ORF54, ORF63, ORF64, ORF68, ORF75b and M12. 
Following the early genes, early-late, and late genes are detected around 12 hours post 
infection, which are mainly structural proteins ORF19 (tegument protein), ORF65 (capsid 
protein) and ORF66 (capsid protein).   
Recently, signature- tagged transposon mutagenesis has identified the genes which are 
essential for lytic infection, along with a number of dispensable genes which can 
significantly enhance the viral replication (Moorman et al., 2004; Song et al., 2005). At 
present, 41 genes have been identified as essential for MHV-68 replication, of which 17 
genes are highly conservative among all herpesviruses.  
Within the stage of early-late gene expression, some cellular homologues are expressed, 
such as a Bcl-2 homologue (M11) (Wang et al., 1999), a cyclin D homologue (ORF72) (van 
Dyk et al., 1999), and a G-protein coupled receptor (ORF74) (Wakeling et al., 2001). There 
are generally two routes for viral transmission from one cell to another, the newly formed 
virion either entering extracellular space and attaching to and entering another cell, or 
transmitting to an adjacent cell through a cell-to-cell route. Two glycoproteins are related to 
these routes respectively. Glycoprotein 150 is encoded by the M7 gene, which is required for 
virion egress into extracellular space (de Lima et al., 2004; Stewart et al., 2004). In contrast, 
gp48 is encoded by the ORF27 gene which is localised at the plasma membrane to assist the 
virion’s egress into the adjacent cell (May et al., 2005b). This process also requires a gene 
product encoded by ORF58 (May et al., 2005a).   
1.3.3.2 Genes associated to latent infection 
Unlike the conservation found in lytic genes among herpesviruses, the viral genes which are 
employed in latent infection are surprisingly different. Lymphocrytoviruses and 
rhadinoviruses have very few homologues of latent genes, and even among rhadinoviruses 
28 
 
Chapter 1                                                                                                              Introduction 
there are still great differences of gene expression in latent infection. Generally, MHV-68 
genes which are associated with latent infection include M1 to M4, vBcl-2 (M11), K3 
(ORF12), v-Cyclin (ORF72), mLANA (ORF73), and vGPCR (ORF74). Among them, M1 to 
M4 are unique to MHV-68; vBcl-2 shares similar functions with some proteins expressed by 
other gammaherpesviruses; and K3, v-Cyclin (ORF72), mLANA, and vGPCR are shared by 
all rhadinoviruses. A bacterial artificial chromosome which contains the MHV-68 genome 
has provided a great tool to manipulate the viral genome (Adler et al., 2000). The role of a 
latent gene is mainly investigated by generating a recombinant virus which lacks a specific 
gene product. MHV-76 is a natural deletion mutant of MHV-68, which lacks the unique 
region at the left end of the genome. Studies with MHV-76 indicated an important role of 
the genes encoded by the unique genome in MHV-68 latent infections (Dutia et al., 2004; 
Macrae et al., 2001). Furthermore, it was used to generate ‘knock in’ mutants with specific 
genes in order to study their functions (Townsley et al., 2004). There are 4 genes located at 
the left end of the genome which are unique to MHV-68: M1 to M4. M1, M3, and M4 are 
secreted proteins, whereas M2 is expressed specifically in B cells. At present, the functions 
of M1 to M3 have been intensively studied, whereas that of M4 remains unclear.  
M1 
Disruption of M1 expression does not affect the establishment of latency, whereas an 
enhanced reactivation was observed in an M1-null virus compared to the wild type (WT) 
virus (Clambey et al., 2000). Interestingly, the virus lacking M1 expression was shown to be 
less virulent in IFNγR-/- mice: it does not induce fibrosis in the lung and spleen in IFNγR-/- 
mice (Evans et al., 2008). M1 is also essential to raise an expansion of Vβ4 CD8+ T cells in 
peripheral blood around 3 to 4 weeks post infection (p.i.), and this population of T cells is 
not strictly viral-antigen specific and expresses IFNγ and IL-2. IFNγ and IL-2 can suppress 
viral reactivation from latency; therefore this observation explains the hyper-reactivation 
observed in the absence of M1 (Evans et al., 2008). One possibility is that M1 drives Vβ4 
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CD8+ T cells’ expansion as a superantigen (Evans et al., 2008). However, the mechanism 
underlying this is still unclear. Similar superantigen activations have been observed in EBV 
and HVS, but with obvious differences. EBV can induce the expression of a human 
endogenous retroviral super antigen –HERV-K18 in the host cell (Sutkowski et al., 2001), 
whereas the HVS superantigen is encoded by viral ORF14 which binds to MHC class II 
directly (Yao et al., 1996).   
M2 
The role of M2 was first studied by transcription profile of latent genes in an MHV-68 
infected S11 B cell line (Husain et al., 1999). M2 plays a critical role in both latency 
establishment and reactivation from latency. Deletion of M2 did not affect viral replication. 
However, it shows dose- dependent defect in establishing latency on day 16 p.i. and a 
profound deficiency in reactivation (Jacoby et al., 2002; Macrae et al., 2003). In the spleen, 
the M2 deficient virus showed no differences from the WT virus in inducing splenomegaly 
and occurrence of IM-like syndrome. However, it failed to increase the latent viral load 
during the acute latent infection (Macrae et al., 2003). In addition, M2 was shown to be 
essential for latently infected germinal centre B cells to transit to memory B cells. This 
indicates M2 is involved in manipulating B cell differentiation to establish latency in long-
lived memory B cells (Simas et al., 2004; Herskowitz et al., 2005). The molecular basis of 
this function of M2 is unknown; some studies have addressed its binding ability, suggesting 
that it may function as a molecular scaffold which modulates specific signal transduction 
pathways (Herskowitz et al., 2008; Pires de Miranda et al., 2008). Liang et al. has 
demonstrated that M2 may also suppress STAT-1 and STAT-2 in a cell-type dependent 
manner, therefore inhibiting IFN response, including apoptosis (Liang et al., 2004).   
Moreover, M2 was shown to induce IL-10 expression both in vitro and in vivo. The elevated 
IL-10 was predicted to inhibit the host’s immunity. Indeed, a CTL response against MHV-
68 was enhanced in the absence of M2. In addition, M2 suppressed the expression of MHC 
30 
 
Chapter 1                                                                                                              Introduction 
II, b220, and IgD in B cells, while germinal centre B cell markers and IgG expression were 
up-regulated. These results indicate that M2 drives B cell differentiation (Siegel et al., 2008). 
Recent studies show that the fluorophore-labeled M2-null virus is observed in germinal 
centre B cells, but is completely absent from the plasma cells. Moreover, viral reactivation is 
associated with plasma cell differentiation, thus explaining the essential role of M2 
facilitating viral reactivation (Liang et al., 2009). 
M3 
M3 is highly secreted in both lytic and latent infection and is a broad-spectrum chemokine 
binding protein encoded by MHV-68 (Simas et al., 1999; van Berkel et al., 1999). All 
classes of chemokines (CC, CXC, C, and CX3X) can bind to M3, although the binding with 
CXC chemokine is quite limited (Parry et al., 2000; van Berkel et al., 2000). Disruption of 
the M3 gene by inserting a β-galactosidase expression cassette did not affect the lytic 
replication in the lung or the initial spread to lymph organs. However, it caused a significant 
defect in the establishment of latency in the spleen (Bridgeman et al., 2001). Another study 
using the M3-stop virus which has an insertion of a translational stop and a frameshift 
mutation, showed normal establishment and reactivation in the spleen, while the mutant 
virus showed 100-fold less virulence than the rescued virus after intracerebral inoculation 
(van Berkel et al., 2002). In the same study, the M3 expressing virus induced meningeal 
infiltration of neutrophils, whereas the M3-stop virus induced inflammatory infiltration was 
mainly composed of macrophages and lymphocytes. This result suggests that M3 has a 
function in the modulation of the immune response. Interestingly, a recent study 
demonstrated that wood mice infected with the M3-stop virus showed impaired germinal 
centre reaction in the spleen (Hughes et al., 2011), which is the evidence that the virus may 
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M4 is a glycosylated protein and its function is still unclear (Evans et al., 2006; Geere et al., 
2006). It is dispensable for in vitro replication and is known to contribute to viral expansion 
during acute-latent infection in the spleen.   
K3 (ORF12) 
K3 is the homologue of KSHV K3 and K5 proteins (Virgin et al., 1997). It is expressed in 
lytic infection in the lung and in splenic germinal centre B cells at the peak of latency. In the 
absence of K3, MHV-68 had a normal lytic infection in the lung, but exhibited a decreased 
frequency of latently infected splenocytes and enhanced viral-specific CTL response. 
Moreover, the K3 protein is shown to inhibit antigen presentation of MHC class I molecules 
(Stevenson et al., 2002a; Stevenson et al., 2002b). With its RING domain, K3 can react with 
the MHC class I heavy chain and initiate ubiquitination which leads to proteasome-
dependent degradation (Boname and Stevenson, 2001). In addition, recent research showed 
that K3 impaired the assembly of MHC class I heavy chain with β2-microgloblin, resulting 
in MHC class I molecules unable to assemble with high-affinity peptides. These findings 
imply that K3 may prevent MHC class I molecule assembly by blocking its binding with 
chaperones (Yu et al., 2002). Altogether, K3 plays an important role in latent infection by 
suppressing the expression of the MHC class I molecule. 
M11 (vBcl-2) 
vBcl-2 is encoded by the MHV-68 M11 gene and is a homologue of cellular protein Bcl-2. 
All gammaherpesviruses encode at least one Bcl-2 homologue. Sequencing of vBcl-2 
encoded by MHV-68 shows it has a BH-1 domain but no BH-2 domain, which is different 
from homologues encoded by other gammaherpesviruses. Given the known function of 
cellular Bcl-2, vBcl-2 is involved in preventing the host cell undergoing apoptosis in chronic 
infection (Wang et al., 1999). Studies showed that vBcl-2 encoded by MHV-68 could inhibit 
apoptosis by blocking the signaling induced by anti-Fas antibody or TNF-α. The M11 gene 
is expressed in both lytic and latent infection, which suggests that the inhibition of caspase-
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dependent apoptosis is required for both viral replication and also latency in the lung and 
spleen (Roy et al., 2000). By inserting stop codons in the coding region of the gene, a vBcl-
2-stop virus was generated and utilised to study the role of M11 in vivo. The depletion of 
vBcl-2 did not significantly affect latency establishment, but it diminished the viral 
reactivation from latency (Gangappa et al., 2002). More recently, a surface binding groove 
of vBcl-2, BH-3 domain, was identified, which is important to anti-apoptotic function (Loh 
et al., 2005). This domain was later shown to inhibit autophagy more efficiently than cellular 
Bcl-2 (Ku et al., 2008). Subsequent study using a virus which had a mutation in the M11 
gene suggested vBcl-2 inhibition of autophagy is important during MHV-68 persistent 
infection (E et al., 2009). The role of vBcl-2 in spleen latent infection is under debate: vBcl-
2 deficiency was found to have no effect in spleen latency following intraperitoneal 
inoculation (Gangappa et al., 2002), while in an independent study using a different mutant 
virus a role was found for vBcl-2 in establishing latency in the spleen after intranasal 
inoculation (de Lima et al., 2005). The conflicting results may have arisen because of the 
different mutant viruses used and the different route of inoculation applied (intraperitoneal 
versus intranasal).  
v-Cyclin (ORF72) 
MHV-68 v-Cyclin is encoded by ORF72. It is a homologue of cellular cyclin D and is 
shared among rhadinoviruses. In a study using transgenic mice in which v-Cyclin was 
expressed under the control of proximal promoter LCK, expression of v-Cyclin led to the 
growth of T cell lymphoma (van Dyk et al., 1999). Crystal structure analysis shows that it 
binds to both CDK1 (Cyclin-dependent kinase) and CDK2, in which CDK1 regulates the 
cell cycle through S phase, while CDK2 controls the transition from G1 phase to S phase. 
Moreover, it was shown to be resistant to inhibition from CDK inhibitor CKIp27Kip1 (Card et 
al., 2000; Swanton et al., 1999). 
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A recombinant virus marked by a reporter gene as well as knock-out of ORF72 exhibited 
defects in both acute viral replication and reactivation from latency (Hoge et al., 2000). 
Another study showed that in B cell knockout mice, maintenance of latent infection also 
required v-Cyclin (van Dyk et al., 2003). In vivo study using a v-Cyclin-null virus showed 
an impaired acute replication in the lung and failure to induce splenomegaly. The same 
changes were also observed when using v-Cyclin-CDK binding deficient mutants. However, 
following intraperitoneal infection, the reactivation was suppressed in peritoneal elucidate 
cells when infected with the v-Cyclin-null virus but not the v-Cyclin-CDK binding deficient 
mutants. This suggests that v-Cyclin has a function in peritoneal macrophage infection 
which is independent from binding with CDKs (Reviewed by Upton and Speck, 2006). 
Therefore, v-Cyclin may functions in lytic infection as well as in reactivation in a cell type-
specific manner. 
mLANA (ORF73) 
ORF73 encoded latency associated nuclear antigen (LANA) is conserved among 
rhadinoviruses. Moreover, EBNA1 of EBV has a function similar to that of LANA (Lee et 
al., 1999). In the absence of mLANA, mutant MHV-68 is severely impaired in latency 
establishment in the spleen and this finding agrees with the predicted function of EBNA1 in 
EBV and LANA in KSHV, which is maintaining the viral genome as an episome during 
latency (Fowler et al., 2003). The mLANA null virus also exhibited a defect in lytic 
infection in the lung following intranasal inoculation (Moorman et al., 2003b). Using the 
same virus, however, in vitro experiments indicated that there was a more rapid and higher 
level of viral gene expression, as well as p53 activity, corresponding with accelerated cell 
death which may impair virion production. This suggests that mLANA may function as a 
suppressor of lytic gene expression and, moreover, may inhibit cellular apoptosis (Forrest et 
al., 2007). Interestingly, LANA homologues in RRV and KSHV were observed to have a 
similar role in enhancing viral gene expression (Wen et al., 2009; Li et al., 2008). Recent 
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research showed the mLANA-null virus could infect spleen cells in immune-compromised 
mice which lacked IFNαβ response. However, although the viral genome was maintained 
and carried for months post infection, it was not maintained in the form of episome and was 
unable to reactivate from latent infected spleen B cells, which confirms the essential role of 
mLANA in maintaining latent infection (Paden et al., 2010).  
v-GPCR (ORF74) 
ORF74 is a homologue of mammalian G protein coupled receptors (GPCR) and its 
homologue is also expressed by KSHV. It is expressed in both viral replication in vitro and 
latent infection in vivo in the lung and the spleen. Like KSHV, vGPCR can transform NIH 
3T3 fibroblasts (Wakeling et al., 2001). A study using a mutant virus in which ORF74 was 
partially deleted showed the dysfunction of vGPCR had no effect on viral replication but 
was less efficient in reactivation in long-term persistency (day42 p.i.) (Moorman et al., 
2003a). In another study, MHV-68 with deletion of ORF74 replicated similarly to WT, and 
was impaired in reactivation from spleen cells. It was also demonstrated that chemokines 
KC and MIP-2, but not IP-10, enhanced lytic infection in the WT virus infection but not the 
in vGPCR knockout virus. This suggests that vGPCR can enhance replication and 
reactivation by modulating host immune response (Lee et al., 2003). While another 
chemokine binding protein, M3, binds to all kinds of chemokines, vGPCR seems to bind 
preferentially to CXC chemokines. Moreover, Verzijil et al. showed that chemokines such as 
KC and MIP-2 may function as agonists of vGPCR, whereas the vGPCR binds IFNγ 
inducible IP-10 as an antagonist (Verzijl et al., 2004). These studies suggest that vGPCR 
modulates the immune system by limiting the activity of these chemokines, which 
contributes to the maintenance of latency.  
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1.3.4 MHV-68 infection in immune competent mice following 
intranasal inoculation 
Although there are many data generated from studies using intraperitoneal and intracerebral 
inoculation, the intranasal route is considered the likely natural route of MHV-68 infection. 
Therefore here we introduce the events which occur following intranasal inoculation. There 
are generally 4 distinguishable stages:  
1. Productive (lytic) infection: A productive infection first occurs in the lung, which is 
characterised by viral replication within epithelial cells and profound expression of 
viral proteins. It occurs within days after inoculation and is followed by latency 
establishment in specific cell reservoirs such as lung epithelial cells, macrophages, 
dendritic cells, and B cells in secondary lymph organs.  
2. Acute phase of latent infection: This stage is also termed latency expansion, in 
which key features include viral gene driven proliferation and differentiation of 
latently infected B cells. From 2 to 3 weeks post infection, the secondary lymph 
organs, such as the spleen, shows significant enlargement while the latent viral load 
is increasing. The virus only expresses a number of latent-associated genes which 
regulate cell cycle and signaling pathways, as well as those which facilitate immune 
evasion.  
3. Long-term latency: This is a state of life-long carriage. The viral gene expression is 
switched off except for a few proteins essential for viral episome maintenance. Most 
likely memory B cells are the main site of long-term latency, while macrophages, 
DCs, and epithelial cells can also be latently infected; however, the role of the latter 
in long-term latency is not clear. 
4. Reactivation: Reactivation occurs in both acute and long-term latency: there is a 
relatively high level of reactivation during latency expansion which rapidly 
diminishes to a low but detectable level in long-term latency.  
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Infection in the long-term can be considered a balance between latency and reactivation. 
Infection studies using peritoneal inoculation show that a reservoir of persistent, low-level 
productive infection may exist in peritoneal macrophages during long-term MHV-68 
infection (Flano et al., 2000; Weck et al., 1999). However, the nature of this type of 
infection remains unknown.  
1.3.4.1 Lytic infection in the lung and viral dissemination to lymph organs 
Following intranasal inoculation of immune competent mice with MHV-68, an acute 
respiratory infection occurs in which the virus replicates rapidly in lung epithelium. In the 
lung, the virus can be detected in the first 24 hours post infection, and the replication peaks 
at 3 to 5 days p.i., and the virus is not detectable by plaque assay by 10 days p.i. but still 
show positive in PCR. Both lung epithelial cells and mononuclear cells are infected (Sunil-
Chandra et al., 1992a). Stewart et al. have shown that lung epithelium is one of the sites for 
MHV-68 persistency (Stewart et al., 1998). The virus enters the mediastinal lymph node 
(MLN) where dendritic cells, macrophages, and B cells are infected (Nash et al., 2001). The 
transmission of the virus from lung to lymph node has been intensively studied. It is already 
known that there are no detectable cell-free viraemia formed in MHV-68 infection (Sunil-
Chandra et al., 1992a). Moreover, disruption of essential proteins in virion binding or release 
does not prevent the establishment of latency (de Lima et al., 2004; Gillet et al., 2007), while 
deficiency in gp48 which is important cell-to-cell transmission, significantly affects long-
term persistency (May et al., 2005b). The studies above suggest a cell-associated route for 
MHV-68 to traffic to lymph nodes from lung epithelial cells. Therefore it is generally 
believed that the dendritic cells are responsible for initially transporting the virus to the 
draining lymph node and colonising B cells. Studies using GFP label MHV-68 infecting 
normal mice and B cell deficient mice (uMT) reveal DCs and macrophages in MLN were 
infected no matter whether B cells were present or not, whereas in the absence of B cells the 
infection appeared to be transient (Selvarajah, unpublished data). More recently, by tracking 
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a DC-specific virus using cre-lox system, Gaspar et al. showed a great proportion of the 
latent virus in B cells were passed from DC. They also showed that a virus which only 
underwent genome deletion in DCs was impaired in its ability to infect B cells (Gaspar et al., 
2011). The above results support the conclusion that MHV-68 colonises B cells through 
dendritic cells. However, this was only observed in superficial cervical lymph nodes (SCLN), 
which collect lymph from the upper respiratory tract, and seemed not to be the case in MLN, 
which collect the lymph from the lung (Gaspar et al., 2011).   
1.3.4.2 Latent infection in the spleen 
MHV-68 establishes latent infection in lymph follicles after reaching the spleen. In the 
absence of B cells, MHV-68 can reach MLN but not spleen, which suggests that B cells 
carry the virus to the spleen (Selvarajah, 2001). The viral titre is detectable in the spleen as 
early as day 5 p.i.(Sunil-Chandra et al., 1992a), whereas the first detection of infection by in 
situ hybridisation appears on day 10 (Gangadharan, 2006). The virus can be recovered 
consistently from spleen B cells (Sunil-Chandra et al., 1992b); coupled with its cell tropism 
which showed in vitro infections on different cell lines (Sunil-Chandra et al., 1993), this 
indicates that spleen B cells are a major site of MHV-68 latent infection.  
Compared with asymptomatic long-term latency, the acute phase of latent infection features 
a rapid proliferation of B cells by 2-3 weeks p.i., corresponding with a rapid increase in the 
number of latently infected B cells. During the acute phase, pathologically the host shows 
splenomegaly, and the latently infected B cells appear to be located within the germinal 
centres, which increase both in number and size of germinal centres (Gangadharan, 2006; 
Nash et al., 2001). As in the MLN, the high viral load in the spleen seems to be transient: the 
frequency of latently infected cells increases from 1 in 107 splenocytes up to 1 in 104 
splenocytes within days and then drops to 1 in 106 splenocytes by week 4 p.i.(Sunil-Chandra 
et al., 1992a; Usherwood et al., 1996a). Usherwood et al. have shown that the splenomegaly 
is controlled by CD4+ T cells. In the absence of CD4+ T cells, neither splenomegaly nor a 
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rapid increase of infected cells was observed, but the virus could still infect B cells and 
establish latency in the spleen. These findings also suggest that the establishment of latency 
in the spleen does not require CD4+ T cells. (Usherwood et al., 1996a). On the other hand, 
the viral latency in the spleen appears to rely on the presence of B cells. Mice lacking mature 
B cells (uMT mice) showed no infection in the spleen following intranasal inoculation of 
MHV-68. Moreover, B cells/latently infected B cells were required to develop splenomegaly 
(Usherwood et al., 1996c). These data indicate that MHV-68 may manipulate the B cell 
proliferation and differentiation to establish latent infection. However, the work of another 
group using intra-peritoneal infection showed that in uMT mice the latency was established 
at a level of 100-fold higher than in normal mice (Weck et al., 1996), which suggests the 
impact of the different route of infection. Despite these contradictory results, more recently, 
accumulating evidence has shown that in the acute phase of latency, MHV-68 can activate 
the infected B cells, drive its proliferation, and utilise the germinal centre reactivation to 
expand the pool of infected B cells. Eventually, these latently infected germinal centre B 
cells undergo differentiation and become either memory B cells or plasma cells (reviewed in 
Barton et al., 2011). The detail of MHV-68 utilising germinal centre reaction in the spleen is 
discussed in the introduction of Chapter 4. 
1.3.4.3 Reactivation from latency 
Although they both lead to cell death and virion production, reactivation from latency is 
different from primary lytic infection in the lung in many respects. First, the immune 
environment in the host is changed after productive infection. The lytic infection generally 
occurs in the lung epithelium whereas reactivation mostly takes place in secondary lymph 
organs, in which an abundance of antibodies and effector cells have been generated or 
recruited. Moreover, the initiation of reactivation is from inside latently infected cells; 
therefore the molecular basis involved in reactivation is different from lytic infection, for the 
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latter requires the process of attachment and entry into the cell (reviewed in Barton et al., 
2011). 
Reactivation was measured by detecting the infectious virus using the method of modified 
plaque assay (Sunil-Chandra et al., 1992a). In another study, a subpopulation of activated 
CD8+ T cells which is specific for epitopes generated from lytic infection were still present 
in latent infection, which provides evidence for a low level of reactivation or productive 
infection during long-term latency (Liu et al., 1999). Steed et al. showed that IFNγ 
significantly suppressed reactivation from latency in PEC and spleen cells from B cell 
deficient mice (Steed et al., 2006); however, the same group found later on that in wild type 
mice, reactivation from spleen cells could not be controlled by the same mechanism, which 
suggests IFNγ can only control reactivation from latently infected macrophages but not from 
B cells (Steed et al., 2007). Viral gene transcription profiling shows that apart from latent 
genes, the key gene for lytic infection, ORF50, as well as other lytic-associated genes are 
expressed in macrophages and dendritic cells, but not B cells at day 14 post infection 
(Marques et al., 2003). Moreover, Fowler et al showed that an essential gene for latent 
infection, ORF73, was not transcribed in latent infected macrophages, or possibly the 
transcription was too low to be detected (Fowler et al., 2003). These findings indicate that 
the mechanism of reactivation from latency and its control vary according to cell type.  
1.3.4.4 Infectious mononucleosis-like syndrome in periphery 
Another characteristic feature of MHV-68 infection is the massive expansion of CD8+ T 
cells in peripheral blood around 3 weeks post infection. The expanded population is 
dominated by Vβ4+ T–cell receptor expressing cells, which suggests the possibility of a 
response against a superantigen (Flano et al., 2004; Hardy et al., 2000; Tripp et al., 1997). 
This infectious mononucleosis-like syndrome appears after the resolution of the acute phase 
of infection and persists for more than a month, which is comparable with the infectious 
mononucleosis in EBV primary infection in adults (reviewed in Nash et al., 2001). However, 
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the expanded CD8+ T cells induced by EBV are largely viral-specific MHC-I restricted T 
cells, while MHV-68 induced CD8+ T cell are not viral-antigen specific. Previous research 
shows that the expression of M1 is essential for the expansion of a specific subset of T cells 
(Evans et al., 2008).  
1.3.5 Immune responses involved in MHV-68 infection and 
pathologies 
As discussed above, there are different components of MHV-68 infection: productive 
infection, acute latency, long-term latency, and reactivation from latency. The pattern of 
viral gene expression and protein production in each stage is distinct. Therefore, the host 
response generated against the present stage of infection may be inadequate to control the 
next phase of infection. Moreover, the genes expressed during latency establishment and 
reactivation in each type of cells that is infected are different; therefore the immune response 
against the infection of each reservoir is also likely to be distinct (Tibbetts et al., 2002). To 
investigate the immune responses against MHV-68 and the role of host immunity in the 
subsequent pathologies, transgenic mice with a specific deficiency in their immune system 
are widely utilised.  
1.3.5.1 Adaptive immune responses 
Numerous studies show that the lytic MHV-68 infection in the lung is well controlled by the 
host’s immunity, in which CD4+ T cells (Stevenson et al., 1999b) and CD8+T cells 
(Ehtisham et al., 1993) may contribute against viral infection, while the control from 
antibodies is relatively inefficient (Usherwood et al., 1996c). However, the host immune 
system fails to completely clear the long-term latency, which is facilitated by viral immune-
evasion mechanisms such as viral protein K3 (Stevenson, 2004).  
B cells and antibodies 
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The antibody response against MHV-68 appears to be slow and established only after acute 
infection has been controlled. MHV-68 specific antibodies are dominated by IgM, produced 
in the first week post infection, followed by production of IgG2a and IgG2b, in the second 
week post infection (Sangster et al., 2000; Stevenson and Doherty, 1998). Compared to wild 
type mice, infected uMT mice which lack B cells and have no antibody production show 
little difference in lung pathology, which indicates that the antibodies are unlikely to control 
the lytic infection in the lung (Usherwood et al., 1996c). Moreover, a recent study shows 
that in vitro, using cells expressing IgG Fc receptors, such as macrophages and dendritic 
cells, specific antibodies failed to block and even enhanced MHV-68 infection (Rosa et al., 
2007). On the other hand, studies in which antibodies are introduced before infection 
indicate important functions of MHV-68 specific antibodies. It has been shown that MHV-
68 specific antibodies can control the number of latently infected cells as well as reactivation 
from latency (Kim et al., 2002; Tibbetts et al., 2003). However, the immunity of vaccinated 
mice may not reflect the actual host immune environment in the natural infection of 
gammaherpesviruses.   
CD4+T cells 
CD4+ T cells specific for MHV-68 are activated and remain so during chronic infection 
(Christensen and Doherty, 1999). Control of MHV-68 infection in B cell deficient mice 
appears to be mediated by CD4+ T cells, largely through the function of IFNγ (Christensen 
et al., 1999). These cells appear to undergo activation and proliferation, as well as IFNγ 
production (Stuller et al., 2010). IFNγ supresses viral reactivation ex vivo (Steed et al., 2007; 
Steed et al., 2006) by directly inhibiting the transcription of viral ORF50 (Goodwin et al., 
2010). Moreover, IFNγ may enhance the immune function of CD4+ and CD8+ T cells 
(Badovinac et al., 2000; Whitmire et al., 2007). CD4+ T cell depleted mice infected with 
MHV-68 exhibit no defects in controlling lung and spleen infection by day 12 post infection, 
and develop neither splenomegaly nor lympho-proliferative disorder  (Ehtisham et al., 1993). 
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Moreover, depletion of CD4+ T cells during acute infection leads to a reduced viral load in 
the spleen but no effect on latent infection level at day 30 (Usherwood et al., 1996a). MHC 
class II deficient mice (I-Ab-/- mice) are also used to study CD4+ T cell function. CD4+ T 
cell depleted mice fail to develop splenomegaly, as well as viral specific antibodies. 
However, a progressive loss of control in long-term MHV-68 infection which is mediated by 
CD8+ T cells is observed in mice that have CD4+ deficiency, indicating a crucial role of 
CD4+ T cells (Cardin et al., 1996). Interestingly, the absence of MHC class II molecules 
leads to elevated reactivation and chronic disease in the lung (Cardin et al., 1996). This lung 
disorder is not protected against but partially improved by vaccination using protective T 
cell epitopes (Belz et al., 2000), whereas CD4+ T cells function can be restored by the 
stimulation of CD40, which is expressed on B cells and professional APCs (Sarawar et al., 
2001).  
CD8+T cells 
The absence of CD8+ T cells leads to exacerbation of MHV-68 infection in the lung and 
spleen. Moreover, CD8+ T cells deficient mice also show pathology in the liver and adrenal 
gland, which suggests a major role of CD8+ T cells in controlling productive infection 
(Ehtisham et al., 1993). Several studies indicated that the role of CD8+ T cells largely 
depends on the functions of perforin, granzyme, and Fas induced cell death (Loh et al., 2004; 
Topham et al., 2001). Perforin-mediated mechanisms suppress the latent viral load in spleen 
B cells, but not macrophages. Perforin-knockout mice do not show significant defects in 
either lytic infection in the lung or latent infection in the spleen (Usherwood et al., 1997), 
which indicates an alternative protection. Mice with double knockout of perforin and the 
IFNγ receptor showed much higher mortality than mice with either single knockout 
following MHV-68 infection, indicating an important role of perforin-mediated cytotoxicity 
which is independent of the IFNγ signal (Tsai et al., 2011). CD8+ T cells raised specifically 
against the lytic viral gene products (ORF6 and ORF61) were detected in the lung up to 22 
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days p.i. (Stevenson et al., 1999a), and the presence of these subpopulations is independent 
from CD4+ T cells and MHC class II molecules (Stevenson and Doherty, 1998). It was 
thought that CD8+ T cells which control all phases of MHV-68 infection are MHC class Ia 
restricted. However, knocking out MHC class Ia led to the development of a large number of 
β2M-dependent CD8+ T cells which control both lytic and latent infection. Moreover, this 
subpopulation, which appears to be class Ib MHC restricted, is independent of CD1d and it 
is not clear what antigen induced the activation and proliferation of these CD8+ T cells 
(Braaten et al., 2006). Part of these T cells are Vβ4 CD8+ T cells which may be related to 
the M1-induced Vβ4 CD8+ T cell expansion in peripheral blood around 2 weeks post 
infection (Evans et al., 2008). The expanded Vβ4 CD8+ T cells express IFNγ and TNFα, but 
it remains unknown whether they can trigger cell death. 
1.3.5.2 Cell intrinsic responses and Innate immune responses 
Although adaptive immunity against MHV-68 has been investigated intensively, the 
importance of cell intrinsic response and innate immunity in controlling MHV-68 infection 
is now receiving great attention. Most cells’ intrinsic response is modulated by at least one 
viral gene product. It has been reported that the host cell responds to viral infection through 
apoptosis and autophagy, and the latter has recently been shown to be well inhibited by v-
Bcl2, suggesting autophagy has an important role in the MHV-68 lifecycle. NF-κB, which is 
involved in regulation of both innate and adaptive immunity, has been shown to be inhibited 
by mLANA. Moreover, NF-κB family member p50 has been shown to be essential in 
controlling the acute phase of latency in the spleen: mice which lack p50 failed to control 
viral replication in the lung (Krug et al., 2009). 
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1.3.6 Role of IFNγ in murine gammaherpesvirus infection: MHV-68 
infection in the absence of IFNγ response 
1.3.6.1 IFNγ and its receptor 
IFNγ is the only member of type 2 interferon, and it is structurally different from type 1 
interferon but shares some functional similarities with the later. So far, all mammals 
examined have an IFNγ gene. Mouse IFNγ has about 40% protein homologue with human 
IFNγ. It is a poly-peptide with 136 amino acids and approximately 17 kDa in molecular 
mass (Gray and Goeddel, 1983). In early studies, T cells were considered to be the major 
source of IFNγ, which includes the population of Th1, Th0, and CTL. The production from 
CD4+ T cells is primarily stimulated by MHC class II molecules binding with antigens, 
whereas MHC class I molecules bind to CD8+ T cells. NK cells are another important 
source for IFNγ, which require stimulation from TNFα and macrophages (Vilcek et al., 1985; 
Farrar et al., 1986; Johnson et al., 1986; Johnson and Torres, 1984). Nowadays, evidence 
shows that B cells, dendritic cells, and macrophages also secret IFNγ (reviewed in Schroder 
et al., 2004). Most likely the production of IFNγ from NK cells, and APCs is important in 
innate immunity and the early adaptive immunity against infection, whereas that of CD4+ T 
cells and CTL is a part of the antigen-specific adaptive immune response (Frucht et al., 2001; 
Sen, 2001). Generally, the production of IFNγ is enhanced by APC-secreted cytokines such 
as IL-12 and IL-18, whereas the cytokines related to Th2 and Treg types of immunity such as 
IL-4, IL-10, and TGF-β down-regulate IFNγ production (Schoenborn and Wilson, 2007). 
The IFNγ receptor is comprised of two ligand-binding IFNγ R1 chains and two signal-
transducing IFNγ R2 chains. Both chains are of the class II cytokine receptor family and 
IFNγ R2 is considered the limiting factor of IFNγ signaling since IFNγ R1 is expressed 
constitutively (Bach et al., 1997; Bernabei et al., 2001). The level of IFNγ R2 expression 
depends on the cell states, such as differentiation or activation (Bach et al., 1997). IFNγ 
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signaling transduction is carried out by IFNγR1 binding to Jak 1 and IFNγR2 to Jak 2, 
which subsequently lead to the activation and translocation of STAT1 molecules which 
initiate certain transcription of interferon-regulated genes (reviewed in Schroder et al., 2004). 
Interferon regulatory factors (IRFs) such as IRF-1, IRF-2, and IRF-9 are involved in the 
regulation of IFNγ signaling (Darnell et al., 1994; Mahboubi and Pober, 2002; Rouyez et al., 
2005). The negative regulation of IFNγ signaling also involves specific feedback inhibitor 
SOCS-1, which inhibits IFNγ signaling by interacting with Jak 1or Jak 2 and regulating 
tyrosine kinase activity. Transgenic mice in which SOCS-1 is over-expressed exhibited 
deficient IFNγ responses (Sakamoto et al., 1998; Fujimoto et al., 2000).  
1.3.6.2 Antiviral activities of IFNγ response 
The IFNγ system can act directly against infection within infected cells, and functions as a 
secondary mediator to other immune cells. Therefore it plays antiviral roles in intrinsic cell 
response, as well as innate and adaptive immunity. IFNγ can induce key antiviral enzymes 
including double-stranded RNA activated protein kinase PKR, 2’-5’ oligoadenylate 
sythetase, and double-stranded RNA-specific adenosine deaminase (Hovanessian, 1991; 
Patterson et al., 1995; Meurs et al., 1990). For example, PKR is a serine/threorine kinase 
which is induced by interferon and its activation requires dsRNA which is produced by RNA 
viruses (Hovanessian and Galabru, 1987). Activated PKR can prompt phosphorylation of 
cellular substrate eIF-2α, and subsequently inhibit viral and cellular protein synthesis (Meurs 
et al., 1990). Moreover, IFNγ also shows pro-apoptotic functions. After IFNγ treatment, 
cells which over-express IFNγ receptor undergo apoptosis through activated STAT1 in an 
IRF-1-dependent manner (Chin et al., 1997). The IFNγ system also facilitates apoptosis by 
up-regulating the expression of the Fas/Fas ligand and TNF-α receptor (Deiss et al., 1995; 
Deiss et al., 1996; Xu et al., 1998).  
As one major product of Th1 cells, IFNγ enhances the activity of CTL and skews the host’s 
immunity to Th1 phenotype by promoting the differentiation of Th0 cells into Th1 cells, 
46 
 
Chapter 1                                                                                                              Introduction 
regulating the activities of APCs, and limiting the Th2 cell population. IFNγ can up-regulate 
the expression of MHC class I (Wenner et al., 1996) and class II molecules (Chang and 
Flavell, 1995), therefore elevating both antigen-presentation pathways, by which IFNγ 
contributes to host immunity against intracellular pathogens.  
1.3.6.3 Dysfunction of IFNγ signaling: IFNγ receptor knockout mice 
IFNγ-knockout mice, as well as mice with deficiency in either chain of IFNγ receptor, have 
been generated. All these mice show immune deficiency against viral, bacterial, and 
parasitic infections (Huang et al., 1993; Pearl et al., 2001; van den Broek et al., 1995). 
IFNγR-/- mice with a disrupted IFNγR1 chain were widely used to study the role of IFNγ 
signaling in a variety of viral infections. Studies on the effect of viral infection on IFNγR-/- 
mice are summarised by Tau and Rothman (Tau and Rothman, 1999): see Table 1.2. 
Notably, the outcome of these studies reflects partial redundancy of the antiviral function if 
IFNγ, possibly because of the similarities between the function of IFNγ and Type 1 
interferon (Muller et al., 1994). The studies using IFNγR-/- mice also emphasise another 
important function of IFNγ: tumour surveillance. IFNγR-/- mice, as well as cells treated with 
IFNγ-neutralising antibodies, and cells with IFNγR1 mutations, exhibit compromised 
tumour resistance (Kaplan et al., 1998; Dighe et al., 1994; Tannenbaum and Hamilton, 2000).    
1.3.6.4 Model of MHV-68 infection in IFNγ R-/- mice 
A cytokine profile of MHV-68 infected C57BL/6J mice shows that IFNγ is largely produced 
during acute viral infection. High levels of IFNγ and IL-6 and lower levels of IL-2 and IL-10 
are expressed in the cells obtained from spleen and lymph nodes, whereas IL-4 and IL-5 are 
barely detected (Sarawar et al., 1996). Moreover, the peak of IL-6 and IFNγ detected 
corresponds with the clearance of acute infection in the lung on day 10 p.i.. Surprisingly, 
mice with the IFNγ gene deficiency (IFNγ -/- mice) show clearance of lung infection in 
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kinetics similar to that in wild type mice, which suggests IFNγ is not essential for clearance 
of lytic infection in the lung (Sarawar et al., 1997).   
Following intranasal inoculation of interferon gamma receptor deficiency (IFNγ R-/- mice) 
mice on a background of 129Sv/Ev strain with MHV-68, the lytic infection in the lung 
showed no differences in the viral titers of infectious virus throughout the lung infection, 
which is consistent with Sarawar’s finding in IFNγ R-/- mice under the background of 
C57BL/6J strain (Dutia et al., 1997). A series of distinctive pathologies have been observed, 
which include inflammatory disorders consisting of lymphocytic infiltrations in multiple 
organs and fibrosis in the spleen, lymph nodes, liver, and lung (Ebrahimi et al., 2001). The 
lack of interferon gamma provides a Th2-dominated host environment which is marked by 
elevated expression of IL-4, IL-13, IL-21, and IL-5 (Gangadharan et al., 2008). MHV-68 
infection leads to atrophy and fibrosis in the spleen of IFNγ R-/- mice by day 20 post 
infection (Dutia et al., 1997). Significant loss of spleen cells, which was mostly evident on 
day 23 post infection, is concomitant with the peak of leucocytosis on day 23 p.i.. This 
suggests the trafficking of peripheral blood cells into the spleen is blocked by fibrosis 
developed around spleen follicles where the latently infected B cells mainly existed 
(Ebrahimi et al., 2001). During the same time period post infection, in situ hybridisation for 
infected cells in the spleens of IFNγ R-/- mice shows that the number of these cells decreases 
dramatically. This result suggests the loss of viral latency in fibrotic spleen (Gangadharan et 
al., 2008). Interestingly, the spleen of IFNγ R-/- mice at a later time point shows recovery 
from fibrosis which appears to be a resolution of MHV-68 latency. However, the infectious 
centre assay for the latent virus shows there are still latent virus still in those spleen tissues 
in a very low frequency (Dutia, personal communication). It is clear that the CD8+ T cells 
mediate fibrosis in IFNγ R-/- spleens. But the mechanism of the fibrosis in MHV-68 infected 
IFNγ R -/- mice is still unclear. It has been observed that CD4+ T cells and CD8+ T cells 
infiltrate germinal centres around day 12 post infection. Also, in the very early days of the 
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infection (before extensive fibrosis developed) macrophages are detected in the spleen 
germinal centres and then become alternatively activated. The RT-qPCR assay shows that 
the level of Arginase 1 gene expression in the spleen of IFNγ-/- mice is obviously higher than 
that in wild type mice (Gangadharan et al., 2008). The above observation suggests a 
complex interaction involving host B cells, T cells, and macrophages. Importantly, Dutia et 
al have demonstrated that the infection of IFNγR-/- mice with MHV-76 which lacks unique 
region at the left end (encoding M1-M4 and vtRNA like molecules) does not lead to spleen 
pathology (Dutia et al., 2004). Moreover, M1, not only is required for Vβ4+ CD8+ T cell 
expansion in natural infection, but also plays an important role as an activator in the 
formation of fibrosis in IFNγ R-/- spleens (Clambey et al., 2000; Evans et al., 2008). The 
mechanisms of M1 mediating Vβ4+ CD8+ T cell expansion and activating fibrosis within 
IFNγ R-/- spleens are still uncertain, although it is supposed that it works as a super antigen 
(Evans et al., 2008). On the contrary, mice infected with a virus which has disrupted 
vtRNA3 but still can encodes M1 to M4 in vitro, shows no splenic pathology (Dutia et al., 
2004). However, this result may be caused by the insertion disrupting the transcription of 
mRNA which is involved in triggering splenic pathology in vivo (Dutia et al., 2004). So far, 
the role of viral activity in MHV-68 mediated splenic pathology is still unclear. 
1.3.7 Strain-dependent variation in MHV-68 infection 
Recent studies of MHV-68 infection in IFNγ deficient mice on the BALB/c background 
showed surprising variations caused by different mouse strains. IFNγ deficient mice on 
BALB/c background show high mortality during day 9 to 14 post infection. These mice 
display poor control of acute productive infection and die from acute pneumonia, which is 
dependent not only on the viral dose, but also on the expression of v-Cyclin and v-Bcl2 (Lee 
et al., 2009). Interestingly, M1-null virus infection of IFNγ deficient mice on BALB/c 
background shows no difference compared to wild type virus in developing lethal 
pneumonia, except an elevated reactivation rate. These results show that the control of lytic 
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infection in the lung of BALB/c mice is highly dependent on IFNγ response, which is 
different from C57BL/6 mice and 129Sv mice. One possible explanations is that BALB/c 
mice have a different cytokine response against MHV-68 in comparison with C57BL/6 mice, 
which involves a significantly higher expression of CC and CXC chemokines (Weinberg et 
al., 2004). Similar studies from an independent group also show the requirement of IFNγ in 
controlling lytic infection in the lung following intranasal inoculation is strain-dependent 
(Tsai et al., 2011).  
These findings raise interest to investigate the difference between natural hosts and strains of 
laboratory mice in immune responses against MHV-68 infection. In fact, common 
laboratory strains of mice such as 129Sv/Ev and C57BL/6 have been widely used to study 
MHV-68. Studies on Sv129 and C57BL/6 showed little differences in pathogeneses and host 
response (Brownstein, 1998). Hughes et al. compared MHV-68 infection in immune-
competent wood mice and BALB/c mice following intranasal infection, finding that BALB/c 
mice have higher viral replication in the lung and develop pneumonitis. Moreover, MHV-68 
established spleen latency in both strains of mice, with significant germinal centre reactions 
observed in wood mice but not BALB/c mice, and subsequently a higher production of 
specific antibodies was observed in wood mice in comparison with BALB/c mice (Hughes 
et al., 2010). However, another group concluded that the replication and the latency site of 
MHV-68 are comparable in bank voles and laboratory mice (Francois et al., 2010). The 
author further argues that the wood mice may not be the true natural host of MHV-68 and 
therefore cannot reflect the pathogenesis as well as bank voles. Hence, although being 
questioned, laboratory mice are still considered as suitable model to study MHV-68 
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Pathogen Phenotype in wild type mice Phenotype in IFNγR-/- mice 
MHV-68 Resistant to multi-organ 
fibrosis and arteritis 
Multi-organ fibrosis and 
arteritis 
Pseudorabies virus Vaccine effective; resistant 
to re-challenge 
Vaccine failed; susceptible 
to re-challenge 
Sendai virus Infection cleared Infection cleared 
LCMV Transient immunodeficiency No transient 
immunodeficiency; failed in 
viral clearance; persistent 
infection 
Vaccinia virus Resistant Increased susceptibility; 
normal TCL response 
Vesicular stomatitis virus Mount CTL response Normal CTL response  
Theiler’s virus Resistant Chronic disease 
Coronavirus Hepatitis Severe hepatitis with 
increased mortality 
Murine cytomegalovirus Infection cleared Failed to clear infection; 
chronic arteritis 
MMTV  Same clinical phenotype as 
normal mice with increased 
Th2 parameters 
Table 1.2 Summary of phenotype of IFNγR-/- mice in comparison with wild type mice in 
different models of virus infection (adapted from Tau and Rothman, 1999)  
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1.4 Fibrosis 
Fibrosis is characterised by disordered accumulation of extracellular matrix in and around 
inflammatory or damaged tissue, and leads to scarring and loss of function (Wynn and 
Ramalingam, 2012). It was reported in the USA that 45% of human mortality is associated 
with fibrosis (Wynn, 2004). Fibrosis can be induced by many factors, and the site of 
occurrence varies according to the situation. In humans, the major fibrotic diseases include 
cirrhosis, idiopathic pulmonary fibrosis (IPF), systemic sclerosis (SS), atherosclerosis, 
pancreatic fibrosis, rheumatoid arthritis, and glomerulonephritis. Fibrosis was once 
considered to be irreversible, and there is currently no effective cure for fibrosis. However, 
recent studies suggest that fibrosis can be reversed to a great extent. This has been confirmed 
in several studies on fibrosis diseases under different circumstances and in different organs 
including kidney (Eddy, 2005), lung (Mizuno et al., 2005), and liver (Iredale et al., 1998). 
The multi-organ fibrosis observed in IFNγR-/- mice induced by MHV-68 infection, including 
lung, liver, and spleen, shows pathological similarities with human fibrosis (Ebrahimi et al., 
2001). Especially, it raises the possibility to generate small animal models to study viral 
infection associated fibrosis. Therefore in this section, we first introduce the general 
mechanism of fibrosis, then discuss virus–associated human fibrosis in the lung and liver, 
and finally discuss the study based on the fibrosis model in MHV-68 infected IFNγR-/- mice.   
1.4.1 Mechanisms of fibrosis 
Although the origin of collagen-producing myofibroblasts varies in different organs (e.g., in 
the liver HSC cells are the main origin of myofibroblasts, whereas in lung fibrosis resident 
mesenchymal cells and epithelial cells are the main origin), fibrosis in different organs 
generally shares a common cellular and molecular basis (Wynn, 2008). As a response to the 
various stimuli, inflammatory infiltrates, including platelets, macrophages, neutrophils, 
eosinophils, plasma cells and T cells, accumulate at the site of tissue damage. These cells 
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generate a series of pro-fibrotic factors such as platelet-derived growth factor (PDGF), 
tumour necrosis factor-α (TNF-α), IL-1β, and TGF-β. A Th2 immune response which is 
dominated by production of cytokines IL-4 and IL-13 is crucial for the development of 
fibrosis (Wynn, 2004).  
1.4.1.1 The key mediator: Transforming growth factor (TGF-β)  
As one of the key regulators of the development of fibrosis, TGF-β has been intensively 
studied. There are 3 isoforms of TGF-β found in mammals, TGF-β1 to 3, and their functions 
appear to be very similar (Gorelik and Flavell, 2002). Among them, TGF-β1, which is 
mainly produced by circulating monocytes and tissue macrophages, is most involved in 
fibrosis. TGF-β1 is produced as an inactive form and stored inside the cell. Its activation and 
binding to its receptor requires cleavage of the latent form, which involves disassociation of 
latent associated protein (LAP). Several agents, such as macrophage derived 
plasminogenactivator, matrix metalloproteinase (MMP), cathepsins, alpain, thrombospondin, 
and integrin-αvβ6, participate in the activation of TGF-β1, and many of them make potential 
targets for anti-fibrosis drugs (Gorelik and Flavell, 2002; Letterio and Roberts, 1998; 
Munger et al., 1999). Activated TGF-β1 is secreted into the intracellular environment, binds 
to target cells, and regulates the transcription of many important genes, such as procollagen I 
and III, through transmembrane receptor signaling and intermediate functions of Smad 
proteins (Roberts et al., 2003). Generally, TGF-β1 directly activates local mesenchymal cells 
and epithelial cells which undergo epithelial- mesenchymal transition (EMT), and then these 
cells differentiate into collagen-producing myofibroblasts. However, fibrosis can be induced 
by other mediators such as Th2 cytokines IL-13 in a TGF-β independent pattern (Kaviratne 
et al., 2004). Therefore, Th2 cytokines mediate fibrosis by either an independent mechanism, 
or by triggering TGF-β1 production and activation in macrophages (reviewed inWynn, 
2008).    
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1.4.1.2 The platelet –derived growth factor (PDGF) 
The PDGF family of proteins plays an important role in fibrosis as a major mitogen and 
chemoattractant for mesenchymal cells (Yi et al., 1996). It is produced by many types of 
cells including activated macrophages, smooth muscle cells, and endothelial cells 
(Shimokado et al., 1985). There are 4 isoforms of PDGF (PDGF-A, -B, -C, -D); in fact, they 
are dimeric glycoproteins and form dimers in the form of -AA, -BB, -CC, -DD chains, or a 
heterodimeric isoform of -AB. Many types of cells, including fibroblasts and smooth muscle 
cells, express PDGF receptors on the cell surface. There are two types of PDGF receptors, 
PDGF-α and –β (Matsui et al., 1989); the alpha type binds to PDGF-AA, PDGF-BB, and 
PDGF-AB, while the beta type PDGFR binds to PDGF-BB and PDGF-AB (Heidaran et al., 
1991). The ligand binding activates the receptor, leading to auto-phosphorylation and 
subsequent signal transduction (e.g., PI3K and JAK/STAT pathway) (reviewed in Ostendorf 
et al., 2012). Downstream effects include regulation of gene expression and the cell cycle. 
The smooth muscle cells and fibroblasts which respond to PDGFs may lead to vascular 
pathologies and fibrotic scarring (Andrae et al., 2008). PDGF has been linked to pulmonary, 
hepatic, cardiac, and dermal fibrosis, and functions as mitogen for myofibroblast-phenotype 
cells (Bonner, 2004).  
1.4.1.3 The roles of Th2/Th1 immunity in fibrosis  
Pro-fibrotic functions of Th2 immunity 
The Th2 cytokines such as IL-4, IL-5, and IL13 are considered the key driving force of the 
development of fibrosis. IL-4 has been found to be elevated in patients with IPF (Emura et 
al., 1990). Many human and murine fibroblastic cells have the IL-4 receptor (Sempowski et 
al., 1994; Doucet et al., 1998). One of the functions of IL-4 is inducing collagen synthesis in 
fibroblasts (Fertin et al., 1991). In vitro, IL-4 treatment elevates production of collagen I and 
III and fibronectin in human lung fibroblasts (Doucet et al., 1998). In vivo experiments show 
that neutralising IL-4 diminishes the development of liver fibrosis (Cheever et al., 1994). A 
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similar study in a skin model found that IL-4 inhibition reduces fibrosis (Ong et al., 1998). 
IL-13 shares similar functions and even part of the signaling pathway with IL-4 (Zurawski et 
al., 1993), and accumulating evidence suggests a role of IL-13 as dominant cytokine in the 
development of fibrosis (Chiaramonte et al., 1999). The mechanism by which IL-13 induces 
fibrosis is still under debate: some studies show that IL-13 regulates production of TGF-β 
(Lee et al., 2001a), while others show that the function of IL-13 is independent of TGF-β 
(Liu et al., 2011), and it may directly regulate the activity of fibroblasts, epithelial cells, and 
smooth muscle cells (Lee et al., 2001b). IL-5 is shown to be associated with the 
differentiation, activation and circulation of eosinophils which produce a series of 
profibrotic cytokines including TGF-β and IL-13. In vivo study using bleomycin-induced 
fibrosis in IL-5-/- mice shows that IL-5 may not be a direct mediator of fibrosis in this 
particular fibrosis model, but most likely is an enhancer which exacerbates the disease 
(Huaux et al., 2003).      
Anti-fibrotic functions of Th1 immunity 
It has been demonstrated that Th1 immunity has anti-fibrotic activity, which is mainly 
related to the production of IFNγ (Baroni et al., 1996; Oldroyd et al., 1999). IFNγ producing 
NK cells have a similar anti-fibrotic function (Kim et al., 2005; Jeong et al., 2008). Th1 
cytokine IL12 also shows anti-fibrotic functions by enhancing the expression of IFNγ. One 
of the important roles of IFNγ is limiting the Th2 cell population and therefore the 
production of Th2 cytokines (discussed above). Furthermore, IFNγ inhibits the function of 
TGF-β1by down-regulating the phosphorylation of the signal transducer Smad3 and, as a 
consequence, suppressing the downstream expression of pro-collagens I and III. IFNγ also 
induces production of Smad7, which suppresses interactions between Smad3 and TGF-β 
receptors. Moreover, IFNγ directly inhibits fibroblast proliferation, as well as down-
regulates collagen production in myofibroblasts (reviewed in Gurujeyalakshmi and Giri, 
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1995). There is also evidence that IFNγ prevents circulating monocytes differentiating into 
fibrocytes, one of the cell origins of myofibroblasts in organ fibrosis (Shao et al., 2008).  
Apart from Th1/Th2, which has long been discussed as a paradigm in the formation of 
fibrosis, Th17 and Treg immunity have been recently associated with fibrosis. A subset of 
Th17 CD4+ T cells which express IL-17A, which is a pro-inflammatory cytokine, have been 
shown to play an important role in fibrosis. IL-17A has been related to fibrosis in the lung 
(Wilson et al., 2010), liver (Wang et al., 2011), and heart (Feng et al., 2009). Moreover, it is 
already known that Treg cells are also induced in many fibrotic diseases; however, the 
function of Treg cells associated with fibrosis is still unclear.  
1.4.1.4 Cell origins for fibrosis 
The key cell in fibrosis is the myofibroblasts, which produces collagen once activated. The 
known cell origins of myofibroblasts include local resident mesenchymal cells such as 
fibroblasts, epithelial and endothelial cells which undergo epithelial/endothelial-
mesenchymal transition, and fibrocytes which are circulating cells derived from bone-
marrow stem cells (reviewed in Wynn, 2008). Epithelial cells can differentiate into 
myofibroblasts through a process termed epithelial- mesenchymal transition (EMT) (Willis 
et al., 2006), while endothelial cells undergo a similar process termed endothelial- 
mesenchymal transition (EndMT) (Zeisberg et al., 2007). Bone marrow derived fibroblastic-
like cells are also identified as another origin of myofibroblasts (Bucala et al., 1994), and 
these cells circulate and contribute to fibrosis in multiple-organs (Direkze et al., 2003; 
Forbes et al., 2004). The origin of myofibroblasts may vary according to the site of fibrosis: 
fibroblast is generally the main origin of myofibroblast in kidney fibrosis; in the liver, one 
type of mesenchymal cell, the hepatic stellate cells (HSC), is considered to be one of the 
main sources of myofibroblasts, while circulating fibrocytes also contribute (Forbes et al., 
2004; Russo et al., 2006). The function of circulating fibrocytes raises a question: what is the 
driving force for these cells to travel to the injured location? Studies have suggested that 
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chemokines play an important part in the development and recruitment of myofibroblasts. 
For example, chemokine CCL3 is mainly produced by macrophages and epithelial cells, and 
anti-CCL3 antibodies can reduce the pulmonary fibrosis induced by bleomycin (Smith et al., 
1995).                                                                         
1.4.1.5 Alternative regulatory functions of macrophages in fibrosis 
Generally, macrophages are considered as the master controller of fibrosis. Accumulating 
evidence indicates that macrophages play an important role in both induction and resolution 
of fibrosis.  
The pro-fibrotic mediators produced by macrophages TGF-β and PDGF directly activate 
differentiation into myofibroblasts from different cell origins. As discussed above, TGF-β is 
an important inducer of fibrosis in multiple-organs. Take liver fibrosis as an example: TGF-
β mediates fibrosis by: (1) up-regulating the differentiation from HSC into myofibroblasts, 
(2) increasing the expression of tissue inhibitors of metalloproteases (TIMP) which inhibit 
MMPs the functions of which include degrading ECM, and (3) directly up-regulating 
collagen-related genes through the Smad pathway (reviewed in Bataller and Brenner, 2005). 
PDGF functions as a mitogen to promote proliferation of myofibroblasts (Friedman and 
Arthur, 1989). Previous research shows that macrophages are critical producers of pro-
fibrotic factors in both the liver (Wahl et al., 1990) and the lung (Bonner et al., 1991). In 
fibrosis which involves infection, macrophages function as APCs presenting antigens to 
activate T-cell response, which in turn, may enhance fibrosis by triggering cell death (e.g., 
CTL targeting infected cells) or producing pro-fibrotic cytokines such as IL-4 and IL-13. 
Moreover, chemokines produced by macrophages can attract fibroblasts, circulating bone-
marrow derived fibrocytes and other inflammatory cells.   
On the other hand, previous studies have shown that macrophages also have anti-fibrotic 
functions. For example, in a study of carbon tetrachloride-induced liver fibrosis in transgenic 
mice in which macrophages could be selectively deleted, removal of macrophages during 
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advanced fibrosis led to reduced scarring and fewer myofibroblasts, whereas by contrast 
macrophage depletion during the recovery phase led to a failure of matrix degradation 
(Duffield et al., 2005). This result suggests the existence of subpopulations of macrophages 
with distinct functions in the same tissue and that these macrophages play critical roles in 
both the injury and recovery phases of inflammatory scarring (Duffield et al., 2005; also 
reviewed in Wynn and Barron, 2010). Macrophages can regulate the progress of fibrosis by 
controlling production of both MMPs and TIMPs (Tissue inhibiters of MMPs). The function 
of MMPs was thought to be degrading extracellular matrix proteins. For example, MMP9 
degrades the basement membrane so that the inflammatory cells can be easily recruited 
(Wynn, 2008). However, recent studies suggest multiple modulatory roles performed by 
MMPs (and therefore macrophages) during fibrosis can be much more complicated than 
expected. Some of the MMPs are required in the activation of TGF-β (discussed above). 
However, recent research has shown that MMP12 produced by macrophages enhances 
fibrosis by inhibiting the expression of other ECM-degrading MMPs such as MMP2 and 
MMP13 (Madala et al., 2010). The alternative functions found in MMPs reflect multiple 
roles of macrophages in fibrosis. 
For their close association to Th2 type immunity and the fact that they are commonly 
observed in the lesion of advanced fibrosis, alternatively activated macrophages, also called 
M2 macrophages, have long been indicated to be pro-fibrotic. Compared with classically 
activated macrophages (M1) induced by IFNγ, M2 macrophages are activated by Th2 
cytokines such as IL-4 and IL-13 and have distinct functions (Gordon and Taylor, 2005). 
This phenotype expresses a series of factors such as CD206 (mannose receptor), chitinase-3-
like protein-3 (Ym1), resistin-like molecule-α (FIZZ-1), MHC II, and arginase-1 (Arg 1). 
Arginase 1 is an enzyme which controls L-proline production, and the latter is necessary for 
collagen synthesis in myofibroblasts (Hesse et al., 2001). Therefore M2 cells have long been 
indicated to be pro-fibrotic by their response to Th2 signals, suppression of Th1 type 
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immunity, attraction of fibroblasts, and direct production of fibrosis mediators (Song et al., 
2000). However, more recently, emerging evidence has shown that alternatively activated 
macrophages may pay an important role of suppressing fibrosis. Mice with cre-lox 
recombination which results in IL4R-α depletion show that the Th2 immune response and 
the formation of liver fibrosis induced by Schistosoma mansoni infection do not require M2 
cells (Herbert et al., 2004), which suggests that IL-13 activated HSC is more likely to be the 
main cause of fibrosis. More interestingly, the function of Arginase 1-expressing 
macrophages is shown to be the suppression rather than promotion of Th2 immunity and 
pathology in the liver (Pesce et al., 2009a). One possible mechanism of this suppressive 
function is that macrophage-specific Arginase 1 competes for L-arginine (L-arginine is 
required for the production of L-proline and polyamines) with fibroblasts and Th2 cells and 
subsequently inhibits the function of Th2 cells and the development of fibrosis (Pesce et al., 
2009a). However, whether this unexpected role of alternatively activated macrophages is 
consistent in fibrosis of other organs remains unclear. 
1.4.2 Idiopathic pulmonary fibrosis (IPF) 
Idiopathic pulmonary fibrosis (IPF), also called cryptogenic fibrostic alveolitis (CFA), is a 
progressive fibrotic lung disease with no known cause. It is characterised by fibroblast 
hyperplasia and excess collagen disposition, leading to loss of lung function. Forty-two per 
cent of patients die within 5 years and there is no existing method to cure IPF or improve the 
quality of life of patients except lung transplant (Lok et al., 1998; Nonn and Garrity, 1998). 
Risk factors associated to IPF include age, smoking, occupational dust exposure, genetic 
factors, and viral infection.  
1.4.2.1 Viral aetiology of IPF 
Previous studies suggested a viral aetiology of IPF, and the possible mechanisms include 
viral induced lung injury or exacerbating fibrosis. HCV, adenovirus, human 
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cytomegalovirus, and EBV are reported to be linked with IPF (Borchers et al., 2011). The 
link between herpesviruses and IPF was first found in EBV, when elevated levels of EBV-
specific IgG and IgA antibodies in IPF patients were detected, compared to patients with 
known fibrotic diseases (Vergnon et al., 1984). In addition, EBV was found to actively 
replicate within alveolar epithelial cells in IPF patients (Egan et al., 1995). In vitro, EBV 
infection results in an increase in the activated fibrosis mediator TGF-β in type 2 human 
alveolar epithelial cells (Malizia et al., 2008). In addition to EBV, HCV is shown to be 
associated with IPF. The proportion of IPF patients who are seropositive for HCV is higher 
than in control groups (Meliconi et al., 1996; Ueda et al., 1992). Moreover, 15 out of 6,150 
HCV patients developed IPF during 8 years’ observation, while none of the 2,050 patients 
with HBV developed IPF (Arase et al., 2008). Thus, these data indicate the possibility that 
apart from inducing liver fibrosis and cirrhosis, HCV infection in the long term may also 
contribute to lung fibrosis. However these investigations are controversial: a study in the UK 
failed to link HCV to IPF, which may reflect regional differences (Irving et al., 1993). 
1.4.2.2 Pathogenesis of IPF 
The pathogenesis of IPF has been studied intensively although there are major questions yet 
to be answered. Recent hypothesis involves repeated epithelial injury which leads to alveolar 
epithelial cells being activated. Subsequently, fibroblasts are attracted and activated at the 
site or around the injury, where they differentiate into myofibroblasts (reviewed in Borchers 
et al., 2011). These cells in IPF lungs are highly responsive to pro-fibrotic mediators 
including growth factors (TGFβ), chemokines (CCL2 and CCL21), and cytokines (IL-13) 
(Hetzel et al., 2005; Murray et al., 2008; Pierce et al., 2007).   
The number of myofibroblasts is remarkably increased in IPF lungs. Alveolar epithelial cells 
overlying the fibroblastic foci express CXCL12, which binds to CXCR4 on fibrocytes 
(Mehrad et al., 2007). The number of these bone marrow-derived circulating collagen 
producing cells is significantly increased in the peripheral blood of IPF patients (Moeller et 
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al., 2009). These results suggest that circulating fibrocytes contribute to IPF, and alveolar 
epithelial cells at certain stage can recruit fibrocytes into the site of pathology. Furthermore, 
some alveolar epithelial cells undergo epithelial-mesenchymal transition (EMT) and 
contribute to the myofibroblast population in IPF lungs (Larsson et al., 2008).  
Immunohistochemical study shows that there are more apoptosis in IPF lungs (Plataki et al., 
2005). Interestingly, however, cultured fibroblasts from IPF lungs are resistant to apoptosis 
which induced by Fas (Moodley et al., 2004) or plasminogen (Chang et al., 2010). This 
suggests the fibrosis-associated cells can survive with specific anti-apoptosis strategies, 
while fibrosis leads to apoptosis of functional cell in the lung during IPF.  The structure of 
lung epithelium is severely destroyed in IPF lungs. In some cases, the epithelium completely 
disappeared, while in others, cuboidal type 2 cells replaced squamous type 1 cells (reviewed 
in Borchers et al., 2011). Although several studies have shown that alveolar epithelial cells 
may undergo excessive apoptosis (Lepparanta et al., 2010; Tzouvelekis et al., 2007; Uhal et 
al., 1998), it is still under debate in which type of cells the first injury occurs. Morphological 
studies suggest that type 2 alveolar epithelial cells in the unaffected area in IPF lungs 
undergo apoptosis is detected in this type of cells (Barbas-Filho et al., 2001; Waisberg et al., 
2010).  However, in other studies, apoptosis was observed in both alveolar and bronchiolar 
epithelial cells, which is associated with elevated expression of apoptotic factors (e.g p53, 
p21, bax, and caspase-3) and inhibition of the expression of anti-apoptotic factors (e.g bcl-2) 
(Plataki et al., 2005). Fas-mediated pathway of apoptosis and perforin/granzyme B mediated 
apoptosis may contribute to the cell death of epithelial cells (Kuwano et al., 1999; Maeyama 
et al., 2001; Miyazaki et al., 2004). 
1.4.3 Liver fibrosis 
Liver fibrosis, also including biliary fibrosis, is a sequel of chronic liver disease. As IPF, 
liver fibrosis occurs as an abnormal response to persistent injury. Wound healing process 
initiates after the injury occurs, in which parenchymal cells replace damaged liver cells and 
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rebuild the ECM while inflammatory cells clean the debris of the dead cells. However, in the 
presence of persistent injury, a disordered wound healing process may lead to over 
production of ECM and disrupt the liver architecture. There are multi aetiologies of liver 
fibrosis which include viral hepatitis, alcohol, and non-alcoholic fatty liver disease 
(reviewed in Hayashi and Sakai, 2011).   
1.4.3.1 Viral hepatitis fibrosis 
Chronic infection of hepatitis B, C or D can lead to liver fibrosis. Every year, there are 170 
million people affected by HCV infection and 300,000 deaths due to the subsequent 
cirrhosis and hepatocellular carcinoma in the world (Poynard et al., 2003).  Pathologically, 
viral hepatitis fibrosis is characterized by lymphocytes infiltration, piecemeal necrosis of 
hepatocytes, and fibrosis in the periportal areas (reviewed in Hayashi and Sakai, 2011).  
1.4.3.2 Recent studies on liver fibrosis 
Unlike lung fibrosis, in the liver quiescent hepatic stellate cells (HSCs) are one of the major 
cell origins of fibrogenic myofibroblasts in the liver (reviewed in Wallace et al., 2008). 
Current studies have made great progress in studying pathogenesis and searching for 
potential mechanism leading to the reversal of liver fibrosis, with special attention on HSCs. 
In a mouse model of liver fibrosis induced by CCl4, some resolution was observed in 4-6 
weeks after stop of dosing (Iredale et al., 1998), which is due to a rapid loss of 
myofibroblasts by apoptosis (Friedman, 2008). This result is confirmed in another mouse 
model (Issa et al., 2001). Interestingly, the survival of myofibroblasts depends on local ECM. 
The contact between myofibroblasts and collagen 1can increases cell survival and pro-
fibrotic activity (Zhou et al., 2004). In addition, MMPs-TIMPs regulation is also shown to 
be important in the reversal of fibrosis. A rapid decrease of TIMPs during resolution, 
suggests an enhanced function of MMPs which is degrading the ECM (Iredale et al., 1998; 
Issa et al., 2004). Overexpression of TIMP-1 exacerbates liver fibrosis and leads to failure of 
resolution (Yoshiji et al., 2002). Moreover, TIMP-1 shows a function of preventing 
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myofibroblasts undergo fibrosis (Elsharkawy et al., 2005). These studies suggest that 
TIMPs-MMPs regulation is a key factor in liver fibrosis and inhibiting TIMPs may promote 
resolution of fibrosis.  
1.4.4 Animal models for studying virus induced fibrosis 
To overcome the limitations of studying viral- associated IPF in humans, animal models 
were developed to study the pathogenesis and test potential therapies. Bleomycin and FITC 
have been widely utilised to establish mouse models for pulmonary fibrosis (Moore and 
Hogaboam, 2008). A murine model for viral-induced fibrosis has been established using 
MHV-68, which is very close to EBV in humans. In immune-competent mice, MHV-68 
infection can exacerbate existing fibrosis (McMillan et al., 2008), as well as augment 
fibrosis induced by other factors such as FITC (Vannella et al., 2010).  
Research on transgenic mice which lack IFNγR-/- mice shows MHV-68 infection alone can 
trigger pulmonary fibrosis (Ebrahimi et al., 2001). This then becomes a good animal model 
for viral- induced IPF, because some IPF patients show a Th2-dominated immune response 
(Wallace et al., 1995). Generally, the development of lung fibrosis in IFNγR-/- mice shows 
similarities to human IPF, including collagen deposition, increased TGF-β, and viral 
persistency in type 2 epithelial cells, which suggest the tissue damage caused by infection in 
these cells may be the cause of fibrosis (Mora et al., 2005). Moreover, the Th2 induced 
alternatively activated macrophages have been reported to be important in promoting MHV-
68 infection induced lung fibrosis in IFNγR-/- mice (Gangadharan et al., 2008; Mora et al., 
2006). 
1.5 Project outline 
The project aims to extend the investigation on the nature of MHV-68 infection in an 
environment dominated by an extensive tissue fibrosis. The research involves a detailed 
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understanding of host and virus mechanisms operating in the spleen of MHV-68 infected 
IFNγR-/- mice and particularly focusing on the viral latency in the spleen.  
First, we confirm and extend the previous study on pathological changes and viral infection 
during latent infection.  
Second, we investigate the mechanisms which result in the loss of splenocytes, in particular 
the reduction of latently infected B cells. The possible mechanisms investigated include 
excessive apoptosis and viral reactivation. We also examine the infection in each B cell 
subpopulations to explore the possible link between virus-manipulated germinal centre 
reaction and fibrosis.  
Third, we investigate the dynamics of macrophages in the induction, expression, and 
recovery of fibrosis. 
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2.1 Mice  
Wild type 129Sv mice and interferon gamma receptor knockout (IFNγR-/-) mice (Huang et 
al., 1993) on the 129Sv background were purchased from B&K Universal (Hull, UK) and 
were bred at the University of Edinburgh Animal Facility. 
Transgenic C57BL/6 mice (Macgreen mice) with insertion of a 7.2 kb promoter element of 
the c-fms gene with EGFP gene show green fluorescence in macrophage, trophoblast, and 
granulocyte lineages (Sasmono et al., 2003; Sasmono et al., 2007). Macgreen mice were 
obtained from Prof. David Hume of the Roslin Institute. In order to produce Macgreen 
IFNγR-/- and wild type mice on 129Sv background, Macgreen mice on C57BL/6 background 
were crossed with IFNγR-/- mice on 129Sv background. Heterozygotes of F1 generation 
were crossed to produce IFNγR-/- Macgreen mice and wild type Macgreen mice on a mixed 
background of 129Sv and C57BL/6. Mice were genotyped by PCR to identify Macgreen 
IFNγR-/- , Macgreen wild type (IFNγR+/+), and Macgreen wildtype / IFNγR+/- (appear as 
IFNγR+/+), littermates matched as pairs. The work of cross-breeding and typing the mice 
was done by Dr B. M. Dutia and Mr Ian Bennet using the animal facility of Hugh Robson 
Building and Royal (Dick) School of Veterinary Medicine. All mice were housed under 
specific pathogen-free conditions, and mostly used in experiments at 8 to 12 weeks of age 
(unless otherwise stated).  
2.2 Cell culture 
Baby hamster kidney 21 (BHK-21) cells (Macpherson and Stoker, 1962) are a continuous 
fibroblastoid cell line which were cultured in Glasgow modified eagle’s medium (GMEM, 
Invitrogen, UK) with 10% NBCS, 10% tryptose phosphate broth (TPB, Invitrogen, UK), 
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Master stocks of cells were stored in FCS (with 10% DMSO) in liquid nitrogen. When 
required for working stocks, the cells were thawed rapidly at 37ºC. Pre-warmed media was 
added slowly to the cells followed by centrifuging at 1500rpm for 5 minutes. Cell pellets 
were re-suspended in 5–10ml of media and cultured in sterile plastic-ware (Nunc, UK) and 
incubated at 37ºC with humidified 5% CO2. Cells were sub-cultured when they reached 80% 
confluent growth by incubating in 0.25% trypsin (Invitrogen, UK) until the cells could be 
removed from the surface of the flask by gentle tapping. The trypsin was then diluted by 
adding an equal volume of medium, and cells with diluted medium were collected in plastic 
universals in medium and centrifuged at 1200rpm for 5 minutes. The cell pellets were re-
suspended in growth medium. The number of cells was determined by mixing them 1:1 with 
0.1% Trypan Blue, then counting using a haemocytometer and optical microscope. 
Approximately 5×106 cells were reseeded into a T175 flask in 40ml of medium.  
2.3 Viral stock preparation, titration, and infection of mice 
2.3.1 Viral stock preparation 
Working stocks of MHV-68 were prepared by infection of BHK-21 cells in GMEM 
(Invitrogen, UK) with 10% NBCS, 10% TPB, 100u/ml Pen-strep, and 2mM L-G. The virus 
was added to cells at a multiplicity of infection (MOI) of 0.001 plaque forming unit per cell, 
followed by incubation at 37ºC for 90 minutes. Then 3×106 cells were plated into each T175 
flask. Infected cells were incubated at 37ºC until plaques had formed and the cell monolayer 
started to fall off (about 6 days). Cells carrying the virus were made pellets by centrifugation 
at 1300 x g for 20 minutes at 4ºC. The pellets were homogenised by grounding in a sterile 
dounce homogeniser and then sonicating in an ice bath for 15 minutes. The homogenised 
mixture was then centrifuged at 1300 x g for 20 minutes at 4ºC. The supernatant was 
collected and the remaining was re-suspended. Homogenisation was repeated once followed 
by centrifugation at 1300 x g for 20 minutes at 4ºC. Supernatant were pooled together with 
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the lysate collected from the last step, which carried the majority of the virus. The viral stock 
then was aliquoted and titrated. All viral stocks were stored at -80ºC. 
Genetically modified virus mLANA-MHV68 (Nealy et al., 2010) working stock was 
obtained from Scott Tibbetts’s lab (Louisiana State University, USA) and was cultured as 
the same as wild type MHV68.  
2.3.2 Titration 
The virus was serially diluted in complete GMEM from 10-2 to 10-9 pfu/ml, 4ml each. To 
each dilution of virus were added 2×106 BHK cells, followed by incubation at 37ºC while 
shaking for 1 hour. For each dilution, 2 Petri dishes were set up by adding 2ml of infected 
cells to each. Two uninfected controls were set up at the same time. After incubation at 37ºC 
for 4 days, the medium was removed and the cells were fixed with 10% Neutral Buffered 
Formaldehyde and stained with 0.1% Toluidine blue. The number of plaques was counted 
for 3 dilutions and the titre was calculated by the equation below: 
Titre = (number of plaques × dilution 1) + (number of plaques × dilution 2) + … / the lowest 
dilution × number of petri-dishes counted × final volume of each dish (2ml) 
2.3.3 Infection of mice 
Age-matched mice were anaesthetised using either Halothane or Isoflurane (Merial) and 
inoculated intranasally with either 4×105 or 4×103 pfu of virus in 40μl of sterile PBS. The 
infection was done by dropping the viral solution onto the mouse’s nostrils. Mice were 
sacrificed by CO2 asphyxiation on day 12, 16, 20, 24, 28, 32, 35, 48, and 60 post infection. 
2.4 Spleen cell harvesting 
Spleens were teased out of the capsule with a scalpel blade into RPMI medium (with 10% 
FCS, 2mM L-G, and 100μg/ml Pen-strep). Red blood cells were lysed by a quick mixing 2–
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3ml of ddH2O for 10–15 seconds, followed by rapid addition of 10–12ml of PBS or RPMI 
media to prevent destruction of the lymphocytes. The cells were pelleted by centrifugation at 
1500rpm for 5 minutes and re-suspended in fresh medium. In certain circumstances, 
collagenase digestion was applied to release cells from fibrotic spleens using Liberase TL 
research grade (Roche) (alternative: Collagenase 4). Spleen tissue was finely chopped with a 
scalpel in a small amount (1–2.5ml for each spleen) of digestion buffer (PBS with 5% Pen-
strep, 1.8mM CaCl2, and 1mM MgCl2). Liberase and DNase solution were added and 
followed by an incubation of 20 minutes at 37ºC with horizontal shaking. The digestion was 
stopped by adding 1ml of EDTA stop solution (0.1M EDTA pH7.3) and mixing. Cells were 
washed and re-suspended for the next step. The number of splenocytes was determined by 
mixing them 1:1 with 0.1% Trypan Blue, then counting using a haemocytometer under 
optical microscope. 
2.5 Cell selection by magnetic beads (MACS) 
CD19 Microbeads (mouse, Miltenyi, 130-052-201) were used to select spleen B cells from 
the spleen cell suspension. For each sample, the total cell number and the proper amount of 
suspension for selection was determined. Before selection, cells were suspended in 90μl 
MACS buffer (which contains PBS pH7.2, bovine serum albumin 0.5% [w/v] and EDTA 
2mM within a total volume of 1.5L) per 107 total cells, and 10μl CD19 Microbeads were 
added per 107 total cells. The mixture was incubated for 15 minutes at 4–8ºC, after which the 
cells were washed with MACS buffer and re-suspended in 500μl of MACS buffer. Then 
samples were applied to the top of prepared MACS columns which were set up on a 
magnetic cell selector. The columns were then removed from the magnet and selected cells 
were collected by adding 1ml MACS buffer and flushing through with a plunger. The cell 
number after selection was determined and 10,000 selected cells were preserved for flow 
cytometry. Selected cells were then pelleted by centrifugation and stored at -70ºC. CD11b 
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Microbeads (mouse/human, Miltenyi, Germany) were used to select macrophages by the 
same method described above.  
The purity of selected cells was tested by flow cytometry. Cells from CD19 Microbeads 
positive selection were stained using CD 45R (B220)-FITC antibody (mouse, Miltenyi, 
Germany). Cells were then fixed with 2% (v/v) formaldehyde and stored in the dark at 4ºC 
before FACS analysis. Selected macrophages were tested using CD11b-APC Antibody 
(mouse/human, Miltenyi, Germany).  
2.6 DNA extraction 
2.6.1 DNA extraction from spleen tissue using DNeasy tissue kit 
RNAlater treated spleen tissues (up to 30mg) were stored at -70ºC and were defrosted on ice, 
and then roughly disrupted into small pieces. The purpose of RNAlater treatment was to 
prevent RNA degradation for other experiments, and according to the manufacturer, 
RNAlater does not affect DNA extraction. Total DNA was extracted using a DNeasy tissue 
kit (Qiagen) following the manufacturer’s instructions. First, buffer ATL with Proteinase K 
was added, and samples were incubated overnight at 55ºC to disrupt the cells. Then 200μl of 
Buffer AL was added, and samples were incubated at 70ºC for 10 minutes. To precipitate 
DNA 200μl ethanol was added and the mixture was loaded onto the spin column, followed 
by centrifugation at 11300 x g for 1 minute. The column was washed once with buffer AW1, 
and washed again with buffer AW2. Finally, DNA was eluted within 100μl buffer AE. The 
concentration of DNA extracted was then tested by Nanodrop spectrophotometer. 
2.6.2 DNA extraction from 96-well microtiter plates 
This method is adopted from Molecular Cloning: A Laboratory Manual, third edition, 
chapter 6.19, protocol 4: isolation of DNA from mammalian cells grown in 96-well 
microtiter plates. Briefly, the correct amount of cells was added into each well, the plates 
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were first centrifuged and then the supernatant was removed by pipetting, followed by 2 
washes in PBS. Then 100μl cell lysis buffer (10mM NaCl, 10mM Tris-Cl pH7.5, and 10 
mM EDTA Ph8.0, 0.5% SDS, Proteinase K 100μg/ml) was added into each well, followed 
by overnight incubation at 60ºC in an oven or water bath in a sealed humid box. After 
cooling down to room temperature, 100μl of NaCl/ethanol solution (add 100μl of 5M NaCl 
per 10ml of absolute ethanol; store at -20ºC) was added. Plates were then left on the bench 
without mixing for 30 minutes at room temperature until a stringy precipitate of nuclear acid 
was formed. The solution was then decanted by slowly inverting each plate over a sink or 
towel papers while the precipitate remained in the wells. The remaining ethanol was drained 
by placing the plates upside down on a bed of dry towels for a short time. To wash the 
precipitates, 150μl of 70% ethanol was slowly added to each well, and drained in the same 
way as described above (repeat 3 times). The plates were dried at room temperature until the 
rest of the ethanol had evaporated. Total DNA was eventually dissolved in 50μl of TE 
(pH8.0) buffer by gentle rocking for 12–16 hours at room temperature. The concentration of 
DNA extracted was tested by Nanodrop spectrophotometer. 
2.7 Extraction and quantification of total RNA  
2.7.1 Total RNA extraction from spleen tissue or cell pellet 
Spleen tissue was preserved in RNAlater at 4ºC overnight, then removed from RNAlater and 
stored at -70ºC until use. Cells were made pelleted by centrifugation. Supernatant was 
decanted and stored at -70ºC. Total RNA was extracted using RNeasy mini kit (Qiagen) 
following the manufacturer’s instructions. For samples less than 106 cells, RNeasy micro kit 
(Qiagen) were used to extract total RNA. Spleen tissue (around 30mg) was disrupted and 
homogenised using a blue pestle (Sigma) in 600μl buffer RLT with 1/100 volume of β-
Mercaptoethanol, followed by centrifugation passing though Qiashredder homogeniser 
(Qiagen). The clear lysate was centrifuged at the speed of 11300 x g for 3 minutes, and then 
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the supernatant was transferred into a 1.5 centrifuge tube. For extraction from cells, buffer 
RLT was added directly to re-suspend and make cell lysate. Then 600 μl of 70% ethanol was 
added and mixed immediately. The mixture was loaded into an RNeasy spin column, and 
then centrifuged for 15 seconds at 11300 x g, and flow-through liquid was discarded after 
centrifugation. The rest of the sample was loaded onto the same column by repeating the last 
step. The column was washed by adding buffer RW1. DNA contamination was eliminated 
by on-column DNase digestion (Qiagen), followed by washing twice in Buffer RPE. Total 
RNA bound on the silicon net was eluted by adding 30μl to 50μl (varies according to 
starting materials) RNase free water then spinning down.   
2.7.2 RNA quality test and quantification  
For reverse transcription, RNA quality and concentration were tested by both nanodrop 
spectrometer (Thermal) and Agilent nano/pico RNA microchip (Agilent). 
2.8 Reverse transcription  
SuperScript III Reverse Transcriptase Kit (Invitrogen, UK) and Random Primers (500μg/ml, 
Promega) were used in first-strand cDNA synthesis. For each 20μl reaction, 500ng to 1ul of 
RNA, 1ul of random primers (500μg/ml), and 1ul of dNTPs (10mM) were added first, and 
incubated at 65ºC for 5 minutes and 1 minute on ice. Then the following reaction 
components were added: 
5×first strand buffer                            4ul 
0.1M DTT (0.1M)                               1ul 
RNase OUT   (40 U/ μl)                      1ul 
Superscript III (200 U/ μl)                  1ul 
 
Samples were left at room temperature for 5 minutes, 50ºC for 60 minutes, and 70ºC for 15 
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2.9 Determination of suitable housekeeping genes in 
spleen B cells 
Twelve candidates for reference gene(s) were tested to find the most stably expressed gene(s) 
in spleen B cells in wild type and IFN-γ R-/- mice in different stages of MHV-68 infection. 
Mouse Normalisation Gene Panel (Quantace) and standard curve materials (PCR product 
with known copy number) for 12 housekeeping genes were adopted from Gillian Campbell 
from Nash/Dutia lab. Groups of cDNA samples were tested as follows: 
 Uninfected Day 12 post infection Day 20 post infection 
Wild type 3  3      3 
γ-129 (IFN-γ R-/-) n/a 3      3    
Table 2.1 The numbers of mice in each group tested 
Real time PCR were carried out for 9 housekeeping genes using qPCR reagents from Roche 
Company.  
 For 20μl reaction (ul) 
Water 10.95 
10×Buffer 2 
dNTPs (10mM each) 0.4 
MgCl2 (2.5mM) 0.4 
Primer pair (concentration varies 
depending on different targets) 
0.4 
Sybr Green 0.7 
Faststart Taq (5U/ μl) 0.15 
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GACTINE Gamma actin, cytoplasmic 
YWHAZ Tyrosine 3-monooxygenase, zeta polypeptide 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
B2MG Β-2 microglobulin 
RPL13A Ribosomal protein L13a 
PGK Phosphoglycerate kinase 1 
BACTIN Β actin cytoplasmic 
RN18S 18S rRNA Genbank 
UBQC Ubiquitin 
Table 2.3 Housekeeping candidates for real time PCR 
Results analysis was performed using the software GeneX (Multi D). 
2.10 PCR  
Conventional polymerase chain reactions (PCR) to amplify housekeeping genes were 
performed to test the cDNA product. For each 50μl reaction, the PCR reagents included 5μl 
of 10×PCR buffer, 3 μl of 50mM magnesium chloride, 1 μl of 10mM dNTP mixture, 1ul of 
10μM primer forward, 1 μl of 10uM primer reverse, 37 μl of water, 1 μl of cDNA, and 1 μl 
of Taq (5U/ μl storage concentration at 1:3 dilution for reaction). A hot start protocol was 
carried out as follows: 94ºC for 5 minutes, 80ºC hold (Taq added during holding), then 
denature at 94ºC for 45 seconds, anneal at 55ºC for 45 seconds, extend at 72ºC for 1 minute 
for 35 cycles, and the last extension under 72ºC for 7 minutes.  
2.11 Quantitative PCR 
qPCR were performed to test viral gene expression. The genes tested and primers’ sequences 
are listed in appendix 2. qPCR for M1 and housekeeping gene YWHAZ were set up for this 
74 
 
Chapter 2                                                                                            Methods and materials 
project. qPCR for DNA polymerase, RTA, ORF73, and M11 were set up by Mr Ian Bennet 
in the Nash/Dutia lab. 
2.11.1 Generating standard material for qPCR 
Amplification using proofreading DNA polymerase 
DNA segments were amplified using PfuTurbo DNA polymerase (Promega). A polymerase 
chain reaction was performed in a 50μl system. The components and reaction programme of 
a PCR reaction is listed in appendix 1. The PCR product was analysed by gel electrophoresis. 
The addition of 3’ adenine post-amplification 
As amplification with Pfu will not result in the 3’ A-overhang which is necessary for cloning 
using the pCR4-TOPO vector, it is essential to add 3’ A-overhang to the amplified product. 
1U of Taq polymerase was added into each PCR reaction, followed by incubation at 72ºC 
for 8–10 minutes. A sufficient number of PCR products with additional 3’ adenine were 
generated for the next step. The products were placed on ice and were used in the cloning 
reaction immediately. 
Cloning reaction and transformation 
Cloning was performed using a TOPO TA Cloning Kit for Sequencing (Invitrogen) 
according to the manufacturer’s instructions. The components are as follows: 
Fresh PCR product   1ul 
Salt solution             1ul 
Water                        3ul 
Topo vector              1ul 
The components were added and mixed gently, then incubated for 5 minutes at room 
temperature. The mixture was immediately used in transformation. 
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The ligated vector with DNA insertion was then transformed in One Shot TOP 10 
chemically competent cells (Invitrogen) according to the manufacturer’s instructions. For 
each reaction, one vial of competent cells was thawed slowly on ice before the addition of 
the cloning reaction product. Cells were incubated on ice for 30 minutes, followed by a 30-
second heat shock at 42ºC. 
The sample was immediately placed on ice. SOC medium was added, followed by 
incubation at 37ºC for 1 hour while horizontally shaking. LB plates with kanamycin 
(50μl/ml) were used to culture the transformed E. coli cells selectively, followed by 
incubation at 37ºC for 12–16 hours. At least 4 colonies were picked from each plate, and 
they were cultured in medium containing kanamycin (50μl/ml). Plasmids were extracted 
using a mini prep kit (Qiagen) and were first analysed by restriction endonuclease digestion 
(EcroRI, Promega) and gel electrophoresis. Sequencing of the inserted DNA segments was 
performed using M13 reverse and M13 forward primers. The sequencing reaction was 
performed as follows: 
Big dye 1ul 
5x sequencing buffer 1.5ul 
Primer 3.2ul (1 pmol/ul) 
Template DNA 1 ul 
Water 3.3ul  
The components were added and the reaction was performed: 
1. 94ºC for 2 minutes 
2. 96ºC for 10 seconds 
3. 50ºC for 5 seconds 
4. 60ºC for 2 minutes (30 cycles, step 2 to step 4) 
5. 72ºC for 5 minutes   
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Sequencing was carried out by the SBS sequencing service (Ashworth Labs, Kings 
Buildings, University of Edinburgh). 
Restriction endonuclease digestions using either NotI or SpeI (Promega) were carried out to 
linearise the circulated plasmid. The linearised PCR product was used as the standard 
material for qPCR. 
Quantification of plasmid copy number 
The concentration of DNA of extracted plasmids was determined by Nanodrop 
spetrophotometry (Thermal). The number of copies of plasmid was calculated using the 
following equation: 
Copy number (/ul) = 6.032×1023 (copies/mol) × plasmid concentration (g/ul) / MW of whole 
plasmid (g/mol) 
MW of whole plasmid (g/mol) = (Bp (insert) + Bp (vector)) × 660 dalton/bp  
According to the copy number calculated, standard materials were aliquot and diluted into 
109 copies/ul and stored at -20ºC until use.   
Optimisation of qPCR 
qPCR was performed in a Rotorgene 3000 qPCR machine (Qiagen) using the SYBR green 
method. SYBR green is an intercalating dye which generates green fluorescence when 
bound to double-strand DNA. Therefore, the levels of dsDNA amplified during PCR 
reaction are reflected by the level of fluorescence generated. Reactions were performed in a 
20μl system in 0.1ml strip tubes (Qiagen), and consisted of the following: 
PCR reaction buffer with 20mM MgCl2 
dNTPs (10mM each) 
0.75U of Faststart Taq DNA polymerase (Roche) 
0.7ul of SYBR green (1/5000 dilution in DMSO, Biogen Ltd) 
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5ul of DNA template (standard material or cDNA/DNA sample); concentration of DNA 
template added varies according to experiments. 
In order to rule out the possibilities that the reaction system was contaminated or the 
florescent signal was generated by by-products such as dimers, 2 to 3 repeats of no-template 
controls were performed in each run. Instead of template DNA, 5μl of water was added. 
The starting qPCR program is as follows: 
95ºC for 5 minutes 
94ºC for 20 seconds, 62ºC for 20 seconds (anneal temperature may vary), 72ºC for 20 
seconds (repeat 45 cycles), acquire after each cycle. 
Hold at 94ºC for 20 seconds. 
Melt from 65ºC to 94ºC, rising by 1ºC for each step, wait for 45 seconds on first step, then 
wait for 5 seconds for each step afterwards, acquire in each step. 
 
For each pair of specific primers, it is necessary to optimise the conditions of reaction, 
including primer concentration, Mg2+ concentration, and anneal temperature.  
Primers at different final concentration, from 200nM to 600nM, were added into reactions, 
and the concentration in which the reaction amplified the most efficiently and generated the 
least primer dimmer was chosen. Similarly, different final concentrations of MgCl2 (from 
2.0 to 5.0) were tested. For the qPCR buffer, which already contained 2.0mM MgCl2, the 
variable tested was the amount of additional MgCl2 needed for each reaction. Annealing 
temperature was originally set as 62ºC and was adjusted up or down within a range of 2ºC 
according to the primers used. 
2.11.2 Absolute Quantification 
Standard curves are required in absolute quantification. To generate a standard curve, 
standard material was diluted into 105 copies /μl and then serially diluted 10 times until 100 
copies /μl in Tris buffer (1mM). There were 3 repeats for each dilution, and 5μl of DNA 
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template was added in each reaction. The qPCR was performed in the optimised condition, 
and standard curves were generated as in the example in Figure 2.1. A tolerance range of 
0.93 to 1.05 was selected for efficiency of qPCR, and the R and R2 values should be close to 
1. The products were analysed by gel electrophoresis and sequencing. 
Normalisation 
According to the result of housekeeping genes selection, one of the cellular genes, YWHAZ, 
was selected. Normalisation with housekeeping gene was performed in order to eliminate 
the effect of starting material and the efficiency of reverse transcription. Considering the 
possibility that one cell may carry multiple viral genomes, the viral DNA was also used as a 
factor to normalise the viral gene expression, in addition to housekeeping gene 
normalisation. For each spleen sample, both total RNA and DNA were extracted (for 
method see DNA extraction). Reverse transcribed cDNA and total DNA extracted were both 
tested using the same pair of primers in qPCR. The data generated from total DNA represent 
the amount of viral genome in the same amount of spleen cells, and it was used to normalise 
the copy number of viral genes transcribed into total RNA. 
Results analysis 
Data processing and statistical analysis were carried out using Rotorgen 6 software 
(Invitrogen), GenEX (MultiD), and Excel (Microsoft). 
2.11.3 Comparative quantification (∆∆Ct method) 
Standard curve material is not required in the method of comparative quantification (ΔΔCt 
method). Instead, a mix of all cDNA samples was used as an inter-plate calibrator. The 
qPCR assays were optimised as absolute quantification, and the components and 
programming of the reaction was mostly similar to absolute quantification. The validation of 
the housekeeping gene is shown in Figure 2.2. Data processing and statistical analysis were 
carried out using Rotergen 6 software (Invitrogen), GenEX (MultiD), and Excel (Microsoft). 
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Figure 2.1 An example of a standard curve generated from qPCR assay for M1 







delta Ct against yw h







Figure 2.2 Validation of comparative quantification: comparison of qPCR efficiency of 
target gene and housekeeping gene. The calibrator (mixed cDNA sample) was serially 
diluted two-fold from 1/10 dilution to 1/160 dilution, similar to standard curves. qPCR was 
performed using both the gene of interest (GOI) and the housekeeping gene (HKG). The ΔCt 
value for each dilution was recorded and the ΔΔCt = ΔCtGOI – ΔCtHKG calculated. The 
purple line represents the linear regression of ΔΔCt changing according to the 
concentration of starting material cDNA. The slope of this line is close to 0, which means 
the efficiency of both primers is similar within the range of concentration of starting 
material tested. The housekeeping gene can only be used when the slope of ΔΔCt linear 




Chapter 2                                                                                            Methods and materials 
2.12 Limiting dilution assay 
IFNγR-/- and 129Sv mice were infected intranasaly with 4000pfu MHV-68 and spleens were 
harvested on day 28, day 40, and day 68 post infection. For each spleen sample, red blood 
cells were lysed by quick mixing with 3ml of sterile water, followed by the addition of 
sterile PBS up to 15ml in total, and whole-spleen cell suspension was prepared and the cell 
number was determined. For each spleen, in a 96-well plate, 106 spleen cells were added in 
the first row as positive control; 2×105 spleen cells were serial diluted twofold 10 times (8 
wells/replicates for each dilution). As background, 9×105 BHK21 cells were added to each 
well. Cell mixtures were lysed and digested by proteinase K overnight and total DNA was 
extracted in each well according to the protocol described in section 2.6.2. For DNA 
samples from each well, PCR was performed using primers for MHV-68 ORF73 on Rotor-
Gene 3000 thermal cycler (Qiagene), with positive and no-template controls for each run. 
Realtime PCR products were confirmed using melt curve analysis using Rotor-Gene 6 
software (Qiagen).  
Data were analysed using GraphPad Prism software. The frequencies of viral genome-
positive cells were determined from nonlinear regression analysis of sigmoidal dose-
response best-fit curve data. Based on Poisson distribution, the frequency at which at least 
one event in a given population is present occurs at the point where the regression analysis 
line intersects 63.2% (Nealy et al., 2010). 
2.13 Flow cytometry 
2.13.1 Sample preparation 
Spleen cell suspensions were prepared by scraping using a scalpel blade. For each spleen 
sample, red blood cells were lysed by quick mixing with 3ml of sterile water, followed by 
addition of sterile PBS up to 15ml in total. Pelleted spleen cells were adjusted to a 
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concentration of 2×107 cells/ml in FACS buffer (PBS, pH7.2, 1% FCS). For each sample, 
2×106 cells/ml to 4×106 cells/ml (depending on cell number recovered from fibrotic spleens) 
cell suspension was preserved for FACS analysis and the rest were loaded with β-lactamase 
substrate for sorting. Spleen cells for analysis were first blocked by adding anti-mouse 
CD16/CD32 Fc block reagent (Stratagene), followed by incubation at 4ºC for 5 minutes. 
After blocking, the samples directly proceeded to the staining steps without a washing step 
in between. 
2.13.2 Immunostaining 
Florescence conjugated antibodies were added, then incubated for 30 minutes on ice in the 
dark. B-cell subsets used these antibodies: APC/Cy7-conjugated anti mouse CD19 (Clone 
1D3, made in rat, Biolegend), APC-conjugated anti mouse CD38 (clone 90, made in rat, 
Biolegend), and biotin-conjugated anti mouse IgD (clone 11-26c, made in rat, Biolegend). 
For monocyte/macrophages and granulocytes labelling, APC conjugated anti-mouse CD11b 
(made in rat, Miltenyi) and PE conjugated anti mouse Ly-6G (made in rat, Biolegend) were 
used. After incubation on ice in a darkroom for 20 minutes, cells were washed by adding 
FACS buffer and mixing, then spinning down 3 times. PE conjugated streptavidin 
(Biolegend) were used as a secondary reagent to detect biotinlated anti IgD antibody and 
washed. Unstained control and single-stain controls were performed in each experiment. 
2.13.3 Detecting β-lactamase 
Cells were adjusted at a concentration of 1×107 cells/ml in FACS buffer. The CCF2/AM β-
lactamase substrate loading kit (Invitrogen) was used according to the manufacturer’s 
suggestions, as well as a published protocol (Nealy et al., 2010), and adapted as needed for 
our facilities and practical reasons. Freshly prepared CCF2/AM substrate (for CCF2/AM 
substrate 100μl 0.6 A +6 B mix and votex, then +93.4ºC, then votex again) was added for 5 
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minutes at room temperature. Cells were then washed in FACS buffer 3 times. Unstained 
and uninfected controls were performed in each experiment. 
2.13.4 Analysis on flow cytometer 
Flow cytometry was performed on FACS Aria III sorter (BD Biosciences) and the results 
were analysed using either Flowjo (Treestar) or FACS Diva (BD) software. For each spleen, 
106 cells were used for B-cell staining and analysing, and another 106 cells were used for 
macrophage/granulocytes-staining and analysing. The rest of cells were loaded with 
substrate and both ORF73-β-lactamase positive and negative cells were sorted into 
RNAlater. Data were then analysed using GraphPad Prisim software (GraphPad software). 
2.14 TUNEL Assay  
Spleen tissue paraffin sections were deparaffinised in 2 changes of xylene for 5 minutes each, 
and hydrated with 2 changes of 100% ethanol for 3 minutes each and 95% ethanol for 1 
minute. After rinsing sections and pre-treatment by proteinase K, endogenous peroxidase 
was blocked by incubating sections in 3% hydrogen peroxide decomposition in PBS for 10 
minutes. After pre-incubation in reaction buffer for 10 minutes, a mixture of terminal 
transferase (New England BioLabs) and Biotin-16-dUTP (Roche Diagnostic) was applied 
for 2 hours at 37°C. The reaction was stopped by adding stop washing buffer (300mM NaCl, 
30mM Sodium Citrate). Positive staining was then detected by streptavidin-POD (Roche, 
1/1000 dilution) and DAB (Sigma). All slides were counterstained with hematoxylin to 
locate the cell nucleus, then re-dehydrated using 95% ethanol for 5 minutes and then 100% 
ethanol for 3 minutes two times, and cleared twice in xylene for 5 minutes before being 
covered with mounting medium and a coverslip. Slides were observed under an optical 
microscope and 10 pictures of continuous views were taken for each spleen. There were at 
least 3 mice in each group. The number of brown stained cells was counted to measure the 
level of cell death in the spleen.  
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2.15 Immunohistochemistry  
2.15.1 Immunohistochemistry on paraffin embedded spleen 
sections 
Paraffin sections were deparaffinised and rehydrated, and endogenous peroxidase was 
quenched as described in TUNEL assay. Antigen unmasking was carried out (according to 
primary antibody used) by bringing the slides to a boil in sodium citrate buffer (10mM, 
pH6.0); sub-boiling temperature was maintained for 10 minutes, then the slides were cooled 
down to room temperature. After blocking non-specific binding (Casblock or normal serum 
according to the secondary antibodies used, 1 hour), the primary antibody was applied at 
optimised concentration overnight at 4ºC. Biotin conjugated secondary antibodies were 
applied at optimised concentration for 1.5 hours at room temperature. Enzyme conjugate and 
substrate (DAB, Sigma) were applied, counterstained, and dehydrated as in the TUNEL 
assay.   
Target  Pre-treatment  1st Antibody 2nd Antibody 
B cells Block with 
casblock 
CD45R/B220 (rat 
IgG2a 1/300 diluted) 
Rabbit anti-rat biotin 
conjugated (BA4000, 1/300 
diluted) 




(cell signalling Rabbit 
mono IgG) 
Goat anti-rabbit biotin 
conjugated (1/300 diluted) 
Table 2.4 Reagents used in immunohistochemistry on paraffin sections 
2.15.2 Immunohistochemistry on frozen spleen sections 
expressing EGFP 
Tissue processing and sectioning 
Spleens were harvested and fixed for 2 hours in 4% paraformaldehyde, followed by 18% 
(w/v) sucrose and 30% (w/v) sucrose until they sank to the bottom of the container. Fixed 
tissues were washed in PBS and embedded in OCT compound (Sakura Finetek). The 
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embedded tissues were quickly frozen by immersing the specimens in liquid nitrogen and 
kept at -70ºC until sectioned. To protect the EGFP, all the processing and staining were 
carried out in the dark as much as possible. 
The samples were sectioned using a Cryostat sectioning machine (Leica). Sections 10μm 
thick were cut and collected on poly-L-lysine pre-treated microscope slides (VWR). During 
sectioning, the material was kept at -16ºC and thawing was avoided. The sections were dried 
completely at room temperature before being stored at -70ºC.  
Staining 
After blocking non-specific binding (Casblock or normal serum according to the secondary 
antibodies used, 1 hour), primary antibody was applied at optimised concentration overnight 
at 4ºC. Isotype matched control antibodies were applied to show the possible unspecific 
binding of the primary antibody. Either a biotin conjugated or fluorophore conjugated 
secondary antibody was applied at optimised concentration for 1.5 hours at room 
temperature. Fluorophore conjugated streptavidin was used with the biotin conjugated 
sencondary antibody. Before applying any reagents, the slides were washed in the dark at 
room temperature 3 times for 5 minutes. DAPI (common nuclear dye, applied by Nash/Dutia 
lab, 1/10,000 dilution) was applied to counterstain cell nuclei for 3 minutes at room 
temperature in the dark.  
Target  Pre-treatment  1st Antibody 2nd Antibody 
B cell Block with normal 
rabbit serum 5% 
Anti-mouse 
CD45R/b220 (rat IgG2a 
1/300 diluted) 
Rabbit anti rat biotin 
conjugated (BA4000, 
1/300 diluted) 
T cell Block with casblock 
or 5% normal goal 
serum  
CD3 (1/150 Rabbit, 
monoclonal) 





Block with casblock 
or 5% normal goal 
serum 
Anti α-smooth muscle 
actin (rabbit, 
polyclonal) 
Goat anti-rabbit biotin 
conjugated 




Chapter 2                                                                                            Methods and materials 
86 
 
2.15.3 Observation and image processing 
Slides without fluorescence were observed under an optical microscope (Nikon E800). 
Slides with fluorescence were observed and scanned using a Confocal Microscope (710, 
Zeiss). Pictures were taken and analysed by Zen software (Zeiss) and Image J. 
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3.1 Introduction 
Previous works in the Nash/Dutia lab investigated the role of IFNγ in MHV-68 latency by 
infecting IFNγ receptor deficient mice (IFNγ R-/- mice), in which distinctive pathological 
changes were observed. These changes were characterised by severe fibrosis in multiple 
organs, including lung, liver, and lymphoid tissue (Dutia et al., 1997; Ebrahimi et al., 2001). 
The fibrosis triggered by viral infection showed similarities to the chronic human diseases 
idiopathic pulmonary fibrosis (IPF) (Mora et al., 2005) and sclerosing cholangitis (SC) 
(Gangadharan et al., 2009). IPF has been linked with the presence of EBV, whereas SC is of 
unknown etiology (reviewed in Moore and Hogaboam, 2008; Vannella et al., 2010).  
In contrast to the pathology of the lung and liver, a more dramatic fibrosis was observed in 
the lymphoid system. The spleen and the mediastinal lymph nodes which collect the lymph 
from the lung underwent large-scale destruction of tissue architecture, which most likely 
was the result of persistent tissue damage caused by lytic infection, or host immune response 
in which T cells and macrophages targeted latently infected cells. Macrophages exhibited an 
alternate activation phenotype characteristic of an immune response dominated by Th2 
cytokines (Gangadharan et al., 2008). Collagen production was evident around day 16 post 
infection and played an important role in clustering fragmented germinal centres and walling 
off latently infected B cells. By day 20 post infection, fibrosis was at its most intense, with 
fibroblasts dominating the splenic architecture. There was a dramatic decline in the number 
of splenocytes and any further uptake of cells from the vascular system was inhibited. 
Morphologically, the spleen appeared anemic and shrunken. Remarkably, as the virus was 
reduced the host began to repair the damage and by day 35 post infection, reformation of 
follicles and a return of cell numbers were observed.  
In this chapter, we extended the previous work in the Nash/Dutia lab to address key 
questions relating to the distribution and the fate of latently infected B cells at different 
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phases of the splenic pathology. In this respect we were particularly interested in what 
happens during the loss of latently infected B cells between day 20 and day 28. We 
confirmed previous observations of the development and resolution of splenic fibrosis 
around lymphoid follicles by Masson’s trichrome staining. Furthermore, we investigated the 
distribution of B cells, focusing on late time points between day 16 and day 35 post infection, 
which have not been investigated thoroughly. The study by Gangadharan used in situ 
hybridisation for vtRNAs to detect latent virus in the spleen. This led to the conclusion that 
events in the fibrotic spleen lead to a clearance of latent virus around day 26 post infection 
(Gangadharan, 2006). This surprising observation was further investigated using limiting 
dilution assays and qPCR, which data is contradictory to the previous finding. Finally, we 
investigated the mechanism which may result in the massive loss of splenocytes in IFN-γ R-/- 
mice during fibrosis by looking at excessive apoptosis.  
 
3.2 General pathological studies 
3.2.1 Distribution of fibrosis in the spleen of IFNγ R-/- mice 
IFNγ R-/- mice and 129Sv (WT) mice were infected with 4x103 pfu (if not specified) in 40μl 
sterile PBS intranasally. Generally the dose used in our lab is 4x105 pfu; however, there was 
considerable variation in the development of splenic fibrosis among IFNγR-/- mice even 
within littermates of similar age and same sex. In addition, some mice also died 
unexpectedly. We hypothesized that infection with high doses might cause more variation in 
the acute immune response as small changes in inoculum reaching the lungs would have a 
larger effect on the dose. This would therefore affect the speed of fibrosis development.  To 
address this possibility and to prevent the mortality observed at the high inoculum we 
decreased the dose to 4x103 pfu and observed less mortality in IFNγR-/- mice. The 
development of splenic pathological changes occurs one or two days later than that observed 
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with the high dose, but development and recovery from fibrosis remained. There were four 
mice in each group, and the spleens were harvested and processed for paraffin sections and 
embedded and stained with Masson’s trichrome, in which collagen and bone are stained as 
blue/green, cells plasma is red and cell nuclear is black.   
By day 16 post infection, fibroblast proliferation and collagen deposition was observed 
around the germinal centres in IFNγ R-/- mice (Figure 3.1A), while there were no significant 
extra cellular matrix accumulation in wild type spleen (Figure 3.1B). IFNγR-/- spleens also 
show collapsed red pulp in IFNγ R-/- mice (Figure 3.1A and 3.2C), while in wild type spleen 
the red pulp was congested due to splenomegaly (Figure 3.1B and 3.2D). The peak of 
fibrosis was observed at around day 26 to day 28 post infection (Figure 3.1C). The spleens 
of IFNγ R-/- mice were severely fibrotic with a thickened capsule, completely collapsed red 
pulp and destruction of lymphoid follicles. In wild type spleens, the red pulp had become 
less congested as the splenomegaly had resolved (Figure 3.1D). From day 32 post infection 
the spleen of IFNγR-/- mice showed recovery from fibrosis and there was rebuilding of 
splenic follicle structure. The red pulp was reformed and the level of fibrosis was 
significantly reduced (Figure 3.1E). In comparison, the wild type spleen on day 32 post 
infection showed no significant changes in tissue architecture (Figure 3.1F). 
These results extend the observations made by Gangadharan who investigated spleen 
morphology in IFNγ R-/- mice on day 20. Here we have chosen 3 time points covered from 
day 16 to day 32 post infection and carried out a comparison with wild type mice. We show 
that fibrosis begins from day 16, followed by a much more severe accumulation of collagen 
on day 26, and a reduction of ECM on day 32 post infection. Using this approach we 
demonstrated a gradual increase followed by a rapid decrease of the amount of collagen in 
the spleen of IFNγR-/- mice. 
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3.2.2 The distribution of B cells in the spleen of IFNγ R-/- mice 
To examine changes in B cell distribution in IFNγR-/- mice, immunohistochemistry staining 
was carried out using a pan B cell marker CD45 R (B220). The positive cells were stained 
brown (Figure 3.2). In each group, there were 3 mice aged 8 to 10 weeks. The spleen sample 
was harvested at 6 time points from day16 to day 32 covering the development and recovery 
from fibrosis. Confirming the results of previous work which used FACS analysis, the 
spleen had undergone a massive loss of B cells during fibrosis, and the number of B cells 
recovered following the resolution of fibrosis. To build a more complete picture of the 
pathological events in our study we characterized the pathology in IFNγ R-/- spleen by 
dividing the whole process into 3 phases:  
Splenomegaly: This occurred from day 14 to 18 post infection (Figure 3.2, A and B). 
During this time, collagen started to accumulate around the follicles, germinal centres 
developed and the B cell zone expanded.  
Fibrosis: This occurred from day 20 to 28 post infection (Figure 3.2, C and D).  Over this 
period the fibrosis became severe, the red pulp disappeared, the follicle was highly compact 
and the B cell zone shrunk. Very few B cells were observed outside of the white pulp. As a 
result of fibrosis, the B cells areas were greatly reduced at day 28 post infection and the 
structure of peri-arteriolar lymph sheath (PALS) had disappeared. Although the 
development of fibrosis varied among the individuals, the most severe fibrosis was usually 
observed around day 28 post infection. A massive cell loss occurred in the spleen at this 
stage.  
Resolution/recovery: This occurred from day 31 to 40 post infection (Figure 3.2, E and F). 
During this period, extra cellular materials around the follicles became significantly reduced. 
Follicle structure was rebuilt, which was characterized by the reappearance of the peri-
arteriolar lymph sheath (PALS) and the increased area of B cell zone. The red pulp at this 
stage was also partially recovered. 
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In this experiment, day28 post infection was identified as the key time point when the 
fibrosis was most severe and the B cell number in the spleen reaches the lowest (Figure 3.2, 
D). Our observation identified day 28 as a crucial time point marking the switch from 
fibrosis to recovery phase. The pathological changes in wild type spleen infected with 
MHV-68 are shown for comparison (Figure 3.3). On day 20 post infection, expanded 
germinal centers were observed, suggesting an on-going splenomegaly (Figure 3.3A), which 
was resolved by day 24 and 28 post infection (Figure 3.3B and C).  
Interestingly, the recovered spleen structure of IFNγR-/- mice on day 30 and 32 post infection 
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 Figure 3.1 Characterisation of fibrosis in the spleen by histopathological technique. IFNγ 
R-/- mice and 129Sv (WT) mice were infected with 4×105 pfu in 40μl sterile PBS intranasally. 
Formalin fixed paraffin embedded tissue section of spleen from IFNγ R-/- mice and wild-type 
mice (129Sv) infected with MHV-68 at day 16, 26, and 32 post infection were stained with 
Masson’s trichrome. The collagen of fibrous tissue was stained blue. Pictures were taken 
under 10 x magnification. (GC: germinal centre; RP: red pulp) 
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A: IFNγ R-/- Day 16 B: IFNγ R-/- Day 18 
 
C: IFNγ R-/- Day 20 D: IFNγ R-/- Day 28 
 
 
F: IFNγ R-/- Day 32 E: IFNγ R-/- Day 30 
 
Figure 3.2 IHC stains for B cells (brown) in the spleen of IFNγ R-/- mice from day 16 to day 
32 post infection showing the change of B cells and the size of germinal centres. IFNγ R-/- 
mice were infected with 4×105pfu in 40μl sterile PBS intranasally. CD45R(B220) was used 
to detect B cells. Pictures were taken under 10 × amplification. Note the significant 
reductions of the areas of B-cell zones through the time course. The structure of PALS 
disappeared from day 20 to day 28. However, PALS was observed again (arrows) on day 30 
and 32 post infection, when the spleen was recovering from fibrosis. 
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A: WT Day 20 
 
 
B: WT Day 24 
 
C: WT Day 28 
Figure 3.3 IHC stain for B cells (brown) in the spleen of wild-type mice from day 20 to day 
28 post infection. 129Sv (WT) mice were infected with 4×105 pfu in 40μl sterile PBS 
intranasally. CD45R-B220 was used to detect B cells. Pictures were taken under 10× 
magnification. An elevated lymphocyte proliferation was observed on day 20 post infection 
(A) compared to the later time points (B and C). No collagen accumulation was observed 
through the time course. Note the PALS area (arrows) was always present in wild-type mice 
through the course of time. 
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Charaterisation of infection during fibrosis 
In order to investigate the MHV-68 viral load carried by spleen cells in IFNγ R-/- mice using 
a sensitive method, the frequencies of viral genome carrying cells were determined in 
limiting dilution-qPCR assay at 4 selected time points. There were 5 mice in each group 
aged 8 to 12 weeks (Figure 3.4).  
There were 8 replicates for each dilution, and the percentage positive for viral genome at 
each dilution was calculated (for example, if 3 out of 8 samples tested positive in PCR 
reaction for viral DNA, the percentage was 37.5%). The frequencies of viral genome-
positive cells were determined based on the Poisson distribution. The possibility of no 
infected cells (κ=0) detected within a certain period of time was nearly 36.8%; therefore the 
frequency of at least one infected cell within a given number of splenocytes (n) can be 
determined as where the regression curve intersects 63.2%. Table 3.1 shows the calculated 
number of spleen cells carrying the MHV-68 genome (positive in real-time PCR reaction for 
viral genome) at each time point. The comparison between the viral load in IFNγ R-/- mice 
and in wild-type mice is shown in Figure 3.5. 
At the beginning of fibrosis, on day 20 post infection, there was a much higher level of 
latent infection in knockout mice (about 1 in 400 spleen cells) than in wild-type mice (about 
1 in 20,000). During severe fibrosis, the number of latently infected cells in IFNγ R-/- spleen 
was significantly reduced, falling to a level similar to that in wild-type spleen, as shown in 
Figure 3.4 on day 28. In the recovery phase, the number of infected cells in the spleen from 
IFNγ R-/- mice was less than in wild-type mice. However, the difference between the two 
mouse strains is not statistically significant (p>0.05). This experiment also shows that on 
day 68 post infection, the number of infected cells in both types of mice was reduced (about 
1 in 20,000 in IFNγR-/- mice, and 1 in 13,000 in wild-type mice).  
The change of viral load is a result of interactions between virus activity and the host 
immune response: the high viral load in the spleen on days 14 to 16 post infection suggests 
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that the control of the expansion of latent infected cells in the spleen is reduced in IFNγR-/- 
mice. Both latent and lytic infections were elevated at this time post infection: in situ 
hybridisation identified large numbers of infected germinal centres. Although the vast 
majority of infected cells were latent, during days 14 to 16 post infection, productively 
infected cells were also detected, presumably the result of virus reactivation from latent 
infection. Therefore in limiting dilution assay both latent and lytic infections contribute to 
the increased viral DNA load tested: the latent infected cells replicate viral DNA during 
mitosis, whereas infectious virus are produced and released to infect healthy cells. However, 
considering the number of latently infected cells was much greater than lytic cells, along 
with the fact that the lytic virus was not significantly elevated in the lung (Dutia et al., 1997), 
it is most likely that the proliferation of latently infected B cells is the main reason for the 
high viral load in IFNγR-/- spleen. It is also possible that other cell types, such as 
macrophages and dendritic cells, are infected in IFNγR-/- mice, and these cells can also pass 
the virus to B cells. The infection of macrophages (CD11b+ cells) is discussed in Chapter 4. 
Eventually, the viral load in the spleen is controlled under mechanisms which involve the 
development of severe fibrosis around infected follicles and massive cell loss.  
As expected, there was a significant reduction in viral load from day 20 to day 28 post 
infection, corresponding with the development of fibrosis and massive cell loss. The viral 
load of IFNγR-/- mice dropped as low as that of WT mice and the viral load remained at a 
similar level up to day 68 post infection. A certain level of viral DNA was always detected 
in IFNγR-/- mice, suggesting that although the viral load is controlled, the viral DNA still 
remains in the spleen. This result disagrees with previous study on infected cells using in 
situ hybridisation, in which the infected cells were not detectable in IFNγR-/- spleen after day 
30 post infection (Gangadharan, 2006). The comparison among different methods to detect 










Figure 3.4 (next page) Limiting-dilution qPCR on viral genomic DNA analyses of whole 
spleen cells. IFNγ R-/- mice and 129Sv mice were infected with 4×105 pfu in 40μl sterile PBS 
intranasally. Spleen cells were harvested and limiting diluted-qPCR was performed as 
described in Chapter 2. Single copy sensitive qPCR analysis was performed on splenocytes 
harvested at day 20, 28, 40, and 68 post infection. Spleen cells were serially diluted twofold 
10 times in 96-well plates. There were 8 replicates for each dilution. The percentages of 
wells that were positive for the viral genome were calculated and the frequency of cells 
harbouring viral DNA was determined to be 63.2% according to Poisson distribution. 
(Legend: gamma- IFNγ R-/- mice;WT-129 Sv) 
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Date p.i./Strain Log(n) 1 in (n) spleen cells infected  Infected cells% 
20/ IFNγ R-/- 2.5 316 0.316 
20/ WT 4.3 19,953 0.005 
28/ IFNγ R-/- 3.9 7,943 0.013 
28/ WT 4 10,000 0.010 
40/ IFNγ R-/- 4.4 25,119 0.004 
40/ WT 4 10,000 0.010 
68/ IFNγ R-/- 4.3 19,953 0.005 
68/ WT 4.1 12,589 0.008 
Table 3.1 the frequencies of infected cells in the spleen of IFNγ R-/- mice (gamma) and 129Sv 
(WT). The absolute number of the frequency of cells harbouring the viral genome was 

































Days post infection 
20 
 
Figure 3.5 the percentage of viral genome positive cells in the spleen of IFNγ R-/- mice (KO) 
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3.3 Looking for apoptosis during latency (day 16 to day 32) 
A high viral load in the spleen on day 14 to 16 post infection suggests the control of viral 
load in the spleen is reduced. However, the viral DNA in the spleen dropped significantly 
while severe fibrosis developed around infected follicles and a massive cell loss occurred at 
the same time. The pathology observed in IFNγR-/- spleen may be a Th2 biased host immune 
response which somehow controlled the number of latently infected cells. Therefore, we 
carried out further investigations on the fate of infected B cells during fibrosis.  
There are several possible mechanisms which may lead to B cell loss. First, the persistence 
of fibrosis blocks the blood supply as well as cell recruitment from peripheral blood. Second, 
B-cell survival requires persistence of cell signals, as well as cytokines and chemokines, 
which may be affected by the pathology. Third, perforin, which is related to CD8 T cells’ 
function, is important for the survival of IFNγR-/- mice from MHV-68 infection (Tsai et al., 
2011), so these B cells may also die through CD8+ T-cell triggered cell death. Therefore, we 
carried out several experiments to investigate whether there was more cell death in the 
spleen of IFNγR-/- mice.  
3.3.1 Detecting damaged DNA by TUNEL assay  
TUNEL assay was carried out to detect cell death in the spleen of IFNγ R-/- mice. The 
protocol we used was optimised to minimise the background staining. However, in the cases 
of highly fibrotic spleens, there was still non-specific staining as shown in Figure 3.6. Such 
background staining was not observed in wild-type spleens with the same treatment. The 
high background colour may affect microscope reading and lead to misinterpretation of 
results, which suggests that this method may not be ideal for evaluating the level of cell 












Figure 3.6 TUNEL staining on paraffin embedded spleen sections from an IFNγR-/- mice on 
day 20 post infection. IFNγ R-/- mice and 129Sv (WT) mice were infected with 4×105pfu in 
40μl sterile PBS intranasally. (B)The positive stained cells (brown). (A) shows the control in 
which TdT solution was not added. As shown in this figure, there is a background staining in 
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3.3.2 Detecting apoptotic cells by IHC staining for cleaved 
Caspase3 
Anti-cleaved caspase 3 antibody was used to compare the apoptosis in IFNγR-/- spleen to 
that in wild-type mice. Figure 3.7 shows a selection of figures showing distribution of 
apoptotic cells, in which positive cells are stained brown. Three time points were chosen 
(days 16, 18, and 20) to cover the period of time when the massive loss of cells occurred in 
IFNγR-/- spleen. Generally, the patterns of the distribution of apoptotic cells in both mice 
were similar; apoptosis mainly occurred in the germinal centre, where tingible body 
macrophages were also observed (Figure 3.7, arrow). However, there were more positive 
cells observed outside of the follicle in IFNγR-/- mice compared with wild-type mice. The 
number of positive cells within 10 continuous views at 40 times magnification was counted 
for each sample. The comparison between IFNγR-/- mice and wild-type mice at each time 
point is shown in Figure 3.8. There was no significant difference in the number of apoptotic 
cells in the spleen between IFNγR-/- mice and wild-type mice from day 16 to day 20. The 
result suggests there is no evidence for excessive apoptosis within the spleen of IFNγR-/- 
mice during the development of fibrosis.  
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Figure 3.7 A selection of pictures showing the result of immunohistochemistry staining for 
cleaved Caspase-3 on paraffin embedded spleen sections (18 dpi). IFNγ R-/- mice and 129Sv 
(WT) mice were infected with 4×105pfu in 40μl sterile PBS intranasally. Apoptotic cells are 
shown as brown (3, 3’-Diaminobenzidine, DAB). Cell nucleus were counterstained with 
Hematoxylin . The arrows show the tingible body macrophages within germinal centres 
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Figure 3.8 Quantification of apoptosis through Caspase-3 pathway in the spleen. IFNγ R-/- 
mice (KO) and 129Sv (WT) mice were infected with 4×105pfu MHV-68 in 40μl sterile PBS 
intranasally. For each group, there are 3 to 5 mice; for each section the caspase-3 positive 
cells within 10 continuous views were counted under 40 times magnification.  
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3.3.3 Flow cytometry confirming cell death 
Based on the result of Caspase3 staining, along with previous research based on the TUNEL 
assay, there is no evidence showing that cell death is responsible for the dramatic cell loss in 
IFNγR-/- spleen. However, these experiments were carried out on very thin sections of the 
spleen and may not represent the level of cell death within the whole spleen. Therefore, we 
used a nuclear dye DRAQ7 as a Life/Death indicator in flow cytometry (Figure 3.9). Due to 
a financial limitation and the need to complete the PhD thesis, a ‘look see’ experiment was 
carried out using a pooled sample from 4 mice for each group and the time points chosen 
were days 25 and 33 for the benefit of another experiment. The result showed 15% of cells 
in IFNγR-/- spleen were dead or dying, while only 7% were dying in wild-type mice (Figure 
3.9B). This result shows that more cells where membrane was compromised in IFNγR-/- 
spleen than in wild-type spleen.  
However, other factors may be responsible for this result. For instance, the preparation of a 
single-cell suspension from a fibrotic spleen may cause more cell death. Also, the latent 
virus carried by spleen cells may undergo reactivation which leads to cell death. Moreover, 
individual variation was not considered due to the lack of a repeat experiment. Hence, 
further experiments are needed to validate this result. Nevertheless, it does suggest that the 
loss of B cells may be the result of cell death. 
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Figure 3.9 IFNγ R-/- mice (KO) and 129Sv (WT) mice were infected with 4×103pfu MHV-68 
in 40μl sterile PBS intranasally. For each group, spleen cells were harvested and pooled 
together, and then stained with Draq7 at room temperature for 5 minutes. The stained cell 
were then analysed by FACS. (A) an example of FACS dot plot shows whole spleen cells 
treated with Draq7. Cells which had leaking cell membrane were stained (shown in 
rectancular). (B) Percentage of Draq7 positive cells within total spleen cells (gated as intact 




Chapter 3                                                  Characterising virus-mediated fibrosis in the spleen                          
3.4 Discussion 
 In this chapter, the early observations of Gangadharan were confirmed using histo-
pathological approaches, which also enhanced understanding of the pathological changes 
during fibrosis. Moreover, we investigated the mechanisms leading to rapid loss of B cells 
carrying latent MHV-68 virus. This objective was based on the observations made by 
Gangadharan using in situ hybridisation to viral tRNA-like molecules, a marker for both 
lytic and latent virus, which showed that the loss of germinal centres was accompanied by 
the loss of vtRNA positive cells (Gangadharan, 2006). We hypothesised that the rapid loss 
of B cells occurs as a result of cell death, which was measured by several approaches. In this 
chapter, 3 major experiments are included: first, morphological studies on collagen 
deposition and B cell distribution; second, detection of viral DNA load based on PCR; and 
third, detection of cell death as a potential mechanism of significant cell loss in IFNγR-/-
spleen. 
1. Morphological studies on collagen and B cell 
The pathological changes in IFNγ R-/- spleens following an intranasal inoculation of MHV-
68 in the IFNγ R-/- spleen included a severe fibrosis, along with massive cell loss and 
dramatic reduction of viral load, followed by recovery from fibrosis. Firstly, we focused on 
time points between day 16 and day 35, as the fibrosis developed and started to resolve 
during this period of time. Based on the MT staining for collagen and immune staining for B 
cells, an important time point, day 28, has been identified: it represents the highest level of 
fibrosis and the lowest spleen B-cell number. It appears to be a crucial point at which the 
pathology changes from fibrosis to recovery.  
Interestingly, a return of spleen structure was observed during the resolution of fibrosis: 
areas among B-cell zones, presumably PALS which is occupied by T cells and dendritic 
cells, disappeared during fibrosis (Figure 3.2 C and D), but, surprisingly, reappeared after 
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day 30 post infection (Figure 3.2 E and F). The ‘recovered’ spleen structure in IFNγR-/- mice 
(Figure 3.2 E and F, black arrows) was very similar to that of wild-type mice which was 
consistently observed from day 20 to day 28 post infection (Figure 3.3, black arrows). This 
observation suggests that the rebuilding of PALS is an important part of the splenic recovery, 
and it also indicate a potential role of the loss of PALS in the destruction of spleen structures 
during the formation of fibrosis.  
However, it is also possible that the ‘spaces’ observed among patches of B cells were not 
only PALS, but also the light zones of germinal centres. The light zone is where the B cells 
(centrocytes) are selected, under the control of T cells and dendritic cells. These B cells are 
derived from centroblasts in the dark zone of the germinal centre. Infected B cells may 
reseed the spleen along with uninfected naïve B cells once the fibrosis has resolved and 
naïve B cells may become activated and form new germinal centres. The proliferating B 
cells may be activated by viral antigens and proliferate in order to control infection. On the 
other hand, B cells may be latently infected and proliferate under the driving force of latent 
virus so that the pool of infected spleen B cells can be recreated. The B cell development 
and proliferation can be measured by staining with CD38, and immunoglobulins (IgD, IgM, 
and IgG) and cell proliferation markers such as BrdU.  
2. Detection of total viral DNA load based on PCR 
The limiting dilution-PCR assay shows that on day 20 post infection, the number of latently 
infected cells in the spleen of IFNγR-/- mice was much higher than in wild-type mice. This 
reflects an inefficient control of the expansion of MHV-68 infection in the spleen due to the 
lack of IFNγ responses. Moreover, the Th2 biased immune response of IFNγR-/- mice may 
contribute to the dramatic increase of latently infected B cells by enhancing B-cell 
proliferation and differentiation. One of the important functions of IFNγ is to limit the 
population of Th2 cells. For example, in the absence of IFNγ responses, elevated Th2 
cytokine IL-4 enhances the proliferation of developing B cells and subsequently increases 
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the production of specific antibodies. Indeed, the absence of IFNγ was shown to have 
profound influence on antibody production against MHV-68. It has been reported that in 
IFNγ-/- mice, there were significantly increased frequencies of IgA, IgG1, and IgG2b in 
lymph nodes than in wild-type mice, and a remarkable increase of IgG2b in the serum 
(Sangster et al., 2000). During latent infection, the viral genome persists as an episome in 
the host cell nucleus, and replicates while the host cell undergoes mitosis. This process is 
facilitated by viral gene ORF73 encoded mLANA. Therefore, it is possible that the dramatic 
increase in the number of latently infected B cells is due to the enhanced proliferation of 
spleen B cells responding to the infection. However, the elevated level of antibody may also 
be due to the lytic infection which is less controlled in IFNγR-/- mice (Christensen et al., 
1999; Sarawar et al., 1997), resulting in a greater stimulation of antibody production.  
So far, three approaches have been applied to look at latent virus load in the spleen: in situ 
hybridisation, reactivation assay, and detection of viral DNA by PCR. However, none of 
them can differentiate lytic virus from latent virus, and each method has its own drawbacks.  
In situ hybridisation has a sensitivity issue: Gangadharan investigated the presence of 
latently infected cells in the spleen by in situ hybridisation for MHV-68 vtRNAs 1-4. He 
found that the positive cells for vtRNA 1-4 gradually disappeared over a time course, with 
complete absence at day 30 post infection; so it seemed that the latent infection was cleared 
(Gangadharan, 2006). However the limiting dilution-PCR assay and reactivation assay 
disagree with this result. It was found that up to day 68 post infection, there was a certain 
amount (approximately 1 in 20,000 spleen cells) of spleen cells positive for viral DNA, and 
although the number of infected cells in IFNγR-/- mice was lower than that in wild-type mice, 
there was no statistically significant difference between the two groups (p>0.05). Also, 
reactivation assays have been carried out previously and showed that on day 90 post 
infection, the latent virus could still be reactivated from IFNγR-/- spleen cells and cause 
plaques in cell culture (Dutia et al, unpublished data). Previous research has shown that there 
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is a close link between plasma cell differentiation and viral reactivation, and it is suggested 
that a large proportion of cells which react from latency are plasma cells (Collins et al., 2009; 
Liang et al., 2009; Siegel et al., 2010). In the reactivation assay, some of the latent virus 
cannot react from latency, which leads to the results of reactivation assay lower than the true 
value. Therefore the qPCR based limiting dilution assay is considered to be the most 
sensitive way of detecting infected cells. Here we conclude that in the spleen of IFNγR-/- 
mice, the viral load is greatly reduced but not cleared. The limiting dilution-PCR assay also 
confirmed that day 28 was a very important time point. It seems that after the significant 
reduction, the infection in IFNγR-/- mice reached a level similar to that of wild-type mice, 
and remained at such low level of infection thereafter. 
3. Detection of cell death 
Recent study suggests it is most likely that MHV-68 utilises germinal centre proliferation to 
increase the pool of latently infected B cells, and eventually persists in the memory B-cell 
reservoir (Collins et al., 2009; Collins and Speck, 2012; Flano et al., 2002; Nealy et al., 2010; 
Willer and Speck, 2003). This mechanism is shared by human gammaherpesvirus EBV 
(Babcock et al., 1998; Barton et al., 2011). During fibrosis, from day 20 to day 28 post 
infection, there is a remarkable contraction of both B cells and latent virus in IFNγR-/- mice. 
In wild-type mice, a similar contraction of latently infected B cells was also observed around 
day 16 to day 20 post infection, whereas no massive cell loss was observed (Collins and 
Speck, 2012). This may be because the cell loss was immediately replaced in the spleen of 
wild-type mice while the recruitment from circulation was blocked in IFNγR-/- mice due to 
fibrosis (Ebrahimi et al., 2001). Therefore the IFNγR-/- mice may be a model which reflects 
the mechanism of the reduction of latent infected cells in wild-type mice.  
In the IFNγR-/- mouse model the reduction of spleen B-cell numbers corresponded to the 
drop in viral load during fibrosis. Therefore the fate of B cells in the MHV-68 infected 
IFNγR-/- spleen during fibrosis became one of the main questions we addressed in this 
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project. In this chapter, we have examined cell death during fibrosis. The most likely 
explanation for the drop in B-cell numbers is cell death, especially apoptosis. Therefore we 
were expecting a significantly higher portion of cells undergoing apoptosis or other forms of 
cell death before and during fibrosis in IFNγ R-/- spleens compared to WT spleens. However, 
although we tried different approaches to detect cell death in the spleen, we found no 
concrete evidence for excessive apoptosis throughout the infection.   
Previous research using TUNEL assay showed that the number and location of TUNEL 
positive cells were similar in IFNγR-/- mice and wild-type mice over the course of infection 
(Ebrahimi et al., 2001). To confirm and to extend the time course, we carried out TUNEL 
assay, but found it not suitable for detecting cell death in highly fibrotic tissue in our case, 
due to high background staining caused by unspecific binding. Also, there was no evidence 
of increased numbers or boosted activity of tingible body macrophages which remove dead 
cells from the tissue over the course of infection (Gangadharan et al., 2008). 
Immunohistochemistry for cleaved Caspase3 showed there was no significant difference 
between IFNγR-/- mice and wild-type mice during the development of fibrosis. This result 
shows that excessive loss of splenic cells is not due to apoptosis via the caspase-3 pathway. 
However, spleen sections can only show a thin layer of tissue in a snapshot, so they may not 
represent the overall level of apoptosis within the whole spleen. It is also possible that the 
activated Caspase3 is only elevated for a very short period of time so that we missed it in our 
assay. On the other hand, flow cytometry offers a more thorough way of analysing cell death 
though the viral reactivation during cell preparation which may increase the rate of dead 
cells. It might also be interesting to double stain these dead cells with an apoptosis marker 
such as Caspase3 to confirm the role of apoptosis. Moreover, FACS analysis also makes it 
possible to type these dead cells using specific cell markers. Our results, using a stain for 
‘leaking’ cells, show an increased number of dead cells in IFNγ R-/- spleens. However, this 
was not the result of excessive apoptosis. Moreover, the flow cytometry data suggest an 
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elevated ratio of spleen cells with a damaged cell membrane. Therefore it would be very 
interesting to further examine cell death, as well as apoptosis, by flow cytometry. 
Although apoptosis is the most recognised cause of programmed cell death, there are other 
possible mechanisms which are not dependent on Caspase3. For example, pryoptosis, also 
termed Caspase1-dependent cell death, has been observed causing cell death during 
inflammation. Autophagy has also been studied as an intrinsic pathway against MHV-68 
infection, especially in the maintenance of latently infected cells (Reviewed by Barton et al., 
2011). Therefore autophagy may be involved in the host cell response under the stress of 
fibrosis and contribute to cell loss. The possibility of pryoptosis and autophagy leading to 
cell loss are discussed in detail in Chapter 6. Furthermore, there is another possibility that 
viral reactivation from latency kills the infected B cells. In order to answer this question we 
have investigated the expression of viral genes which are essential for reactivation and lytic 
infection. This is discussed in Chapter 4.  
Moreover, it is possible that cell death is not the only fate of these spleen cells. One 
possibility is that B cells exit the spleen due to the high tension of the tissue during fibrosis 
and/or the lack of survival signals. One finding which may support this assumption is that an 
elevated numbers of lymphocytes in the peripheral blood were observed, corresponding to 
the peak of fibrosis in IFNγR-/- mice infected with MHV-68 (Ebrahimi et al., 2001). In the 
same publication, green fluorescent labelled B cells from peripheral blood were shown 
unable to travel into a fibrotic spleen, which may also impair the recruitment of splenic B 
cells. The mechanisms which may be responsible for the reduction of infected B cells in the 
spleen of IFNγR-/- mice are discussed further in Chapter 6. 
We paid special attention to the great reduction of spleen B cells for they are the main site of 
infection during latency and long term persistency. However, it is important to note that not 
only B cells, but all spleen cells, including T cells and macrophages (and also presumably 
dendritic cells), were reduced; the reduction of these cell types is illustrated in Chapter 4. 
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Among these cell types, T cells are not susceptible of infection, whereas peritoneal 
macrophages are considered another site of latent infection when infecting the mice 
following peritoneal cavity injection (Weck et al., 1999). This fact suggests that the fibrosis 
in the spleen is not specifically directed against the infected cells. However, the mechanisms 
by which these cells are erased from the spleen as well as their influence on latent infection 
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4.1 Introduction 
4.1.1 Germinal centres 
Germinal centres are the sites where B cells are activated and undergo somatic 
hypermutation and affinity maturation, and subsequently generate antigen specific plasma 
cells and memory B cells. In mice which have not been exposed to any pathogen, lymphoid 
follicles in secondary lymph organs are composed of naïve B lymphocytes and no germinal 
centres are formed. Once the host is infected, germinal centres develop in B-cell zones, and 
the rest of the naïve B cells are pushed aside and become the so-called B cell mantel 
(MacLennan, 1994). Each germinal centre can be divided into two parts based on the cell 
types and functions. The dark zone, located close to PALS, contains mainly B cells 
(centroblasts) with a high ability of proliferate, and tingible body macrophages (TBMs) 
among them. The light zone consists of B cells (centrocytes), T cells, TBMs, and some naïve 
B cells scattered within a follicular dendritic cells network (FDCs). Compared to naïve B 
cells, which rarely proliferate, germinal centre B cells divide rapidly (reviewed by Victora 
and Nussenzweig, 2012). Recent studies show that germinal centre B cells in both the dark 
zone and the light zone can proliferate, and have an irregular and changing morphology 
(Hauser et al., 2007). Moreover, they migrate frequently within either zone, as well as 
migrate between the two zones (Schwickert et al., 2007). Also, a certain number of naïve B 
cells constantly move from the mantle area into the light zone (Schwickert et al., 2007). For 
decades, centroblasts and cetrocytes were considered two distinct stages of differentiation, 
but recently it has been demonstrated that the dark zone and light zone B cells are one type 
of cell in alternating states (Victora et al., 2012).  
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4.1.2 MHV-68 infection in B cells 
Following intranasal inoculation, MHV-68 is able to establish latency in a variety of cell 
populations (14 days post infection), including naïve B cells, germinal centre B cells, 
memory B cells, macrophages, and dendritic cells in the spleen (Willer and Speck, 2003). 
However, results from two independent groups have shown that MHV-68 latency is 
preferentially established in germinal centre B cells and memory B cells, which are surface 
IgD negative subsets during long-term latency (Flano et al., 2002; Willer and Speck, 2003). 
However, how the viruses gain access to mature B cells and how the infected population is 
maintained are still under investigation.  
As found for EBV, research has suggested that MHV-68 may exploit the germinal centre 
reaction in secondary lymph organs by driving B-cell proliferation and differentiation. 
However, attempts to immortalize B cell lines for MHV-68 and KSHV have failed, which 
may be due to the cell surface of primary B cells making it difficult for viral entry (Jarousse 
et al., 2008). Recently, Liang et al. have demonstrated that MHV-68 is able to immortalise 
foetal liver-derived B cell progenitors, and this process requires ORF72 (v-Cyclin) and 
ORF73 (mLANA), in which cells eventually differentiate into B plasmablasts (Liang et al., 
2011). Moreover, Coleman et al. have shown that in acute-latent infection, immature B cells 
in bone marrow as well as transitional B cells in the spleen are infected in long-term latency 
(Coleman et al., 2010). This suggests that the virus may use immature B cells within primary 
lymph organs as a reservoir which may keep circulating till they develop in secondary 
lymph organs such as lymph nodes and the spleen, and differentiate into long-lived mature B 
cells. Using YFP labelled MHV-68, Collins et al. found that the frequency of virus infected 
plasma cells accounted for the majority of viral reactivation from spleen cells ex vivo 
(Collins et al., 2009). The MHV-68 unique gene M2 has been shown to be necessary in 
manipulating the processes of developing B cells differentiating into plasma cells. Infecting 
mice with M2-null virus leads to the absence of viral infected plasma cell population in the 
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spleen. In the absence of all other viral gene products, transfection of M2 can drive B 
lymphoma cells to differentiate into plasma cells (Liang et al., 2009). Moreover, Blimp-1, an 
essential cellular transcriptional regulator of plasma differentiation, plays an important role 
in the establishment of latency and reactivation from latency (Siegel et al., 2010). In the 
absence of plasma cells, both B-cell and CD4+ T-cell responses are reduced, and germinal 
centre reaction in the spleen is diminished and fewer germinal centre B cells are infected. 
This result indicates that reactivation from plasma cells may play an important role in the 
establishment and maintenance of latency (Siegel et al., 2010). 
4.1.3 Pathogenesis study using recombinant MHV-68 
Several approaches have been developed to investigate the dynamics of a latent herpesvirus 
infection in vivo. Most groups have looked to modify the relevant herpesvirus through 
introduction of a marker gene under the control of latent gene promoters. However, this has 
met with mixed results mainly due to the stability of the marker gene and the reduced 
efficiency of transmission to various cells in vivo. To overcome these difficulties in the 
study of MHV-68 latency, Nealy et al. generated a virus encoding a modified β-lactamase 
molecule at the C-terminus of the ORF73 (mLANA) encoding sequences. They reported that 
this virus could be detected in a stable fraction of B cells throughout latent infection until at 
least day 90 post infection. As a reporter molecule, β-lactamase can cleave the β-lactam ring 
of a passively-diffusing, membrane-permeating flourogenic substrate, allowing versatile and 
sensitive means to detect mLANA expression in living cells. It has been demonstrated by 
limiting dilution reactivation assay that this recombinant virus undergoes normal lytic and 
latent infection compared with wild type MHV-68 (Nealy et al., 2010). 
Recombinant MHV-68 has been widely utilised to study the pathogenesis of 
gammaherpesviruses. However, although the lytic infection was not affected by the insertion 
of the foreign gene, most of the recombinant viruses were attenuated in latent infection, 
which makes it very difficult to track infection at later time points (Milho et al., 2009). 
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mLANA-MHV-68 is still detectable as late as day 90 post infection, and provides a sensitive 
system to identify the infected cells expressing mLANA (ORF73). Therefore it is one of the 
best recombinant viruses available so far for the study of MHV-68 long-term latency.  
Based on this system, Nealy et al. have examined the infection in B-cell subsets, whereas the 
infection in IFNγR-/- spleen B-cell subsets during fibrosis is yet to be studied. In this chapter, 
our aim was to understand how fibrosis generated by a Th2 biased immune system 
influences the infection in B-cell subsets in the spleen using the mLANA-MHV-68 virus. 
First, we investigated the proportion of each B-cell population (naïve B cells, germinal 
centre B cells, and memory B cells) in total splenocytes, as well as the level of infection 
within each population at crucial time points. Then we collected these infected cells for 
further study. To profile the viral activity during infection in IFNγR-/- mice, we investigated 
selected viral genes expression profiles within infected cells by reverse transcription 
quantitative PCR. 
4.1.4 Profile of selected viral gene expression in spleen 
Previous research has shown that at least one viral gene, M1, is essential for inducing 
fibrosis (Evans et al., 2008). Therefore, we were very interested in finding out if an IFNγ 
receptor deficiency affects important viral gene expression, especially that of the M1 gene. 
As discussed in Chapter 3, there is a possibility that viral reactivation from latency may 
contribute to cell loss occurring during fibrosis. Therefore, we examined the transcripts of 
important lytic viral genes. Massive research has been done in analysing important viral 
genes; for example, Marques et al examined viral gene expression in B cell subsets, 
macrophages and dendritic cells (Marques et al., 2003). However, the studies so far cover 
only a short period of time and very little work has been done using IFNγR-/- mice. In the 
second part of this chapter, we investigate 5 viral genes (M1, ORF73, RTA, viral DNA 
polymerase, and M11) by reverse-transcription-quantitative PCR, and discuss the possible 
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viral activities in IFNγR-/- mice during fibrosis. It is the first time that these genes have been 
tested in IFNγR-/- mice over the period from day 16 to day 60 post infection. 
4.2 mLANA-MHV-68 provides a reliable reporting system of 
infection in the spleen of IFNγR-/- mice and 129Sv mice 
4.2.1 Detection of β-lactamase 
The pathogenesis of mLANA-MHV-68 recombinant virus in immune competent mice is 
very similar to that of wild type MHV-68 (Nealy et al., 2010). We first checked the 
pathology caused by recombinant virus in IFNγR-/- mice compared with wild type MHV-68: 
following intranasal inoculation (4x103pfu), the IFNγR-/- mice infected with mLANA-MHV-
68 virus developed fibrosis to the same extent as those infected with the wild type virus on 
day 20 post infection. Then we moved on to looking at whether the detection system works 
in the IFNγR-/- splenocytes: FACS analysis showed β-lactamase mLANA expression was 
not affected by the IFNγ receptor deficiency (Figure 4.1). The FACS system successfully 
detected the transformation of fluorescence from green to blue (Figure 4.1 right). The non-
infected control shows (Figure 4.1 left) that all cells were loaded with CCF2/AM and no 
background colour change was detected. Therefore we have confirmed that β-lactamase 
works well as a reporting system in live cell flow cytometry and this system is suitable to 




















Figure 4.1 Detection of spleen cells which express mLANA by flow cytometry. IFNγ R-/- mice 
(KO) and 129Sv (WT) mice were infected with 4×103pfu mLANA MHV-68 in 40μl sterile 
PBS intranasally. Infected IFNγR-/- spleens were harvested on day 16 post infection (i.n.); 
uninfected spleens were harvested on the same day as control. Single-cell suspensions were 
loaded with substrate CCF4/AM for β-lactamase reaction and subjected to FACS analysis. 
For both figures the x axis shows the green fluorescence signal excited by 488nm laser, and 
the y axis shows the blue fluorescence signal exited by 405nm laser. The left figure shows 
FACS analysis of uninfected spleen loaded with substrate: the substrate with green 
fluorescence (at 520nm) has penetrated into every live cell and there is no β-lactamase 
reaction in uninfected cells (gated). The right figure shows the infected population (red 
circle) in which the green fluorescence signal has been transformed into blue due to β-
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4.2.2 Change of viral load in spleen 
Although the nature of infection of this recombinant virus in normal mice has been 
thoroughly investigated, infection of IFNγR-/- mice has not been studied. Due to the 
limitation of animals and time, plaque assays were not carried out. Instead, we analysed the 
infection rate of mLANA-MHV-68, and compared it with the result of limiting dilution 
assay. The change of viral load in the spleen of mLANA MHV68 infected mice (Figure 4.2 
A) followed a trend very similar to that of wild type virus in IFNγR-/- mice and 129Sv mice 
(Figure 4.2 B). Figure 4.2 B summarises the results from a limiting dilution assay (Chapter 
3), showing that the spleens of IFNγR-/- mice carried more virus than that of wild type mice 
in the phase of acute latency (day 16 post infection). The viral load was greatly reduced 
during fibrosis during the recovery phase. The same trend was also found when using the 
mLANA-MHV-68 virus. At different time points, the percentage of mLANA β-lactamase 
positive cells within spleen cells determined by flow cytometry in IFNγR-/- mice was 
compared with that in wild type mice. Flow cytometry to detect mLANA-MHV-68 showed 
that 0.5% of total spleen cells were infected in wild type spleens, while in the limiting 
dilution-qPCR assay for MHV-68 infection, 0.01% was infected. This difference in numbers 
may be caused by the different experiment methods: the result of FACS analysis was 
calculated based on the live-gated cells (in order to rule out debris and clumps by looking at 
the size and shape of each particle) which led to a relatively higher percentage of positive 
cells than the true value. Also, in a limiting dilution assay, samples were incubated overnight 
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mLANA positive cells in spleen
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Figure 4.2 Comparison of mLANA-recombinant virus and MHV-68 viral load in the spleen: 
the behaviour of the mLANA virus compared with the wild type virus is similar in IFNγR-/- 
mice and 129Sv mice. (A) IFNγ R-/- mice (KO) and 129Sv (WT) mice were infected with 
4×103pfu mLANA MHV-68 in 40μl sterile PBS intranasally. Spleen cells were harvested on 
day 16, 20, 28, 48. The percentage of mLANA-positive cells detected by flow cytometry 
within total spleen cells were shown in the figure.  (B) shows the percentage of MHV-68 
wild type virus genome carrying cells detected by limiting dilution-PCR assay (see figure 





Chapter 4                                                        Characterization of latent infection in the spleen  
4.2.3 Confirmation of infected cell isolation by qPCR 
To further confirm that the β-lactamase positive cells detected by flow cytometry were 
actually infected, we sorted both positive and negative cells and carried out qPCR for viral 
gene transcripts. Four IFNγR-/- mice and 4 wild type mice were tested and for each 
individual there were 3 qPCR repeats. As expected, all of the β-lactamase-mLANA positive 
samples from both IFNγR-/- and wild type mice were expressing viral genes, whereas most 
of the β-lactamase-mLANA negative samples tested did not express viral genes. Using 
ORF73 as an example, all β-lactamase positive samples were found to be expressing 
mLANA (ORF73) (24 out of 24 reactions). Among the negative samples, although some 
reactions were found to be positive for expression in melt curve analysis (5 out of 24 
reactions), their copy numbers were less than the detection limit of 5 copies/20μl reaction 
(24 out of 24 reactions). The results above show that the isolation of infected cells using the 
recombinant virus was successful. However, it also shows that a small proportion of the rest 
of the splenocytes still expressed ORF73, which is not detected by this system. It may be 
because of the incomplete reaction between β-lactamase and the substrate, or the sensitivity 
of the FACS facility. Based on the observation of the gross change of the spleen and viral 
load analysis and qPCR results, this method is a sensitive way to enrich and separate 
infected cells which express mLANA. Therefore we believe the mLANA virus is a good 
reporting system reflecting the nature of long-term infection in the spleen of IFNγR-/- mice 
and 129Sv mice. 
 
4.2.4 mLANA-MHV-68 detection in macrophages  
We concluded that the mLANA virus is a powerful tool to track the infected cells in IFNγR-/- 
mice. We then used this virus to detect the viral infection in the spleen-cell populations. 
Fluorescence conjugated antibodies were used in this series of experiments. As the β-
lactamase detection system needs both blue and green channels, we could only choose 
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antibodies conjugated with red and far-red fluorophores. We first examined the infection in 
macrophages. CD11b-APC and Ly-6G-PE antibodies were used to identify macrophages 
and neutrophils. As the regular macrophage marker F4/80 is reported to be problematic in 
flow cytometry, we chose CD11b as the macrophage marker for spleen macrophages. 
CD11b is expressed mainly on macrophages and some granulocytes and dendritic cells.  
Neutrophil infiltration was also observed during infection; therefore we used Ly-6G to 
separate the neutrophils from the macrophages.  
For every spleen sample, we stained 1x106 cells to put through FACS. Very few events 
showing beta-lactamase positive in macrophages (less than 0.1% of total cells) and no 
positive events were detected in neutrophils. These events were checked again using FACS 
analysis software based on the cell size (forward scatter) and cellular granularity (side 
scatter), as well as the level of auto-fluorescence generated (data not shown), in which the 
results suggest that they were most likely debris or lymphocytes. Indeed, CD11b was also 
expressed in a low level on a small proportion of activated lymphocytes. Therefore we 
conclude that mLANA-MHV-68 is not detected in the macrophage/monocytes lineage in 
both IFNγR-/- and wild type mice. mLANA-positive cell population was not observed in the 
macrophage population. However, considering the limitation of techniques, there are three 
other possibilities. First, the number of infected macrophages was very low so that a much 
larger number of spleen cells needed to be analysed in order to get a recognisable population. 
Second, the virus infecting macrophages did not express ORF73 so that beta-lactamase was 
not expressed either. Some work in vitro and in vivo, based on other strains of mice supports 
this idea (Marques et al., 2003). Third, the macrophages were not infected between day 16 
and day 35 post infection in both IFNγR-/- and 129Sv (wild type) mice.   
The percentage of macrophages and neutrophils within the total spleen cells through the 
time course of infection is shown in Figure 4.3 D: in the phase of splenomegaly (day 16 post 
infection), there were more macrophages in IFNγR-/- spleens than in the wild type. Then, 
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during fibrosis, both the number and the percentage of macrophages were reduced from 6% 
to 2% of total spleen cells. Moreover, considering that during the dramatic reduction the 
total number of spleen cells in IFNγR-/- mice dropped greatly, the loss of macrophages 
during fibrosis was more severe in terms of absolute numbers. In wild type mice, there was a 
similar but smaller reduction, from 4.5% to 2.5%; however, the percentage recovered to 3% 
on day 35 post infection. On day 20 and day 35 post infection, the percentage of 
macrophages in the spleen of IFNγR-/- mice was significantly lower than that in wild type 
mice (p<0.05). The results suggest a boosted macrophage activity on day 16 post infection in 
both types of mice; however, in IFNγR-/- mice there was an extra cell loss of macrophages 
during fibrosis. Neutrophils showed similar patterns, where there were no significant 
differences observed between the two strains of mice. These results add to the previous 
observation of cell loss in IFNγR-/- spleens during fibrosis. Therefore, in the massive cell 
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Figure 4.3 FACS analysis of multi-colour staining for macrophages/monocytes lineage 
subsets with β-lactamase detection. IFNγ R-/- mice and 129Sv mice were infected with 
4×103pfu mLANA-MHV-68 in 40μl sterile PBS intranasally. Spleen cells were harvested on 
day 16, 20, 28, 35 and were stained as described in Chapter 2. (A) shows mLANA positive 
cell population (blue) in total spleen cells. (B) shows macrophages (CD11b-APC+) and (C) 
shows granulocytes (CD11b-APC+ Ly6G-PE+). Very little mLANA positive cells were 
detected in macrophages and splenomegaly. (D) shows the percentage of macrophages and 
granulocytes populations in the spleen. Left: CD11b+Ly6G-; Right: CD11b+Ly6G+ 
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4.3 mLANA-MHV-68 infection in B-cell subsets 
4.3.1 Distributions of B-cell subpopulations in the spleen during 
fibrosis 
We then focused on changes in population of each B-cell subset and the infected cells within 
these subsets through the infection time course. Using FACS analysis we were able to 
observe how the population size of each subset of B cells changed over time. To identify B-
cell subsets, CD19-APC-Cy7, CD38-APC, and IgD-PE were used. An example for the 
gating for B-cell subsets and β-lactamase reaction positive cells is shown in Figure 4.6. We 
were interested to see how the fibrosis in the spleen of IFNγ R-/- mice would affect these B-
cell subpopulations, in comparison to that in wild type mice, which we consider to represent 
a normal MHV-68 infection. The total number of spleen cells recovered from IFNγR-/- 
spleen was significantly reduced during fibrosis (from more than 1x108 cells/spleen on day 
12 post infection to 3x106 cells/spleen on day 28 post infection), whereas in wild type mice 
there were around 1x108 cells/spleen with a reduction of around 10% because of the 
resolving of splenomegaly (Figure 4.4 A). For each spleen, a similar number of total spleen 
cells were used for FACS analysis (around 2x106 for most of the samples; however, in the 
cases of highly fibrotic spleen, fewer cells were analysed). The total number of B cells in 
IFNγ R-/- mice was reduced from 53% to 35% of total spleen cells analysed (Figure 4.4 B, 
top), while in wild type mice, the number dropped from 55% to 43% of total spleen cells. 
The decrease in wild type mice may be caused by resolution from splenomegaly. In IFNγ R-
/- mice, due to the fibrosis, the spleen lost about 70% (estimated number) of its cells, 
consisting of B cells, T cells, and macrophages. The decreased percentage of B cells 
suggests that there was more cell loss in the B-cell population than in other cell types.  
The changes of B-cell subsets showed different patterns between wild type mice and IFNγR-
/- mice (Figure 4.4 B and C). Generally, the proportion of naïve B cells in the spleen was 
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relatively stable, comprising more than 50% of the total number of B cells. The rest were 
germinal centre B cells and memory B cells, which vary according to the state of infection 
(Figure 4.4 C).   
In WT mice, the percentage of naïve B cells was reduced while the number of germinal 
centre B cells and memory B cells increased from day 16 to day 35 post infection. The 
percentage of germinal centre B cells of total spleen cells was first reduced slightly from day 
16 to day 20 post infection then return to the original level on day 35 post infection (Figure 
4.4 B, left). In the case of memory B cells, the percentage reached the peak on day28 post 
infection and was only slightly reduced by day 35 post infection (Figure 4.4 B, middle). The 
percentage of naïve B cells in total spleen cells was reduced from day 16 to 20 post infection 
(Figure 4.4 B, right). The percentage of B-cell subsets in total B cells are shown in Figure 
4.4 C; the germinal centre (GC) and memory B cells decreased from 25% to 18% of total B 
cells on day 20 post infection and then gradually increased to 35% from day 20 to day 35 
post infection (Figure 4.4 C). The changes observed in WT mice pictured the activity of 
naïve B cells differentiating into germinal centre B cells and memory B cells in the spleen. 
The driving forces underlying this may include both virus-driven differentiation and host 
immune response against infection. However, according to the limiting dilution-qPCR assay 
(Chapter 3), the proportion of infected cells was very low in WT spleen throughout the time 
course (<0.005% in total spleen cells). Hence, the immune response, rather than virus 
activity, seems to be the main driving force of the B-cell differentiation.  
In contrast to WT mice, IFNγR-/- mice, from day 20 to day 28 post infection, the germinal 
centre B cell population of IFNγR-/- mice was reduced significantly from 15% to less than 
5% of total spleen cells (p=0.008, Figure 4.4 B, left), and the percentage of memory B cells 
reduced from 3% to 1% of total spleen cells (p=0.01, Figure 4.4 B, middle). The percentage 
of naïve B cells reduced from 35% to 30% of total spleen cells and there were no differences 
between IFNγR-/- mice and wild type mice (Figure 4.4 B, right). The result shows the 
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germinal centre B cells and memory B cells in IFNγR-/- mice suffered extra cell loss 
compared to primary B cells. In IFNγR-/- mice, 33% of total B cells on day 20 post 
infection were under differentiation; this number kept dropping during the development of 
fibrosis and recovery phase (day 48 post infection ), and remained less than 10% of total B 
cells (Figure 4.4 C). Interestingly, on day 35 post infection, 33% of B cells in wild type 
spleen were GC B cells and memory B cells, while these were only 10% in IFNγR-/- spleen 
(noted in the rectangle in Figure 4.4 C). Moreover, this low level of GC and memory B cells 
remained so on day 48 post infection (Figure 4.4 C). Wild type mice on day 48 post 
infection were not tested, for it is generally accepted that there is little change in wild type 
spleen after day 35 post infection. To conclude, the populations of germinal centre B cells 
and memory B cells in IFNγR-/- mice were reduced during fibrosis (day 20 to day 28 post 
infection, p<0.05), resulting in a significantly lower level than that in wild type mice at the 
same days post infection (day 28 and day 35 post infection, p<0.05). In the next section, we 
continue to discuss the viral infection in each population in order to further understand the 
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Figure 4.4 Percentage of B-cell subsets in the spleen of IFNγR-/- and wild type mice infected 
with mLANA-MHV-68. IFNγ R-/- mice (KO) and 129Sv (WT) mice were infected with 
4×103pfu mLANA-MHV-68 in 40μl sterile PBS intranasally. Spleen cells were harvested on 
day 16, 20, 28, 35 and were stained as described in Chapter 2. (A) Changes of the number of 
total spleen cells recovered from IFNγR-/- and wild type mice. (B) Changes of total B cells 
(CD19+), naïve B cells (CD19+ IgD+ CD38+), germinal centre B cells (CD19+ IgD- CD38-), 
and memory B cells (CD19+ IgD- CD38+) within total B cells. (C) Distribution of B-cell 
subpopulations (total B cell in each group was considered 100%; value shown is an average 
of 4–5 individuals). The significant difference between IFNγR-/- and wild type mice on day 
35 post infection is noted. 
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4.3.2 Distribution of infected B cells in subpopulations during 
fibrosis 
Infected cells in each spleen cell sample were detected by flow cytometry and the 
distribution of these cells in each cell population was analysed. For all samples tested, over 
95% of infected cells detected were B cells (defined as CD19 positive, Figure 4.5). The 
percentages of infected cells in different cell populations compared with total spleen 
numbers are shown in Figure 4.6, in which the infected cell populations were looked at in 
different ways: the percentage of infected cells within total spleen cells (Figure 4.6 C to E), 
the percentage of infected cells within each B-cell subpopulation (Figure 4.6 F to H), and the 
percentage of different types of B cells within the infected cell population (Figure 4.6 I).  
Generally, in wild type mice, about 0.1% of total spleen cells and 0.2% of splenic B cells 
were infected, and this changed very little during the time course. In contrast, in IFNγ R-/- 
mice, there was a significantly higher viral load in IFNγ R-/- spleen, in which 0.4% of 
spleen cells (0.8% of B cells) were infected on day 16 post infection. Furthermore, this 
number kept increasing to 0.9% of spleen cells (2% of B cells) infected on day 20 post 
infection, which may be due to proliferation of latently infected B cells and low-level lytic 
virus from reactivation. As expected, a dramatic fall of viral load was observed during 
fibrosis (day 20 to day 35 post infection). On day 35 post infection very few infected cells 
were detected (Figure 4.6 A and B).  
Interestingly, the infection of each B-cell subset showed differences between WT and 
IFNγR-/- mice throughout the time course. On day 16 post infection, germinal centre B cells 
contributed the most to the infection in both types of mice. In IFNγR-/- mice, 2% of 
germinal centre B cells were infected, while 1% were infected in WT mice (Figure 4.6 F). In 
IFNγR-/- mice 1.5% of memory B cells were infected, while in WT mice 1.5% of memory 
B cells were infected (Figure 4.6 G). However, germinal centre B cells contributed (about 
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70% in both types of mice) much more in the infected population than did memory B cells 
(about 15% in both types of mice) (Figure 4.6 I, D16ko and D16wt). This is because the 
population of germinal centre B cells (about 9% of total spleen cells) was larger than that of 
memory B cells (about 3% of total spleen cells) due to the expansion of germinal centres 
(Figure 4.4). On the other hand, naïve B cells, which make up 70% of the B-cell population, 
showed very little contribution to the infection. Only 0.1% of naïve B cells in IFNγR-/- 
mice and 0.03% in wild type mice were infected (Figure 4.6 H). The low infection rate in 
naïve B cells agrees with previous studies (Flano et al., 2002; Willer and Speck, 2003). 
On day 20 post infection, the viral load increased significantly compared to day 16 post 
infection (p<0.05) and reached its peak in IFNγR-/- mice. Eight per cent of germinal centre 
B cells (Figure 4.6 F), 7% of memory B cells (Figure 4.6 G), and 0.45% of naïve B cells 
(Figure 4.6 H) were infected.  
The distribution of infected cells between the B-cell populations had not changed since day 
16 post infection. In wild type mice, 2.5% of germinal centre B cells, 4% of memory B cells, 
and 0.2% of naïve B cells were infected. Significant changes were observed in the 
distribution of infected cells between the B-cell populations compared to day 16 post 
infection (Figure 4.6 I, D20wt and D16wt), in which memory B cells accounted for about 
40% of the infected population. This change indicates a shift of phenotype of infected B 
cells from day 16 to day 20, suggesting virus-driven B-cell differentiation from germinal 
centre B cells to memory B cells. Moreover, the percentage of memory B cells remained at a 
similar level, which suggests the population of infected memory B cells was maintained long 
term. Another possibility is that the percentage of germinal centre B cells in wild type mice 
from day 16 to day 20 was slightly reduced, which may have led to a reduction in percentage 
of infected germinal centre B cells, and subsequently an increased ratio of cells from the 
other two populations. Such changes were not observed in IFNγR-/- mice from day 16 to day 
20 post infection, but observed on day 20 to day 28 post infection (Figure 4.6 I).     
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Fibrosis persisted in IFNγR-/- spleen from day 20 to day 28 post infection, and resolution 
occurred from day 28 to day 35 post infection. During fibrosis, all cell populations were 
decreasing rapidly, especially the germinal centre B cells and memory B cells. This was 
concomitant with a reduction in the number of virus-infected (mLANA positive) cells. As 
discussed above, there was an increased contribution of memory B cells from day 20 to day 
28 post infection, which occurred later than that in WT mice. Interestingly, this change 
occurred during the significant reduction of the percentages of germinal centre B cells in the 
spleen (Figure 4.6 C), which indicates the contraction of the germinal centre B 
subpopulation was responsible. The infection in naïve B cells on day 35 post infection of 
IFNγR-/- mice was affected by the fibrosis less than any other populations during fibrosis 
(Figure 4.6 E and H). On day 35 post infection, the percentage of infected cells in naïve B 
cells in IFNγR-/- mice was significantly lower than that in WT mice (p<0.05), which 
indicates that in wild type mice, a proportion of infected primary B cells were maintained 
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Figure 4.5 The majority of mLANA-positive cells (blue, gated as mLANA Pos) detected were 
B cells: IFNγ R-/- mice and 129Sv mice were infected with 4×103pfu mLANA-MHV-68 in 
40μl sterile PBS intranasally. Spleen cells were harvested on day20 post infection, and were 
stained with Anti-CD19-APC-Cy7 antibody as described in Chapter 2. In the spleen of both 
IFNγ R-/- mice and 129Sv mice, the majority of mLANA positive cells were CD19 positive. 
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Figure 4.6 FACS analysis of virus positive cells in different splenic cells compartments through the 
time course post infection (See figure 4.4 legend). Infected cells were detected as β-lactamase-ORF73 
(mLANA) positive by flow cytometry. (A) The percentage of infected cells within total spleen cells 
tested (about 2x106 for each spleen). (B) The percentage of infected cells in total B cells. (C to E) The 
percentage of infected cells harboured by either naïve B cells, germinal centre B cells, or memory B 
cells in total spleen cells tested. (F to H) The percentage of infected cells harboured by naïve B cells, 
germinal centre B cells, or memory B cells within total B cell population. (I) Distribution of B-cell 
subpopulations (total infected cells in each group was considered 100%; value shown is an average 
of 4–5 individuals, IFNγ R-/-- KO; 129Sv-WT).  
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On day 35 post infection, although the spleen of IFNγR-/- mice had started to recover from 
fibrosis, the cell populations were not yet recovered (Figure 4.4 A and B). Meanwhile the 
infected cell population in IFNγR-/- spleen also reached its lowest point. Most interestingly, 
by comparing the FACS analysis result of uninfected mice and IFNγR-/- mice on day 35 post 
infection, we saw some similarities which indicate a recovery from infection (Appendix 3 A 
and C).  
First, the IgD- population (GC and memory B cells) was very limited in IFNγR-/- mice and 
uninfected mice (Appendix 3 A and C), while a significant population was formed in WT 
mice (Appendix 3 B). In uninfected mice under specific pathogen-free conditions, the 
germinal centres were not developed in the spleen so that no GC and memory B cell 
populations were detected. However, in IFNγR-/- mice on day 35 post infection, the 
populations of GC and memory B cells were reduced during fibrosis. A significant 
difference was observed in the comparison of IFNγR-/- spleen before the development of 
fibrosis on day 20 post infection (Appendix 3 D) with that on day 35 (Appendix 3 A) post 
infection.  
Second, the number of infected cells in B-cell subpopulations on day 35 post infection was 
significantly reduced and they were hardly detected in some individuals (Appendix 3 A, 
bottom lane), which is distinct from the situation on day 20 post infection (Appendix 3 D, 
bottom lane). In contrast, infected cells were detected in all three B-cell subpopulations in 
WT mice on day 35 post infection (Appendix 3 B, bottom lane). Such observations were 
repeatedly made in 6 out of 8 mice tested in 2 independent experiments.    
Day 35 post infection signalled the recovery phase from fibrosis when the spleen started to 
rebuild its structure and the fibrosis was partially resolved. This result is particularly 
interesting to us, for we saw lower viral activity compared to wild type mice at the same 
time post infection. It appears that the infection was effectively controlled on day 35 post 
infection in IFNγR-/- mice. Some individual IFNγR-/- mice had lost most of their germinal 
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centre B cells and memory B cells during fibrosis; therefore most of the viral load went with 
these cells, hence the lack of virus positive cells. 
Although we already knew that there was a low viral load detected by PCR, we wanted to 
know if IFNγ R-/- mice could stay clear from infection. Therefore, we compared infection in 
IFNγR-/- mice on day 35 and day 48 post infection (Figure 4.7). One mouse out of 5 showed 
a high viral load on day 48. Despite the individual variation, there was no significant 
increase in infection in the spleen from day 35 to day 48 post infection. However, on day 48 
p.i. all 5 mice were positive. The results demonstrate that the infection in IFNγR-/- spleen 
was controlled but not cleared, corresponding with the results from limiting dilution assay 
that there was viral DNA persistence in the spleen cells up to day 68 post infection (Chapter 
3). The infection in the spleen may have reached the lowest point around day 35, and while 
the spleen was repopulated, the latently infected memory cells that circulated in the 
periphery may have re-seeded the spleen when fibrosis resolved. Another possibility is that 
very few infected cells remained in the spleen during fibrosis, so that the infection expanded 
from these cells.     
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Figure 4.7 Comparison of viral load in IFNγR-/- spleens on days 35 and 48 post infection. 
IFNγ R-/- mice were infected with 4×103pfu mLANA-MHV-68 in 40μl sterile PBS 
intranasally. Spleen cells were harvested on day 35 and day48, and were stained as 
described in Chapter 2. There was no significant difference between day 35 and 48 p.i. in 
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4.4 Viral gene expression in mLANA-positive cells  
mLANA-positive and mLANA-negative cells were sorted using flow cytometry.  There 
were many more negative cells than positive, so only a very small fraction of negative cells 
were collected for comparison. Total RNA was recovered from sorted mLANA-positive 
cells, followed by reverse transcription to generate first-strand cDNA which was followed 
by qPCR for selected viral genes. The aim of this experiment was to investigate the 
difference between IFNγR-/- mice and wild type mice and viral gene expression in infected 
spleen cells. We were mainly interested in lytic cycle genes because viral reactivation may 
result in cell loss, especially the loss of IgD-negative B cells in IFNγR-/- spleen. Therefore 
we chose RTA and viral DNA polymerase as target genes. Meanwhile, we also tested M1, 
which is a reactivation inhibitor which is also essential in triggering fibrosis in the spleen of 
IFNγR-/- mice (Clambey et al., 2000). ORF73 expression was also tested. 
The gene expression profile shows the latency related genes ORF73 and M1 were highly 
expressed compared with lytic cycle genes (Figure 4.8 B) in IFNγR-/- mice and wild type 
mice on day 20 post infection. There was no statistically significant difference between 
IFNγR-/- mice and wild type mice for all 4 genes tested. However, M1 and ORF50 in IFNγR-
/- mice were expressed at lower levels than in wild type mice. This suggests that on day 20 
post infection, the infection in IFNγR-/- mice and wild type mice was mostly latent; there 
was no sign of viral reactivation in IFNγR-/- mice. Hence, the results suggest the massive 
loss of spleen cells was unlikely to be caused by lytic infection following viral reactivation. 
However, we chose day 20 in this experiment because the proportion of infected cells for 
sorting reached its peak at day 20 post infection. Attempts to recover total RNA from FACS 
sorted cells on other time points failed, as the cell number from each individual mouse was 
too low to generate enough RNA for reverse transcription using an RNA extraction kit. 
Therefore we were not able to profile the change of gene expression in IFNγR-/- mice in 
infected cells during a period of time. Also, this result was only normalised by the 
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expression of housekeeping gene YWHAZ; viral DNA was not measured, and therefore the 
possibility of one cell carrying different numbers of viral genome was not considered. These 
set-backs may affect the results.   
141 
 
Chapter 4                                                        Characterization of latent infection in the spleen  
 
 

















































































































































































Figure 4.8 Viral gene expression in mLANA-positive cells. IFNγ R-/- mice and 129Sv mice 
were infected with 4×103pfu mLANA-MHV-68 in 40μl sterile PBS intranasally (IFNγ R-/-- 
KO; 129Sv-WT). Spleen cells were harvested on day 20 and were stained as described in 
Chapter 2. Cells were sorted by FACS, and total RNA were extracted and reverse 
transcription-qPCR were performed for Viral genes ORF73, M1, RTA, and viral DNA 
polymerase. The results were normalised against copy numbers of housekeeping gene 
YWHAZ. (A) The expression of ORF73, M1, RTA, and DNApol in IFNγR-/-(KO) and WT 
(wild type) mice. (B) The comparison of viral genes expression. (C) The copy number of 
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4.5 Viral gene expression profiling in spleen tissue 
Finding it difficult to profile the viral gene expression in sorted cells, we had to compromise 
due to the limitation of RNA and DNA extraction. Moreover, we already knew that the 
infected cells do not express ORF73 and therefore could not be collected, so the gene profile 
on sorted infected cells may not reflect the general viral gene expression level of a whole 
spleen. Hence, viral gene expression profiling was performed using the whole spleen tissue 
preserved in RNAlater.  
Viral genes tested were M1, ORF73, RTA, vDNA polymerase, and M11. We investigated 
the viral gene expression at a series of time points ranging from the establishment of latent 
infection (day 16) to the long-term latency (day 60). The important time points which mark 
the development of fibrosis and recovery in IFNγR-/- spleen, such as day 20, day 28, day 32, 
and day 40, were included.  
Absolute quantification was performed and the results were normalised in two ways. First, 
the absolute copy numbers were normalised with housekeeping gene YWHAZ (Figure 4.9 
left row), which shows the level of viral gene expression in the total RNA from the same 
amount of spleen tissue. The housekeeping gene YWHAZ was steadily expressed in the 
spleen of IFNγR-/- mice and wild type mice and therefore a valid gene to use for 
normalisation.  
Although each qPCR reaction contained the same amount of mRNA from spleen tissue, the 
viral load in each sample varied according to mouse strain (e.g., IFNγR-/- mice carried more 
virus than WT mice) and time point post infection (e.g., IFNγR-/- mice carried more virus on 
day 16 than day 28 post infection). Therefore, as the second way to normalise the qPCR 
result, viral DNA was made as a normalisation factor to reflect the gene expression on the 
level of each viral genome (Figure 4.9 right row).    
143 
 
Chapter 4                                                        Characterization of latent infection in the spleen  
  
M1

















M1 normalized with vDNA








































ORF73 normalized with vDNA






































DNApol normalized with vDNA







































RTA normalized with vDNA





































M11 normalized with vDNA






















Copy number (normalized by YWHAZ) Normlized by vDNA
 
Figure 4.9 Result of gene profiling normalised by either YWHAZ or viral DNA. IFNγ R-/- mice (KO) and 129Sv 
(WT) mice were infected with 4×103pfu MHV-68 in 40μl sterile PBS intranasally. Spleen tissues were harvested 
on day 16, 18, 20, 22, 24, 28, 32, 40, 50 and 60, and were preserved in RNAlater. Total RNA was extracted, and 
reverse transcription-qPCR was performed. The left row shows copy numbers of genes of interest normalised 
with YWHAZ expression. Dot line represents the limitation of quantification, which is 5 copies; the right row 
shows copy number firstly normalised by YWHAZ expression factor, then normalised with vDNA factor. Viral 
genome DNA was quantified by qPCR on total DNA extracted from spleen tissue.  
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Generally, M1 and ORF73 were highly expressed, while vDNA polymerase, RTA, and M11 
expression was low in both strains of mice. The results show different patterns of viral gene 
expression between IFNγR-/- mice and wild type mice.  
In wild type mice the M1 gene was stably expressed during the time course, while the other 
four genes tested were expressed at low levels. After day 20 post infection, the copy number 
of RTA, ORF73, and viral DNApol was lower than the sensitivity limitation of the assay (5 
copies, noted in the left row of Figure 4.9). Quantification of results that are below 5 copies 
is not considered to be accurate, although the amplicons can be confirmed by melt-curve 
analysis. The profile shows that from day 16 to day 24 post infection, there was a reduction 
in the expression of all viral genes tested, which remained low at later time points. The 
profile shows that the virus shut down gene transcription from day 16 to day 28, and 
remained latent in a long-term, on the same level as whole spleen tissue (Figure 4.9 left row). 
Interestingly, for each viral genome, expressions of all viral genes did not change from day 
16 to day 24 post infection (Figure 4.9 right row). This suggests the down-regulation of viral 
gene transcripts may be due to the contraction of viral load, rather than the down-regulation 
on the mRNA level. Marques et al. (2003) have shown that viral gene expression on day 14 
post infection in the spleen varies among macrophages and dendritic cells, and B-cell 
subpopulations. Therefore it is highly possible that in our case, the down-regulation of viral 
gene expression reflected a reduction of certain infected cell population(s) in the spleen, 
which may be a result of host immune responses.  
On the other hand, in IFNγR-/- mice, the expression of ORF73 was increased during day 16 
to day 28, corresponding to a boosted viral load in the spleen. The analysis also shows this 
increase was due to the expansion of viral load, for there was no difference between IFNγR-/- 
mice and wild type mice with respect to ORF73 expression normalized against viral genome 
(Figure 4.9 right row). Previous research has shown that the function of ORF73 encoded 
mLANA is as a tethering viral genome as an epitome when host cells undergo mitosis, so 
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that the viral genome can be replicated and persist in daughter cells. Research using 
mLANA-null virus showed that without mLANA, the virus was unable to maintain the 
episomal genome in vivo and could not reactivate from latency (Paden et al., 2010). With its 
essential role in viral infection, ORF73 is expressed through lytic and latent infection. Our 
results demonstrate that mRNA for ORF73 increased while the infected spleen cells 
proliferated, then reduced rapidly during the cell loss caused by fibrosis. ORF73 expression 
showed a different pattern from other genes tested. IFNγR-/- mice had significantly higher 
ORF73 expression from day 16 to day 24 post infection, peaking on day 20 post infection, 
and then dropping to a level similar to that of wild type mice during the fibrosis and 
recovery phase. However, the average level of expression of ORF73 per viral genome shows 
a similar trend in IFNγR-/- mice and wild type mice (Figure 4.9 lane 2). Hence, the change of 
ORF73 expression corresponded with the change of viral DNA load in both strains. 
Moreover, it is obvious that in IFNγR-/- spleen, ORF73 was steadily expressed in most of the 
infected cells.  
However, the other four genes tested showed a different expression pattern compared to 
ORF73. Within the same spleen tissue, the expression of M1 was similar between IFNγR-/- 
mice and wild type mice, and it hardly changed through the time course (Figure 4.9 lane 1, 
left). However, after normalisation with viral DNA factor, M1 expression in IFNγR-/- spleen 
was first comparable to that of WT mice, then became lower during splenomegaly, and then 
back to a level similar to that of wild type mice again (Figure 4.9 lane 1, right). Although it 
is possible that the transcription level of M1 for each viral genome is first inhibited and then 
up-regulated, it is most likely that this change is caused by normalisation by vDNA, which 
suggests that the level of M1 transcripts remains at a similar level in spleen tissue although 
the viral DNA has changed greatly from day 16 to day 28.  
Similar trends were also found in viral DNA polymerase, RTA, and M11 (Figure 4.9 lanes 
3–5). Therefore, we conclude that the increase of infected cells in IFNγR-/- spleen during day 
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16 to day 20 post infection were expressing ORF73 but not M1, vDNA polymerase, RTA, 
and M11. On the level of the whole spleen, the expression of the productive 
infection/reactivation related genes was shutting down over the period from day 16 to day 28 
and remained low in both IFNγR-/- and WT mice. Although there was a significant increase 
in ORF50 expression from day 20 to day 24 post infection which indicates an enhanced 
reactivation in the IFNγR-/- spleen (Figure 4.9 lane 4, left), it did not fit the trend of the 
changing viral load (Figure 4.9 lane 4, right). As discussed in section 4.3.2, on day 16 to day 
20 post infection, the newly increased number of infected cells which expressed mLANA 
were mainly germinal centre B cells and memory B cells, and these two populations 
contributed the majority of B-cell loss as well as viral load reduction during fibrosis. There 
was no elevated expression of reactivation-associated genes corresponding to the change in 
these two B-cell subpopulations; hence, it is unlikely that the viral reactivation caused 
massive cell loss during fibrosis. However, this conclusion needs to be confirmed by 
examining the viral gene expression in enriched germinal centre B cells and memory B cells.  
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4.6 Discussion 
In this chapter, we investigated the change of distribution of B-cell subpopulations, and the 
cells expressing viral ORF73 in IFNγR-/- mice during fibrosis in each subpopulation. Further, 
we examined viral transcripts in both spleen tissue and sorted ORF73 expressing cells for 
selected viral genes.  
1. Reactivation-associated viral genes are not the main reason causing massive cell loss 
in IFNγR-/- mice 
The expression of viral DNA polymerase, RTA, and M11 decreased throughout latent 
infection from day 16 to day 60 post infection in both IFNγR-/- and WT mice. The dramatic 
change of viral infection in IFNγR-/- mice does not contribute to the expression of vDNA pol, 
RTA, and M11. This result shows that an enhanced reactivation from latency is unlikely to 
be the main reason causing massive cell loss during fibrosis in IFNγR-/- spleen. Moreover, 
viral gene expressions in sorted mLANA-positive cells on day 20 post infection confirmed 
that these viral genes were expressed at very low levels in infected cells, and there was no 
significant difference (p>0.05) between IFNγR-/- mice and WT mice on the expression levels.  
Evans et al. suggest that persistent reactivation from latency may cause tissue damage which 
subsequently leads to the occurrence and development of fibrosis in IFNγR-/- mice (Evans et 
al., 2008). The persistent infection includes both latent infection and a low level of 
reactivation from latency. During latency establishment, lytic infection is observed using 
immunohistochemistry method on day 16 to day 20 post infection (Gangadharan, 2006). 
Moreover, a majority of MHV-68 infected cells in the spleen which undergo reactivation 
were shown to be plasma cells (Collins et al., 2009; Liang et al., 2009). Therefore one of the 
possible explanations is that in IFNγR-/- mice, the increased virus-driven B-cell 
differentiation lead to increase in the plasma cell population which lead to an increased 
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reactivation. This enhanced reactivation caused cell death, but it is not the main reason for 
the rapid reduction of germinal centre B cells and memory B cells during fibrosis.  
Our results have pointed out the importance of studying viral gene expression in different 
subtypes of infected cells in IFNγR-/- mice. However, currently, our techniques of cell 
separation and RNA extraction are not ideal. Further experiments and advanced methods are 
required.      
2. M1 expression during fibrosis  
In spleen tissue, the number of M1 transcripts remained steady despite the viral DNA load is 
increasing. This suggests the increased numbers of infected cells were not expressing M1 or 
expressed only a very low level of M1. In enriched mLANA-MHV-68 infected cells, the 
expression of M1 was only detected in infected cells, suggesting there are fewer M1 
transcripts detected in IFNγR -/- mice and wild type mice on day 20 post infection. These 
results indicate that a proportion of ORF73 expressing cells are expressing M1 and other 
genes tested. However, this difference does not appear to be statistically significant (p>0.05). 
M1 has been proved to be essential for fibrosis forming in IFNγR-/- mice (Clambey et al., 
2000; Dutia et al., 2004). Here we show that there was no increased M1 expression 
corresponding to the development of fibrosis. The work of Evans et al. suggests that M1 
may trigger the expansion of Vβ4 CD8+ T cells as a super antigen, which leads to fibrosis. 
However, the role of M1 in the formation of fibrosis is still unclear. Investigations on a 
protein-level may help to understand the role of M1. 
3. ORF73 expression during fibrosis 
The core viral gene in this series of experiments is ORF73, which encodes the latency 
associated nuclear antigen of MHV-68 (mLANA). ORF73 expression was investigated in 
two ways in this chapter. First, we examined ORF73 transcripts in spleen tissue and sorted 
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mLANA cells by qPCR. Second, we utilised recombinant virus mLANA-MHV-68 to isolate 
latent infected virus. 
The qPCR assay shows that IFNγ receptor deficiency had no direct effect on ORF73 
expression on a mRNA level. Our results show that the increase of the crucial latent gene 
ORF73 in the spleen is correlated with the increase of viral genome DNA, which suggests 
there is no enhanced up-regulation of ORF73 expression. In the IFNγR-/- spleen after day 16 
post infection, the significant increase of viral load was mainly due to the increased number 
of latently infected B cells (Gangadharan, 2006). Therefore, our results show that the change 
of ORF73 expression in spleen tissue corresponds to the dramatic increase and decrease of 
the number of latently infected B cells during fibrosis. As discussed before, these newly 
generated cells do not express RTA, DNApol, M11, and M1.  
Using mLANA-MHV-68, Nealy et al. have identified the ORF73 expressing cells which 
comprise around 15% of viral genome positive cells in immune competent mice on day 16 
post infection. On day 28 the percentage of genome positive cells which were labelled with 
the lactamase substrate reached its peak of 42% post infection (Nealy et al., 2010). The same 
studies have not been carried out with IFNγR-/- mice. A similar result was also found when 
identifying spliced mLANA in vivo using RACE analysis (Allen et al., 2006). Namely, 
although ORF73 is expressed throughout the time course post infection, only some of the 
viral DNA carrying cells express ORF73. Its expression may depend on cell type and/or cell 
cycle. ORF73 expression was not detected in follicular B cells and newly formed B cells or 
macrophages in the spleen on day 14 post infection, while it was expressed in germinal 
centre B cells and marginal zone B cells (Marques et al., 2003). Recent research also shows 
that ORF73 has the potential function to manipulate the host cell cycle: ORF73 has been 
shown to bind BET proteins which affect the activation of cell cyclin D1, D2, and E 
(Ottinger et al., 2009). Therefore it is possible that ORF73 is expressed in a certain subset 
and stage of the host cell. There is the low expression of reactivation-associated genes at this 
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stage, where there was also very little reactivation and lytic infection going on compared to a 
latent infection in which ORF73 is expressed. Hence it is likely that the proportion of the 
ORF73 expressing cells within infected cells is higher than that identified by Nealy et al. 
(Nealy et al., 2010). The infected cells not expressing ORF73 may be the cells not 
undergoing mitosis while viral gene expression is been shut down or under detection. Also, 
there may be other type of cells such as macrophages and dendritic cells infected which do 
not express ORF73 or only express it at a very low level (Marques et al., 2003). Therefore, 
although mLANA-MHV-68 is the best tool available so far to examine and isolate latent 
infected cells at late time points, it cannot detect all infected cells. The limitation of the 
system has to be noted before further discussion.  
4. Change of distribution of B-cell subpopulations and infection within these 
subpopulations during fibrosis 
Studies on EBV also show that sIgD-negative memory B cells are the main location of 
persistency (Babcock et al., 1998). Moreover, it has been reported that in long-term latency 
in the spleen after intranasal inoculation, the latent MHV-68 is mainly confined to the 
surface IgD-negative subset of B cells (Willer and Speck, 2003). Our results also show that 
the vast majority of mLANA-positive cells are from IgD-negative B-cell subsets (germinal 
centre and memory B cells) despite the fact that the population is much smaller than the 
naïve B cell population. A significant reduction of infection in naïve B cells was observed in 
IFNγR-/- mice on day 35 post infection, suggesting the presence of fibrosis affected the 
maintenance of the population of infected naïve B cells. The infection of IgD+ naïve B cells 
has been shown to be inefficient (Jarousse et al., 2008; Liang et al., 2011). Therefore the 
infected naïve B cells may also come from infected B-cell progenitors from bone marrow. 
Recent studies indicate that immature B cells in the bone marrow are a site of latency 
(Coleman et al., 2010) and may possibly become the origin of infected cells which reseed 
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the spleen. The reseeding may occur once the fibrosis is resolved and the circulation of 
lymphocytes is unblocked.  
A number of studies have suggested a model of MHV-68 using the B-cell life cycle in a 
germinal centre reaction to expand the pool of infected cells by driving B-cell proliferation 
and differentiation, therefore establishing long-term latency in memory B cells (reviewed in 
Barton et al., 2011). We have found that this crucial strategy for viral persistence seems to 
be disturbed in the spleen of IFNγR-/- mice. The Th2 dominated immune response triggers 
severe fibrosis around splenic follicles, in which the populations of germinal centre and 
memory B cells rapidly decrease, and these two populations account for about 80% of 
infected cells. Therefore on day 35, decreased infections were observed in IFNγR-/- spleens 
corresponding with the disappearance of GC B cells and memory B cells. Why the germinal 
centre B cells and memory B cells in IFNγR-/- spleen cannot survive in the spleen during 
fibrosis is still unknown. We have already known that these cells did not undergo 
accelerated Caspase3-dependent apoptosis; moreover, TUNEL assays show they were not 
elevation within the spleen during fibrosis. Moreover, the viral reactivation within these 
cells was not elevated during fibrosis. The possibility which remains is that the presence of 
fibrosis has blocked the signals such as cytokines and chemokines which are important in 
the survival and homing of the developing B cells. Therefore these cells either leave the 
spleen or undergo cell death which is independent from Caspase3 and does not cause 
significant DNA damage. Further discussion of the fate of B cells will continue in Chapter 6.   
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5.1 Introduction 
MHV-68 induced lung fibrosis is intensively studied as a mouse model for human 
herpesvirus-related idiopathic pulmonary fibrosis (IPF); nevertheless, the fibrosis which 
occurs in the spleen is also of great interest. In MHV-68 infection, the spleen B cells are the 
major site of long-term viral persistence, and in IFNγR-/- mice, it is observed that fibrosis 
forms around follicles (Gangadharan et al., 2008). We have demonstrated in Chapter 4 that 
during fibrosis, germinal centre and memory B cells, which carry the majority of latent virus, 
suffered an extra cell loss, which is not due to viral reactivation. All this evidence suggests 
that fibrosis has an important role in controlling viral latency in the spleen of IFNγR-/- mice. 
However, the detailed cellular basis of fibrosis and its interaction with latent infected B cells 
in the spleen remains unclear. In this chapter, we observe the cellular events during MHV-68 
mediated fibrosis, and we pay special attention to cells that may involve in the formation of 
fibrosis. 
Gangadharan demonstrated a dramatic change of macrophage activities in IFNγR-/- mice by 
staining for different subsets of macrophages and observing their movement into the white 
pulp on days 12 to 16 post infection, where they exhibit signs of activation(Gangadharan, 
2006). IFNγ signalling is one of the main features of Th1 immune response and the lack of 
the IFNγ receptor favours the induction of Th2 cytokines such as IL-4 and IL-13. Under 
such circumstances, alternative activation of macrophages (AAMφ) assumes a more 
dominant role in the immune response (Mills et al., 2000). Elevated expression of markers 
of AAMφ such as Arginase 1, Ym1/2, and FIZZ 1 suggests that AAMφ is associated with 
fibrosis in the spleen (Gangadharan et al., 2008), lung (Mora et al., 2006), liver, and bile 
duct (Gangadharan et al., 2009) in IFNγR-/- mice. In herpesvirus-infected patients, 
reactivation from latency is considered to be the main trigger/stimulus which lead to 
fibrosis—a disorder of wound repair. It has been reported that antiviral therapy which 
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controls reactivation helps to limit MHV-68 infection induced lung fibrosis in IFNγR-/- mice 
(Mora et al., 2007) on the C57BL/6 background. On the contrary, similar studies done in our 
lab on IFNγR-/- on the 129Sv/Ev background show that the inhibition of lytic infection does 
not limit fibrosis in the lung (Dutia et al., unpublished results). This is possibly because of 
the breed of mice, or because of the drug dose or different routes of infection. The 
mechanisms of MHV-68 infection causing splenic fibrosis are still unclear. There are two 
hypotheses: the persistent reactivation from latent infection, and/or tissue damage caused by 
immune response. Further discussion about both hypotheses continues in Chapter 6. 
As introduced in Chapter 1, macrophages play a key role in generation and resolution of 
fibrosis. This is particularly true for hepatic fibrosis, in which macrophages are closely 
associated with the activity of the main ECM producing cells—myofibroblasts (Leicester et 
al., 2004; Wynn and Barron, 2010). In the MHV-68 model, Gangadharan found 
macrophage-like spleen cells stained positive for the myofibroblast marker α-smooth muscle 
actin (α-SMA) (Gangadharan, 2006). Moreover, Mooney et al. have observed CSF1R-EGFP 
positive cells co-expressing α-SMA, which suggests that macrophages may have the 
potential to trans-differentiate into myofibroblasts (Mooney et al., 2010). Based on these 
observations, we set out to investigate in our model whether macrophages contribute to the 
cellular basis of fibrosis by trans-differentiating into myofibroblasts.  
To further explore the possible role of alternatively activated macrophages in the spleen of 
IFNγR-/- mice during MHV-68 induced fibrosis, immunofluorescent assay was carried out 
using mice in which EGFP is expressed in macrophage/monocytes lineage. Macgreen mice 
have a reporter gene EGFP insertion after the colony stimulation factor 1 receptor (CSF1R, 
also called c-fms) promoter (Sasmono et al., 2007; Sasmono et al., 2003). CSF1R is the 
receptor for cytokine CSF1 which regulates macrophage proliferation and differentiation. 
We crossed the Macgreen mice with IFNγR-/- mice to produce IFNγR-/- mice with EGPF +ve 
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macrophages (Macgreen × IFNγR-/-). With visible macrophages, Macgreen × IFNγR-/- mice 
provide an excellent tool to study the role of macrophages in viral induced fibrosis.  
There was a technical problem with traditional microscopy when used at high magnification 
to observe tissue samples: the view is too restricted to show the relationship of cell events 
with other components of the tissue. Pictures shown in this chapter were taken using tiled 
scan based on confocal microscopy, in which several pictures were taken at high 
magnification and then were stitched together to form a general view. With this technique, 
we were able to locate the events in the scale of the whole spleen, and at the same time have 
a very close look at each cell of interest at high resolution and magnification. In this chapter, 
we aimed to explore the role of alternatively activated macrophages in the development of 
the fibrosis. Particularly, we investigate if the α-SMA expressing cells observed by 
Gangadharan are co-expressing macrophage markers. To achieve this, we took high-
resolution images showing the distribution of B cells, T cells, and macrophages by co-
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5.2 Optimisation of multi-colour immunofluorescent 
staining 
5.2.1 α-SMA distribution in the spleen  
Anti-α-smooth muscle actin (α-SMA) antibody was initially used to show the trans-
differentiation of macrophages into myofibroblasts. However, using immunofluorescent 
staining we observed accumulation of α-SMA as extracellular material (Figure 5.1) as a 
component of fibrosis. The spleen structures, such as capsule, spleen trabecular, and blood 
vessel, were all α-SMA positive (Figure 5.1 A and C). The ECM accumulating around the 
germinal centres was also α-SMA positive (Figure 5.1 A), and stained positive for collagen 
in Masson’s trichrome staining (Figure 5.1 B). Therefore we used this antibody not only as a 
marker for myofibroblasts, but also to show the distribution of ECM. 
5.2.2 Single-staining (isotype) controls 
Single-staining (isotype) controls were performed to detect the level of non-specific binding 
for each antibody, as well as to detect the spillover between channels. When compared to 
normal spleen tissue, the fibrotic spleen showed a high background of auto-fluorescence and 
non-specific binding. Therefore we used spleen from IFNγR-/- mice on day 28 post infection 
to see whether severe fibrosis affects single-cell staining with different cell markers 
including α-SMA. As expected, we detected green auto-fluorescence caused by Elastin . 
Also, a low level of non-specific binding of mouse IgG2b isotype control antibody was 
detected in yellow and red channels (data no shown). However, the non-specific staining can 










Day 16 P.I. 
Day 26 P.I.        
Figure 5.1 Comparison of immunostaining for α-SMA (A and C, red) and Masson’s 
trichrome staining for collagen (B and D, blue) in the spleen of IFNγR-/- mice on day 16 (A 
and B) and day 26 (C and D). The patterns of distribution of α-SMA and that of collagen are 
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5.3 Cellular events in the spleen during fibrosis: induction, 
appearance, and resolution 
In this section, we demonstrate the cellular events which occur in the spleen of IFNγR-/- 
mice during the induction (day 12 post infection), appearance (days 16 and 28 post 
infection), and resolution (day 35 post infection) of fibrosis, and compare them with those in 
immune competent mice at the same stages of infection. Special attention is paid to the 
appearance of macrophages and ECM-producing cells in forming fibrosis. Each group had 3 
to 4 mice of mixed age and sex. 
5.3.1 Day 12 post infection: Fibrosis starts from peri-arteriolar 
lymph sheath (PALS) 
In Macgreen × IFNγR-/- mice on day 12 post infection, mild accumulation of ECM was 
observed around lymphoid follicles (Figure 5.2 A), and more evidentlyobserved, in PALS 
(Figure 5.2 B). Interestingly, the α-SMA positive cells followed the distribution of the 
fibroblastic reticular cells (FRCs) network. In comparison to the B-cell zone, the T-cell zone 
(PALS) appeared to be more involved in fibrosis at this stage. Angiogenesis was observed in 
PALS where T cells interacted with macrophages.  
In wild type mice on day 12 post infection there was no accumulation of ECM in the spleen. 
There was neither enhanced signal for α-SMA, nor sign of angiogenesis (Figure 5.2 D). 
Notably, there were two levels of expression of CSF1R-eGFP (Figure 5.2 C and D): 
macrophages with high expression of eGFP lining the red pulp and marginal zone; and cells 
morphologically distinguishable from macrophages with low eGFP expression scattered in 
both red pulp and white pulp. The identity of these cells is not known. A previous study has 
shown that there exists a CSF1R-eGFPlow CD11clow CD45R (b220)+ population defined as 
splenic plasmacytoid dendritic cells (MacDonald et al., 2005). Moreover, these eGFP low 
expressing cells were recently shown to be co-stained with Gr1 and Ly6C; therefore there 
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are possibly neutrophils and monocytes within this population (Mooney et al., 2010). Based 
on previous study, as well as our observation of cell morphology as size, cell shape, and 
nuclear shape, we believe the CSF1R-eGFP low CD45R(b220)+ observed here were follicular 
dendritic cells (Figure 5.2 D, orange arrows), while the dim green cell within germinal 
centre but b220 negative was infiltrating neutrophils. The infiltration of neutrophils into 
germinal centres was observed in wild type mice and IFNγR-/- mice, but to a higher extent in 
wild type mice.  
Compared with IFNγR-/- spleen, the expression of the eGFP is considerably higher in WT on 
day 12 post infection. This could be related to the macrophage function involved in the 
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Day12 p.i Macgreen x IFNγR-/- 
CSF1R-eGFP  






B cell zone 
PALS 
B
Figure 5.2 Spleen frozen section (Confocal microscopy tiled scan 63x magnification oil lens) of a 
Macgreen × IFNγR-/- mouse (A and B) and a macgreen mouse (WT, C and D, next page) infected with 
MHV-68 on day 12 post infection: All scale bars represent 50μm. Macrophages were marked by 
eGFP. Frozen sections were stained with anti-CD45R(B220)and anti-α-SMA antibodies, and 
counterstained with DAPI. (A): Macgreen × IFNγR-/- mouse: 3x3 tiled scan shows overview of spleen 
structure. (B): Amplified rectangular area from A. (C): Macgreen mouse: 3x3 tiled scan shows 
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Day12 p.i. Macgreen (WT) 
 
C Day12 p.i Macgreen (WT) 
CSF1R-eGFP  
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5.3.2 Increased Fibrosis and the destruction of splenic architecture: 
Day 16 and day 28 post infection 
In Macgreen × IFNγR-/- mice on day 16 post infection, the spleen structure, capsule and 
trabecular, were thickened with enhanced α-SMA signal compared to that at day 12 p.i.. 
More angiogenesis and more elastin were produced. There was a higher density of eGFP 
signal compared to day 12 post infection. The cell density in red pulp and PALS had 
significantly increased. Patches of B cells were surrounded by ECM and green macrophages, 
resulting in a decrease in the size of the B-cell zone (Figure 5.3 A). More interestingly, we 
saw α-SMA positive staining in the cytoplasm within some eGFP positive cells in IFNγR-/- 
spleen (Figure 5.3 B, white arrows). It appears that these cells were either producing or 
engulfing ECM, or the yellow signal was caused by auto-fluorescence. However, such 
morphology could only be observed in fibrotic spleens. This may suggest a significant role 
played by macrophages in ECM accumulation. We also observed α-SMA positive cells, 
specifically in IFNγR-/- mice. They were located on the edge of the B-cell zone as well as the 
marginal zone (Figure 5.3 C, white arrows). These cells are myofibroblasts, which play the 
key role of producing ECM and lead to fibrosis. Their appearance around the B-cell zone 
explains how ECM forms around the infected B cell follicle. 
In wild-type mice on day 16 post infection, no fibrosis developed. In the marginal zone, 
some cells expressed CD45R (b220) on the cell surface while CSF1R-eGFP was expressed 
in the cell cytoplasm (Figure 5.4 A). Infiltration of both macrophages and neutrophils into 
the B-cell zone was observed. Neither α-SMA positive-non-green cells, nor macrophages 
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Day 16 Macgreen x IFNγR-/- 
CSF1R-eGFP  





Figure 5.3 Spleen frozen sections (Confocal microscopy tiled scan 63x magnification 
oil lens) of a Macgreen × IFNγR-/- mouse infected with MHV-68 on day 16 post 
infection: All scale bars represent 50μm. Macrophages were marked by eGFP. 
Frozen sections were stained with anti-CD45R(B220)and anti-α-SMA antibodies, 
and counterstained with DAPI. (A): Macgreen × IFNγR-/- mouse: 3x3 tiled scan 
shows overview of spleen structure. (B): Amplified rectangular area from A. (C) 
shows α-SMA positive cells (arrows). 
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Figure 5.4 Spleen frozen sections (Confocal microscopy tiled scan 63x magnification 
oil lens) of a Macgreen × 129Sv mouse on day 16 post infection: All scale bars 
represent 50μm. (A): 5x5 tiled scan shows overview of spleen structure. (B): 
Amplified rectangular area from A. 
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In Macgreen × IFNγR-/- mice on day 28 post infection, the spleen had become highly 
fibrotic and the red pulp had collapsed. The size of PALS was greatly reduced and there 
was an increase in angiogenesis. The number of macrophages in the red pulp had greatly 
decreased and the rest remained in PALS (Figure 5.5 B). The thickened capsule had been 
padded with elastin, which increased the tension of the spleen and caused shrinking in size 
and lack of blood circulation. Overall the spleen structure had been destroyed: the B cells 
were greatly reduced in number, as were macrophages and T cells (Figure 5.5 A). 
Interestingly, there was a depletion of eGFP low expressing population within the B-cell 
zone, suggesting a depletion of dendritic cells (Figure 5.5 B).  
In wild-type mice on day 28 post infection, the spleen had recovered from splenomegaly 
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Day 28 Macgreen x Sv129 (WT) 
CSF1R-eGFP  




Figure 5.5 Spleen frozen section (Confocal microscopy tiled scan 63× magnification 
oil lens) of a Macgreen × IFNγR-/- mouse (A and B) and a Macgreen × 129Sv 
mouse (WT, C) infected with MHV-68 on day 28 post infection: All scale bars 
represent 50μm. Macrophages were marked by eGFP. Frozen sections were stained 
with anti-CD45R(B220)and anti-α-SMA antibodies, and counterstained with DAPI. 
(A): Macgreen × IFNγR-/- mice on day 28 post infection: 5×5 tiled scan shows 
overview of spleen structure. (B): Amplified rectangular area from A. (C): Macgreen 
on day 28 post infection: 3×3 tiled scan shows overview of spleen structure. 
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5.3.3 Resolution of fibrosis and rebuilding of follicle structure: Day 
35 
In the recovery phase of day 35 post infection IFNγR-/- spleen, the T-cell zone (PALS) was 
rebuilt and macrophages appeared again in the red pulp and PALS (Figure 5.6 A). 
Interestingly, green pigments appeared within the macrophages, and these cells were 
distributed very close to the tissue undergoing angiogenesis (Figure 5.6 B, white arrow).  
In the wild-type spleen, the spleen structure was well kept and no sign of infection was 
observed (Figure 5.6 C).
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Day 35 Macgreen x Sv129 
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Figure 5.6 Spleen frozen section (Confocal microscopy tiled scan 63× magnification 
oil lens) of  Macgreen × IFNγR-/- mouse (A and B) and Macgreen × 129Sv mouse 
(WT, C) infected with MHV-68 on day 35 post infection: All scale bars represent 
50μm. Macrophages were marked by eGFP. Frozen sections were stained with anti-
CD45R(B220)and anti-α-SMA antibodies, and counterstained with DAPI. (A): 
Macgreen × IFNγR-/- mice on day 35 post infection: 5×4 tiled scan shows overview 
of spleen structure. (B): Amplified rectangular area from A. (C): Macgreen × 129Sv 
on day 35 post infection: 5×5 tiled scan shows overview of spleen structure. 
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5.3.4 T-cell distribution during fibrosis 
Gangadharan observed a change in the distribution of T cells during fibrosis: CD3+ T cells 
were observed moving from PALS to germinal centres in the spleen of both IFNγR-/- and 
wild-type mice before fibrosis. Once fibrosis had fully formed, T cells were no longer 
observed (Gangadharan, 2006). We confirmed his finding and, using the multi-colour 
system, we were able to observe in more details this process of T-cell trafficking.  
There were 4 to 5 mice in each group aged 12 to 16 weeks. Using the pan-specific CD3 
marker, we observed more infiltration of T cells from PALS to germinal centre in an IFNγR-
/- spleen than in wild-type spleen on day 16 post infection, when fibrosis had just begun 
(Figure 5.7). A large number of macrophages appeared in the area of PALS of IFNγR-/- 
spleen.  
On day 20 post infection, T cells in PALS in IFNγR-/- mice were greatly reduced in number 
and their population was not restored during fibrosis (Figure 5.8).  
On day 28 post infection, in a highly fibrotic spleen, patches of T cells were no longer 
observed, while there were still a number of B cells left. However, there were T cells 
scattered the B-cell zone and also in a shrunken PALS with a decreased number of 
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Figure 5.7 Distribution of splenic T cells during infection with MHV-68: Spleen frozen section 
(Confocal microscopy tiled scan 63× magnification oil lens) of a Macgreen × IFNγR-/- mouse (A and 
B) and a Macgreen × 129Sv mouse (WT, C) infected with MHV-68 on day 16 post infection: All scale 
bars represent 50μm. Macrophages were marked by eGFP. Frozen sections were stained with anti-
CD3 and anti-α-SMA antibodies, and counterstained with DAPI. (A): Macgreen × IFNγR-/- mice on 
day16 post infection: 3×3 tiled scan shows overview of spleen structure. (B): Macgreen × 129Sv on 
day 16 post infection: 3×3 tiled scan shows overview of spleen structure. 
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Day 20 Macgreen x IFNγR-/- 
 
B 
Day 20 Macgreen x Sv129 (WT) 
Figure 5.8 Distribution of splenic T cells during infection with MHV-68: Spleen frozen section 
(Confocal microscopy tiled scan 63× magnification oil lens) of a Macgreen × IFNγR-/- mouse (A and 
B) and a Macgreen × 129Sv mouse (WT, C) infected with MHV-68 on day 20 post infection: All scale 
bars represent 50μm. Macrophages were marked by eGFP. Frozen sections were stained with anti-
CD3 and anti-α-SMA antibodies. (A): Macgreen × IFNγR-/- mice on day20 post infection: 3×3 tiled 
scan shows overview of spleen structure. (B): Macgreen × 129Sv on day 20 post infection: 3×3 tiled 
scan shows overview of spleen structure. 
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Day 28 Macgreen x IFNγR-/- 
 
B 
Day 28 Macgreen x Sv129 (WT) 
Figure 5.9 Distribution of splenic T cells during infection with MHV-68: Spleen frozen section 
(Confocal microscopy tiled scan 63× magnification oil lens) of a Macgreen × IFNγR-/- mouse (A and 
B) and a Macgreen × 129Sv mouse (WT, C) infected with MHV-68 on day 28 post infection: All scale 
bars represent 50μm. Macrophages were marked by eGFP. Frozen sections were stained with anti-
CD3 and anti-α-SMA antibodies, and were counterstained with DAPI. (A): Macgreen × IFNγR-/- 
mice on day28 post infection: 5×5 tiled scan shows overview of spleen structure. (B): Macgreen × 
129Sv on day 28 post infection: 5×4 tiled scan shows overview of spleen structure. 
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5.4 Discussion 
The cellular events in the fibrotic spleen have been investigated by Gangadharan using the 
method of immunohistochemistry (Gangadharan, 2006). However, this method can only 
mark one type of cell at a time. The multi-colour system provides a tool to look at the 
interaction among T cells, B cells, macrophages, and FRCs. Moreover, confocal tiled 
scanning enables a wide overview of the whole spleen structure, as well as high resolution 
and magnification of events at the single-cell level. Using this technology we extended our 
understanding of the change of macrophages in number, location, and morphology during 
fibrosis. Moreover, some of our observations raise questions for further investigation. 
In our model of spleen fibrosis induced by MHV-68, we hypothesised that these 
macrophages trans-differentiate into myofibroblasts. We examined this hypothesis by 
looking for green macrophages co-expressing α-SMA. On day 16 post infection, we 
observed many macrophages in the red pulp and that the areas which were close to spleen 
trabeculae had a dim staining for α-SMA in the cell cytoplasm. Mooney et al. (2010) 
describes the α-SMA expressing cell in the peritoneal cavity as ‘spindle-shaped’, and they 
express α-SMA on the cell surface. However, these cells which we observed seemed to be 
morphologically different from those observed by Mooney et al., and the staining of α-SMA 
was in the cell plasma. Moreover, in the same spleen section, we also observed 
myofibroblasts which were strongly positive for α-SMA, but non-green, located at the 
marginal zone where they produced ECM and formed fibrosis. Therefore, the macrophages 
we observed share little similarity with myofibroblasts, and they are also distinct from the 
trans-differentiating macrophages which have been described in previous studies. 
 
We think the dim signal of α-SMA in green macrophages may be due to auto-fluorescence 
or other activity of macrophages—for example, engulfing dead cells or ECM—and there is 
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still the possibility that they are producing ECM, including α-SMA. Based on what has been 
observed, we conclude that although the macrophages may produce ECM which contributes 
to fibrosis, there is no evidence of macrophages trans-differentiating into myofibroblasts. 
There are two possible roles of macrophages in the generation of ECM in IFNγR-/- spleen: 
first, alternatively activated macrophages may regulate myofibroblasts producing ECM by 
secreting pro-fibrosis factors such as TGFβ1, PDGF, and TIMPs; and second, the 
macrophages may produce ECM; however, morphologically, they do not become 
myofibroblasts. 
Since the myofibroblasts do not come from the macrophages, what is the origin of the 
myofibroblasts? One possibility is bone marrow-derived fibrocytes which circulate through 
the blood stream and contribute to fibrosis in multiple organs (Bucala et al., 1994; Direkze et 
al., 2003; Forbes et al., 2004).  
Another potential origin of myofibroblasts could be the fibroblastic reticular cells (FRCs). 
The functions of the spleen largely depends on its architecture which  is maintained by 
fibroblastic reticular cell (FRC) network which consists mainly of endothelial cells and 
fibroblast-like cells of mesenchyme origin (Cyster, 2005; Junt et al., 2008; Luther et al., 
2011; Mueller and Germain, 2009). FRCs in the spleen include the marginal zone 
macrophages, sinus-lining endothelial cells of the marginal sinus, T cell zone FRCs within 
PALS, as well as FDCs and follicular FRC subsets (Mebius et al., 2004; Balogh et al., 2008). 
Accumulating evidence has shown that FRCs have multiple functions. As the scaffold of the 
spleen, FRCs enwrap ECM in a certain arrangement (reviewed in Balogh et al., 2008). 
Moreover, FRCs are involved in organ homeostasis and immune response and the function 
of each FRC subsets differs (Luther et al., 2011). Reticular cells in the marginal zone 
express a wide range of cytokines and chemokines such as CCL19, CCL21, and IL-7, 
suggesting a regulatory role in adaptive immunity and lymphocyte migration. Interestingly, 
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FRC cells co-express desmin and α-SMA, which form a conduit system which allows 
trafficking of small molecules such as antigens (Sixt et al., 2005).  
FRCs in secondary lymph organs, especially those which reside in the T-cell zone and 
marginal zone, express markers for myofibroblasts and show similar morphology to 
myofibroblasts in cell culture. Moreover, by secreting extracellular materials, these cells are 
capable of providing contractile force, to the same extent as lung myofibroblasts (Link et al., 
2007). These features indicate that fibroblastic reticular cells may share functions similar to 
those of myofibroblasts, which indicates a relation between FRCs and ECM deposition in 
the spleen.  
Accumulated evidence has confirmed that the migration and survival of T cells, as well as 
the structure of the T-cell zone, are highly related to the microenvironment maintained by 
FRCs in PALS (Bajenoff et al., 2006; Link et al., 2007). Interestingly, HIV and SIV 
infection induced fibrosis causes T-cell apoptosis and depletion by disrupting the FRC 
network (Zeng et al., 2011). Zeng’s work has shown that collagen deposition and loss of the 
FRC network lead to loss of contact between T cells and FRCs, which limits T-cell access to 
a major source of survival signal IL-7 and results in apoptosis and reduction of T cells. Loss 
of T cells also includes depletion of the LTβ-producing T-cell population, which in turn 
results in further destruction, for LTβ is necessary in maintaining the FRC network (Zeng et 
al., 2011).  
In MHV-68 infected IFNγR-/- spleen, we first observed fibrosis starting from PALS, 
followed by disruption of the T-cell zone from which T cells disappeared. Therefore it is 
possible that fibroblastic cells in FRC network may differentiate into myofibroblasts, and 
subsequently they lose the function of maintaining T-cell zone structure. This hypothesis 
needs to be confirmed by further experiments by staining spleen sections with anti-IL-7 and 
LTβ, as well as markers for FRCs (Desmin and ER-TR-7) and FDCs (CD35 and CD21) in 
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the spleen during fibrosis. Also, profiling relevant cytokine expression in the host at both the 
mRNA and the protein levels may provide supportive evidence. 
Interestingly, we observed that EGFPlow CD45R (B220)+ cells within B-cell follicles 
disappear during fibrosis, suggesting that they are affected by ECM accumulating around the 
follicle. However, we have not yet identified whether they are follicular dendritic cells on 
spleen sections. Co-staining with the dendritic cell marker CD11c and granulocyte marker 
GR-1, as well as neutrophil marker Ly6G may further identify these cells. Another 
possibility would be the infiltration of neutrophils or other granulocytes in the early stage 
which was resolved later. 
Due to the limitations of our technique, we were unable to visualise the latently infected 
cells in the system. We tried infecting mice with two MHV-68 recombinant viruses with 
insertion of GFP gene but neither showed a signal after day 24 post infection. So far, many 
reporter gene-labelled MHV-68 viruses have been generated; however, the vast majority 
show attenuation at late time points. There are two explanations for this: first, the production 
of reporter proteins may elicit a host immune response; second, the viral gene expression 
may be affected by the insertion so that it cannot establish a latent infection like a ‘normal’ 
virus. Although mLANA-MHV-68 does not show attenuation within 90 days post infection, 
it is not suitable for multi-colour staining as the β-lactamase substrate leaves all cells with 
high green fluorescence. Moreover, as discussed in Chapter 4, there are considerable 
populations of infected cells which do not express ORF73 and therefore cannot be detected. 
Although there are no ideal method to track virus in long-term latency, staining for lytic 
infected cells on spleen sections by Gangadharan demonstrated that on days 12 to 20 post 
infection, lytic infected cells appear in the area around lymphoid follicles in IFNγR-/- mice 
(Gangadharan, 2006). This finding suggests the lytic infection may occur in marginal zone 
macrophages, so that cell death becomes the continuous trigger/stimulus for the generation 
of fibrosis. On the other hand, the work of Speck’s group suggests that a considerable 
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proportion of the lytic infection in the spleen occurs in plasma cells, and that the virus drives 
B-cell differentiation into plasma cells (Collins et al., 2009; Liang et al., 2009). Moreover, 
plasma cells stay in the marginal zone before they enter red pulp and release antibodies, 
which suggest the lytic infection observed by Gangadharan may be in plasma cells. 
Therefore, it is also possible that plasma cells are responsible for the majority of lytic 
infection but not macrophages. Lytic infection is considered as one of the possible reason 
triggering fibrosis, so it would be very interesting to define the lytic infection using anti-
MHV-68 antibody.  
To examine whether the macrophages were infected, we tried detecting mLANA-MHV-68 
in CD11b+ cells and we found no infection in CD11b+ populations. However, it is quite 
possible that ORF73 is not expressed in infected macrophages. Therefore, a PCR for viral 
genome would be a better way of testing whether macrophages are infected. However, 
subsets of macrophages express different markers, causing difficulty to distinguish them. 
Moreover, the population of macrophages is relatively small in the spleen, so that it would 
be costly to use antibodies such as CD11b-Ab. These problems can be solved by using 
Macgreen and Macgreen × IFNγR-/- mice. 
 















Chapter 6                                                                                                                   Discussion 
In this project, we explored the cellular events and viral activities in splenic fibrosis induced 
by MHV-68 infection in mice that lack an IFNγ response. First, we investigated the possible 
mechanisms that may cause massive cell loss in the spleen. We concluded that excessive 
apoptosis and viral reactivation are not responsible for the cell loss. Second, we examined 
mLANA-expressing cells during latent infection using recombinant virus. We have observed 
a loss of latently infected B cells caused by the removal of germinal centre and memory B 
cell subsets. Finally, we investigated splenic macrophages using Macgreen mice during 
fibrosis which show significant changes in number and the pattern of distribution in time 
course, in which we found no evidence of macrophages trans-differentiate into 
myofibroblasts. 
Mechanisms of reducing the number of latently infected B cells 
As discussed in Chapter 4, we have observed a significant reduction of germinal centre B 
cells and memory B cells in IFNγR-/- spleen, whereas the IgD+ B cells (naïve B cells) 
maintained a certain population. Subsequently, on day 35 post infection, the B cells which 
remained in the spleen of IFNγR-/- mice were mostly naïve B cells. Germinal centre B cells 
and memory B cells were carrying the majority of the virus, while naïve B cells showed least 
level of MHV-68 infection. These observations suggest that the significant reduction of 
latently infected B cells is possibly caused by the removal of the subpopulations of germinal 
centre B cells and memory B cells. The low infection rate in naïve B cells is possibly due to 
two reasons: first, naïve B cells are less susceptible; or, once a naïve B cell is infected, it 
becomes activated and become a germinal centre B cell. Furthermore, we hypothesise that 
one possible reason for the reduction of germinal centre B cells and memory B cells is that 
ECM deposition blocked the interaction between B cells and follicular dendritic cells, and 
the interaction between B cells and T cells. Therefore, naïve B cells could not undergo 
somatic hypermutation and class-switching, whereas the germinal centre B cells underwent 
activated apoptosis without survival signals and hence they could not differentiate into 
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memory B cells and plasma cells. However, we did not observe significant elevated 
apoptosis in the spleen during the reduction of B cells. Current study investigating the fate of 
splenic B cells during fibrosis showed no evidence of enhanced cell death caused by 
Caspase 3-dependent apoptosis from day 16 to day 24 post infection. It has been shown 
using the method of TUNEL assay that the reduction of B cells was not due to increased cell 
death from day 4 to day 16 post infection (Ebrahimi et al., 2001). Hence, it is possible that 
the fibrosis may block cell recruitment, and the cells may leave the spleen at the same time. 
However, these studies were carried out using total spleen cells, which may not be sensitive 
enough to reflect the potential cell death in B cells subsets. FACS analysis using a 
combination of apoptosis marker and B cell markers may be a better method with less 
sensitivity issue. Moreover, there are still possibilities that the B cell may undergo 
accelerated cell death which cannot be detected by either TUNEL or caspase 3. 
If the spleen cells do not die during fibrosis, they may leave the spleen and contribute to the 
leucocytosis in the peripheral blood. The development of fibrosis leads to accumulation of 
ECM in structural scaffolding such as the capsule, resulting in high pressure inside of the 
spleen. Together with the observation that fibrosis formed around follicles, the lesion leads 
to blockage of peripheral blood and leukocytes passing though the spleen (Ebrahimi et al., 
2001). Ebrahimi et.al have demonstrated that a leucocytosis peaking at day 23 post infection, 
corresponding to the development of fibrosis. In the same study, injected labelled leukocytes 
could be observed in the spleen of wild type mice but not in IFNγR-/- mice, which suggests 
the recruitment of lymphocytes from the blood into the spleen is blocked because of fibrosis 
(Ebrahimi et al., 2001). However, we do not know to what extent this blockage of cell 
recruitment contributes to the cell loss. One possible way of studying the contribution of cell 
recruitment to maintaining the splenic cell numbers during fibrosis may be transplanting 
bone marrow cells from male mice into female mice (both 129Sv and IFNγR-/- mice), then 
detecting the number of Y chromosomes in newly generated lymphocytes within the fibrotic 
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spleen and wild type spleen. By comparing the percentage of Y chromosome positive cells 
within the IFNγR-/- and wild type spleen, one could figure out how many cells are newly 
recruited in the spleen. Also, the percentage of non-Y chromosome-positive leukocytes in 
the blood in the IFNγR-/- and wild type spleen may indicate the female cells which leave the 
spleen and enter the circulation during splenic fibrosis. 
Apoptosis is the most widely recognised mechanism for programmed cell death. However, 
several forms of cell death which are distinct from apoptosis have been identified recently. 
Among them, pryoptosis and autophagy have been associated to chronic infection. Therefore 
it would be very interesting to investigate their potential roles in reducing the number of 
latently infected B cells in the spleen during MHV-68 infection of IFNγR-/- spleen. 
Pryoptosis, also termed Caspase1-dependent cell death, is distinct from apoptosis 
morphologically and mechanistically. Caspase1 (also called IL-1β-converting enzyme) is 
essential for pryoptosis but dispensable to apoptosis (Kuida et al., 1995; Li et al., 1995), 
whereas the apoptosis-associated, caspases such as Caspase 3 and Caspase 8, are not 
involved in pryoptosis (Bergsbaken and Cookson, 2007; Brennan and Cookson, 2000; 
Jesenberger et al., 2000). Also, pryoptosis is suggested to be a conserved process of cell 
death which can be activated by different stimuli through diverted pathways (Fink et al., 
2008). So far, the mechanism of pryoptosis has mostly been demonstrated using a parasite 
infection model in macrophages. Cell death through pryoptosis is characterised by rapid 
plasma-membrane rupture and release of pro-inflammatory intracellular contents, which is in 
contrast to the features of apoptosis, which include condensed cellular contents and non-
inflammatory phagocytes clearing apoptotic bodies (Albert, 2004). Furthermore, DNA 
cleavage, which is considered as the hallmark of apoptotic cell death, also occurs, but is not 
required in cell lysis by pryoptosis (Fink and Cookson, 2006). Interestingly, in MHV-68 
infection, Caspase3-dependent apoptosis and DNA damage (examined by TUNEL) were not 
elevated; however, the number of membrane-compromised cells in IFNγR-/- mice was higher 
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compared to that in wild-type mice (Chapter 4). Moreover, Caspase1 activation during 
pryoptosis also involves the production of inflammatory cytokines IL-1β and IL-18 
(Fantuzzi et al., 1999). Elevated IL-1β is observed in the spleen of IFNγR-/- mice from day 
10 to day 14 post infection (Ebrahimi et al., 2001). Although IL-18 production has never 
been tested, a slight increase in TNFα and TNFβ has also been observed in IFNγR-/- mice 
(Ebrahimi et al., 2001). Consistently, TNF secretion by Caspase1-deficient mice in response 
to pryoptosis stimulation is significantly reduced (Li et al., 1995; Miggin et al., 2007), which 
suggests that Caspase1 activation is also related to the secretion of TNFs. Caspase1, together 
with IL-12 and IL-18, is reported to stimulate Th1 cell proliferation and enhance IFNγ 
production (Fantuzzi and Dinarello, 1999; Nakanishi et al., 2001). However, stimulation of 
Caspase1 has also been reported to promote Th2 response and humoural immunity 
(Eisenbarth et al., 2008; Kool et al., 2008). The regulatory roles of Caspase1 activation in 
both innate and adaptive immunity still need to be elucidated. Interestingly, in IFNγR-/- mice, 
IFNγ production is highly elevated (Dutia et al., 1999; Dutia et al., 1997; Ebrahimi et al., 
2001), suggesting a feedback mechanism in the response of IFNγ receptor deficiency which 
may be regulated by Caspase1-associated cytokines such as IL18. Therefore, pryoptosis can 
be a possible mechanism which results in the significant reduction of B cells during fibrosis 
in MHV-68 infected IFNγR-/- mice. One possible method of investigating pryoptosis would 
be staining for the activated form of Caspase1.  
In cell biology, autophagy is a catabolic process in which the cell degrades its own 
components through the lysosomal machinery. It is a major mechanism by which a starving 
cell reallocates nutrients from unnecessary processes to more essential processes. Autophagy 
has recently been linked to the progression of several diseases, such as cancer and chronic 
infection. For example, autophagy has been shown to play a role in detection of ssRNA 
virus infection in dendritic cells through pattern recognition receptors (PRR), which are part 
of the innate immune system (Lee et al., 2007). Although it used to be considered as another 
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form of programmed cell death in addition to apoptosis, autophagy does not necessarily lead 
to cell death (reviewed in Rubinsztein et al., 2005). Recently, it is more and more seen as a 
survival mechanism rather than a means of cell death. Moreover, autophagy and apoptosis 
appear to have negative regulation of each other (Gordy and He, 2012). Cellular Bcl-2 has 
been demonstrated to not only inhibit apoptosis, but also prevent autophagy through binding 
to Beclin-1 (Sinha et al., 2008). Gammaherpesvirus encoded vBcl-2 also interacts with 
Beclin-1a; moreover, this binding has higher affinity than the interaction with apoptotic 
proteins. It has been hypothesised that vBcl-2 is an antagonist which frees Beclin-1 from 
cellular Bcl-2 (Ku et al., 2008). Moreover, recent study has been performed using mutant 
MHV-68 whose vBcl-2 cannot prevent autophagy but still retains the ability to inhibit 
apoptosis. This virus showed no difference in acute infection and acute latent infection in the 
spleen; however, it exhibited decreased latent viral load during long-term latency around 
days 28 to 42 post infection (E et al., 2009). The same study also demonstrated another 
mutant virus to lack the anti-apoptotic function of vBcl-2 but maintain the anti-autophagy 
function to establish long-term latency as a wild-type virus, but with compromised 
reactivation. Therefore, this suggests that autophagy may play an important role which is 
different from the role of apoptosis in controlling maintenance of MHV-68 latency. In the 
spleen of IFNγR-/- mice infected with MHV-68, the microenvironment of fibrosis may 
possibly lead to cell starvation, and may induce autophagy of spleen cells. Moreover, as an 
anti-viral infection mechanism, the infected cells may also undergo autophagy. However, it 
is not known if the vBcl-2 expression co-relates with the state of the cell which undergoes 
autophagy. Our experiment shows that the expression of vBcl-2 (M11) was very low and 
that there was no up-regulation in IFNγR-/- mice while the significant reduction of B cells 
occurred. Thus, further experiments are needed to examine whether autophagy actually 
contributes to the reduction of B cells.   
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IFNγ response suppresses viral reactivation in macrophages but not B cells following 
intraperitoneal inoculation (Steed et al., 2006). Moreover, in primary bone-marrow derived 
macrophages, IFNγ can inhibit the activity of ORF50 (Rta) promoters through STAT1 and 
subsequently inhibit lytic replication/reactivation (Goodwin et al., 2010). We have ruled out 
the possibility of viral reactivation leading to cell death by measuring the transcription of 
important lytic viral genes, M11, vDNApol, and Rta in spleen tissue. Furthermore, we have 
confirmed that these lytic genes are not up-regulated in ORF-73-expressing infected cells 
(which are mainly B cells).    
 
MHV-68 mediated splenic fibrosis — protective or pathological? 
In IFNγR-/- mice, the immune response is dominated by Th2 cytokines such as IL-4 and IL-
13, both of which have the function of promoting fibrosis. In chronic parasite infection, 
fibrosis acts as a part of the Th2 immune response in isolating the non-self-pathogen. In the 
case of MHV-68 infection, lacking of IFNγ response results in poor control of latently 
infected cells at early stage, followed by high viral load then rapidly decreased, 
corresponding with a drop in the number of spleen cells. Moreover, during the severe 
fibrosis (around day 20 to day28), the viral load and spleen cell number kept dropping  until 
day 28, when they reached the lowest point and the fibrosis started to resolve. Seemingly, 
the pathological changes of fibrosis were accompanied by the control of the number of 
latently infected cells. Using mLANA-MHV-68, we show that germinal centre B cells and 
memory B cells suffered extra cell loss, which is responsible for the removal of latently 
infected cells (Chapter 4). This may suggest that fibrosis which formed around the follicle, is 
a part of Th2-biased immune response, and is the main force of clearing the latently infected 
B cells.  
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Fibrosis is generally considered to be a disordered wound-repair process triggered by tissue 
damage. To understand the nature of fibrosis, one of the important questions addressed is: 
what causes tissue damage during MHV-68 infection in the spleen of IFNγ R-/- mice? 
Generally, there are two existing hypotheses: persistent lytic infection and/or host immune 
response caused tissue damage.  
Persistent viral replication will cause cell death and is believed to be a trigger of splenic 
fibrosis: inhibition of persistent viral replication has been reported to ameliorate MHV-68 
induced pulmonary fibrosis (Mora et al., 2007). Therefore, it seems that the trigger of lung 
fibrosis induced by MHV-68 followed intranasal inoculation is depending on productive 
infection. However, it seems not the case in the spleen fibrosis: inhibition using anti-viral 
drug 4’-S-EtdU which can effectively clear lytic virus but not latent virus from day 6 p.i., 
fails to prevent the pathologies observed on day 15 post infection (Dutia et al., 1997).  
Indeed, the inhibition observed in pulmonary fibrosis may not reflect the changes that may 
happen in the spleen. The lung is the location of primary lytic infection, and the latency and 
reactivation is occurred in epithelial cells. Whereas in the spleen, the latent infection is 
mostly established in B cells, and reactivation is largely from plasma cells. The terminal of 
virus-driven B cell differentiation is either long-term latency in memory B cells or 
reactivation in plasma cells (Ottinger et al., 2009). Normally, plasma cells stay in marginal 
zone of the spleen for a short time before they move into PALS and red pulp where they 
secrete antibody into the blood, which corresponds with the observation of lytic infected 
cells are mostly located in the marginal zone which is around the follicle from day 12 to day 
16 post infection (Ehtisham et al., 1993; Gangadharan, 2006). These findings indicate a link 
between lytic infection and fibrosis.  
However, there is another possibility that the tissue damage is caused by immune responses, 
such as inflammatory infiltration and CTL targeting infected cells. A significantly higher 
rate of neutrophil infiltration was observed in IFNγR-/- mice at the early stage of spleen 
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infection, suggesting an elevated inflammation and exacerbated tissue damage (Ebrahimi et 
al., 2001). Depletion of CD8+ T cells by injecting specific antibodies prevent the occurrence 
of splenic fibrosis in IFNγR-/- mice while there were no enhanced lytic infection detected in 
the spleen on day 17 p.i. (Dutia et al., 1997). This result shows that CD8 T cells are essential 
for the formation of fibrosis. Moreover, Gangadharan has observed infiltration of CD8+ T 
cells at the start of fibrosis but not in advanced fibrosis (Gangadharan, 2006). These 
observations  are consistent with our data using CD3 antibody detecting T cells during 
fibrosis, in which we found T cells leaving PALS and moving into follicles on day 16 and 
hardly saw them in the spleen on day 28. Indeed, the studies on the role of CD8+ T cells 
emphasise that CD8+ T cells are crucial in clearing lytic infection rather than controlling 
latent infection. The depletion of CD8 T cells has to be carried out after the productive 
infection because mice have IFNγ and CTL response double knockout cannot survive (Tsai 
et al., 2011). Further studies are required to dissect the role of CD8 T cells in latent infection 
without the effect from viral replication. Peritoneal inoculation may offer a route of infection 
in which the influences of lytic infection and associated immune responses raised in the lung 
can be avoided.  
Another question to ask is that if the fibrosis specifically targets the latent infection. From 
day 16 to day 28 post infection, all types of cells in the spleen decreased in number, 
including B cells, CD4 T cells, CD8 T cells, dendritic cells and macrophages. Although 
fibrosis formed around the follicles, appearing to be specifically walling off the infected 
cells, as discussed previousely, this special formation may merely be because of the 
biological feature of the spleen. First, reactivation causes tissue damage to occur mostly in 
the marginal zone where fibroblasts from fibroblastic reticular cell network may differentiate 
into myofibroblasts, or the recruited fibrocytes may also contribute. Second, the shape of 
fibrosis observed might be because of the anatomy of the spleen, in which FRC network 
exists in the T cell zone and marginal zone, but not the compact B cell zone. Third, the virus 
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may drive cellular proliferation in order to exploit the germinal centre reaction to increase 
the number of latently infected cells, which would explains why patches of infected cells 
that we observed in in situ hybridisation for vtRNA like molecules were surrounded by 
collagen.   
On the other hand, Clambey et al have shown that IFNγR-/- mice exhibit 50% mortality 
within 100 days post infection (Clambey et al., 2000). Consistently, we have observed 
higher death rate in IFNγR-/- mice than wild type mice between day 80 and day 90 post 
infection (data not shown).  IFNγR-/- mice infected with the virus with interrupted expression 
of M1 protein survived up to 100 days post infection. These mice did not develop pathology 
such as splenomegaly, Vβ4 CD8+ T cell expansion in the periphery and splenic fibrosis 
(Clambey et al., 2000), in which Vβ4 CD8+ T cell expansion is closely related to splenic 
fibrosis (Evans et al., 2008). It has been reported that in IFNγR-/- mice, MHV-68 attack the 
smooth muscle cells in vascular system therefore the mice may die from large-vessel 
panarteritis (Weck et al., 1997), which indicates the death is not simply caused by the 
pathology occurred in the lung and the spleen. These findings suggest that although in short 
term, the viral load is controlled efficiently without IFNγ response, however, splenic fibrosis 
is more pathological rather than protective. Due to the complexity of the host-virus 
interaction, it is very difficult to define the role of fibrosis without the influence from other 
part of the immune system. Thus whether MHV-68 mediated fibrosis is protective or 
pathological to the host is still under debate.   
 
Role of Macrophages in MHV-68 induced fibrosis  
Macrophages have been proved to be a location for persistent infection (Weck et al., 1999). 
Moreover, IFNγ response can inhibit viral reactivation from latency in peritoneal 
macrophages but not B cells (Steed et al., 2007). However, splenic macrophages are only 
infected following intraperitoneal inoculation, and they are not infected in immune-
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competent mice following MHV-68 intranasal infection. The high viral load detected in the 
spleen of IFNγR-/- mice implies a poor control of viral infection which may amplify the 
pathogenesis which is undetectable in normal mice. Hence, we were interested in the state of 
MHV-68 infection in the macrophages in IFNγR-/- spleen.  
Using mLANA recombinant virus, we failed to detect a considerable population of infected 
cells within CD11b+ spleen cells. This is consistent with the work of Marques et al., who 
have shown that infected macrophages and dendritic cells do not express ORF73 (Marques 
et al., 2003). Therefore, mLANA is not suitable as a marker for detecting infected 
macrophages. More recently, infecting mice with a recombinant virus which was labelled at 
another site of the genome showed signal in splenic macrophages following neither 
intranasal nor intraperitoneal inoculation, whereas viral infection was observed in germinal 
centre B cells (Collins and Speck, 2012). This suggests that the failure of detecting infected 
spleen macrophages is not caused by the marker which has been chosen. However, it is also 
possible that the infection of macrophages requires different machinery of the virus 
compared to that of B cells. There are two possible explanations: first, both of the 
recombinant viruses fail to infect macrophages as a wild type virus; second, the conclusion 
of the splenic macrophages is questionable.        
Alternatively activated macrophages used to be considered as ‘pro-fibrotic’, for their ability 
to produce fibrosis mediators such as TGFβ and PDGF and many other regulative functions. 
One of our main goals was to investigate the possible role of macrophages in the splenic 
pathogenesis of MHV-68 infection in IFNγR-/- mice, and we hypothesised that they may 
contribute to the myofibroblast population through differentiation so that they directly 
produce ECM. However, our data show no evidence of macrophages being potential origins 
of myofibroblasts. Therefore it suggests alternative roles of macrophages in Th2 biased 
immune response. On the other hand, it was recently suggested that Arginase-1-expressing 
macrophages suppressed fibrosis by competing with L-arginine which is required to sustain 
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Th2 CD4+ T cell responses (Pesce et al., 2009a). In addition, IL-10 and Fizz1 produced by 
alternatively activated macrophages were also shown to be anti-fibrotic (Pesce et al., 2009b; 
Wilson et al., 2007). Moreover, macrophages have functions of engulfing and digesting 
ECM components, stimulating other inflammatory cells such as myofibroblasts and 
neutrophils to produce MMPs to degrade collagen (reviewed in Murray and Wynn, 2011; 
Wynn, 2008). Interestingly, we have observed macrophages which appear to be ‘engulfing’ 
ECM during the development of fibrosis, which were no longer observed in the most severe 
fibrosis. In addition, these macrophages came back again during the phase of resolution and 
recovery. These findings suggest a role of macrophages in recovery from fibrosis and the 
rebuilding of spleen structure. Therefore the splenic fibrosis mediated by MHV-68 infection 
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The components of a PCR reaction: 
 
Component                                                Amount per reaction (μl added/50μl reaction) 
Distilled water (dH2O)                                                                           40.6  
10× cloned Pfu DNA polymerase reaction buffer                                  5.0  
dNTPs (2mM each dNTP)                                                                       0.4  
DNA template                                                                              50–200ng per reaction 
Primers (100ng/μl)                                                                              1.0 each  
PfuTurbo DNA polymerase (2.5U/μl)                                                    1.0  
 
A PCR reaction was performed as follows: 
1. 95°C for 2 minutes  
2. 95°C for 30 seconds 
3. Anneal temperature (according to primers, normally start with Tm -5°C) for 30 seconds 
4. 72°C extension for 1 minute for targets up to 1kb and 1 minute per kb for targets longer 
than 1kb (30 cycles of step 2 through step 4) 
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5’-AGACGGAAGGGTGCTGAG-3’                       
5’-GGTATGCTTGCTGTGACTG-3’ 
60 
DNA Pol qPCR-For 






















FACS analysis of MHV-68 infection in spleen B-cell subsets. Each panel is 1 example 
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